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The orphan receptor tyrosine kinase gene Anaplastic Lymphoma Kinase (ALK) was initially 
discovered as an oncogene. ALK kinase over-activation has been associated with a variety of 
human cancers, most importantly neuroblastoma. However, little is known about ALK’s 
endogenous function in development. In this thesis, I identified an alk ortholog in zebrafish 
(Danio rerio) and used this model to analyze the embryonic function of alk. Its full length 
sequence, as well as its expression pattern and functions during neurogenesis are described 
and compared with other vertebrate Alk genes. 
Zebrafish alk is highly expressed in the central nervous system (CNS) during embryonic 
development. To investigate alk function, I generated a heat shock inducible transgenic 
zebrafish line. Constitutive overexpression of non-mutated alk in this line resulted in ectopic 
MAPK activation, elevated cell proliferation, disruption of neurogenesis patterns, as well as 
mis-positioning of differentiated neurons. This indicates that alk is capable of controlling cell 
proliferation in the nervous system, similar to the situation in ALK-related cancers. Loss-of-
function of alk by Morpholino knock-down and a small molecule inhibitor compromised 
neuronal differentiation and neuron survival in the CNS, but left neuron progenitor formation 
intact. This suggests that alk is also important for cell differentiation and survival. Together, 
adequate alk expression levels are critical for cell fate decisions during zebrafish embryonic 
neurogenesis. 
The growth factor Midkine has been proposed as a putative ligand for Alk, and cell culture 
studies have suggested that the receptor protein tyrosine phosphatase zeta (RPTPz) is a 
negative regulator for Alk activity. Here, the expression pattern of the rptpz ortholog in 
zebrafish is studied and possible interrelationships between Midkine, RPTPz and Alk in 
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1.1. Anaplastic lymphoma kinase (ALK) as a human oncogene 
1.1.1. The discovery of ALK and oncogenic ALK fusion proteins 
Anaplastic lymphoma kinase (ALK) was initially discovered as an oncogene in human 
anaplastic large cell lymphomas (ALCL), a subset of T-cell non-Hodgkin lymphomas. In the 
late 1980s, the t(2;5)(p23;q35) chromosomal translocation was described to be linked with 
ALCL pathogenesis (Benz-Lemoine et al., 1988; Fischer et al., 1988). Further genetic 
dissection revealed an oncogenic fusion product (NPM-ALK, also known as p80) at the 
chromosomal breakpoint, comprising a fusion of a nucleolar protein gene nucleophosmin 
(NPM) and a part of a tyrosine kinase gene. This tyrosine kinase was subsequently cloned in 
full length and named anaplastic lymphoma kinase (ALK) (Morris et al., 1994 and 1997; 
Iwahara et al., 1997). WT ALK encodes a 1620 amino acids (aa) long, 177 kDa single chain 
transmembrane protein. It belongs to the receptor tyrosine kinase superfamily. Receptor 
tyrosine kinases (RTKs) are transmembrane signal transduction proteins that control 
fundamental cellular processes, such as cell cycle, migration, survival, proliferation and 
differentiation (reviewed by Schlessinger, 2000). Examples for prominent RTKs include the 
epidermal growth factor receptor (EGFR, also known as ErbB), fibroblast growth factor 
receptor (FGFR), vascular endothelial growth factor receptor (VEGFR), and insulin receptor 
(IR). 
 
In common with other RTKs, ALK includes an extracellular ligand binding region, a 
transmembrane domain and an intracellular kinase catalytic region (Pulford et al., 2004). It 
shares homology with leukocyte tyrosine kinase (LTK), placing both in the insulin receptor 
family. The 1030 aa extracellular region of ALK contains an LDL-A domain, two MAM 
domains and a glycine-rich region. In a 254 aa tyrosine kinase catalytic domain (1122-1376) 
in ALK intracellular region, paired tyrosine residues (Y1282 and Y1283) are present, which 
are characteristic of the major autophosphorylation sites of the insulin receptor family 
(Pulford et al., 2004). 
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More recently another fusion of ALK caused by translocation with the gene encoding 
echinoderm microtubule-associated protein-like4, leading to EML4-ALK, was reported to be 
the pathogenic cause for non-small-cell lung cancers (NSCLCs) (Soda et al., 2007). Up to 
date, several more ALK fusions with other gene products have been identified in various 
cancer types, such as TRK-fused gene (TFG)-ALK, tropomyosin 3 (TPM3)-ALK, 
tropomyosin 4 (TPM4)-ALK, clathrin heavy chain-like 1 (CLTCL1)-ALK, and moesin 
(MSN)-ALK (reviewed by Chiarle et al., 2008). In most of the resulting oncogenic ALK 
fusion products, same as in NPM-ALK, the ALK tyrosine kinase part is fused with proteins 
having oligomerization domains, which lead to fusion partner stabilized spontaneous 
dimerization and constitutive autophosphorylation, hence activation of ALK tyrosine kinase. 
 
1.1.2. ALK mutations in neuroblastoma 
Endogenous ALK is expressed in neural tissue, and overexpression of ALK is often observed 
in neural tumors such as retinoblastoma, neuroblastoma and glioblastoma (Dirks et al., 2002). 
Neuroblastoma is an embryonic tumor of the peripheral sympathetic nervous system mostly 
derived from neural crest tissues. It is one of the most frequent pediatric solid tumors, 
accounting for about 15% of childhood cancer mortality (Maris et al., 2007). Previous clinical 
research had linked its pathogenesis to a genetic alteration of chromosome band 2p23-24, 
where the well-known neuroblastoma oncogene MYCN is located. Through high resolution 
single nucleotide polymorphism (SNP) genotypic scans on this block, another signal peak was 
recently noticed at the locus of the ALK kinase domain (Chen, et al., 2008; Mosse et al., 2008). 
At least ten ALK mutations, all found in its tyrosine kinase domain were correlated with the 
neuroblastoma samples. Among these, R1275Q, F1174L and F1245L/V/C occurred most 
frequently. F1174 is located in the C-helix of ALK tyrosine kinase domain, similarly F1245 
in its catalytic loop, while R1275 in its activation segment (Mosse et al., 2008). Increase in 
copy number and gene amplification was also often detected at the ALK locus in 
neuroblastoma patients (Chen, et al., 2008; Janoueix-Lerosey et al., 2008). These germ line 
mutations in ALK explain most inheritable neuroblastomas, but activating mutations can also 
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be somatically acquired. These mutations lead to constitutive autophosphorylation of mutated 
ALK, which displays increased kinase activity and excess phosphorylation on downstream 
targets like Akt, STAT3 and ERK1/2 (Chen, et al. 2008; George et al., 2008). Mutated ALK 
from neuroblastoma samples is capable of transforming interleukin-3-dependent 
haematopoietic Ba/F3 cells into cytokine-independent growth (George et al., 2008), as well as 
NIH3T3 fibroblasts into colony and tumors in nude mice (Chen, et al. 2008). Knock-down of 
ALK by siRNA (Chen, et al.; 2008; Mosse et al., 2008), or ALK inhibition by small molecules 
PF-2341066 (Janoueix-Lerosey et al., 2008) and TAE684 (George et al., 2008) leads to 
suppressed cell growth, with decreased proliferation and increased apoptosis in 
neuroblastoma cells harboring mutated or amplified ALK.  
 
These studies established a strong correlation of ALK deregulation with neuroblastoma 
development. It suggests that during normal situation, suitable ALK gene expression level and 
its protein integrity are crucial for cell proliferation and survival in neural tissues. The 
endogenous Alk expression in vertebrate developing nervous system also indicates such an 
idea (See in 1.2.). 
 
1.1.3. ALK downstream signaling pathways 
Deregulation of ALK kinase activity has been implicated in oncogenesis and can be caused by 
point mutations, gene amplification or fusions to other genes, such as NPM. To date, the 
knowledge about ALK downstream signaling is mostly obtained from carcinoma samples, or 
experiments utilizing oncogenic versions of mutated ALK in cell culture. Extensive analysis 
of the NPM-ALK pathogenesis have elucidated the complicated cellular signaling networks, 
which are mostly in common with other ALK-related cancers including neuroblastoma 
(reviewed by Chiarle et al., 2008; Palmer et al., 2009). Of particular importance, three major 




MAPK pathway: ALK activates the Ras-MAPK pathway, which is essential for elevated 
proliferation (Pulford et al., 2004), most probably through phosphorylation of ERK1 
(extracellular signal-regulated kinase 1, also known as MAPK3) and ERK2 (MAPK1) 
(Marzec et al., 2007). In NPM-ALK transformed NIH 3T3 cells, a direct physical interaction 
of the ALK kinase domain with and phosphorylation of SHC, IRS1 and GRB2 has been 
shown. Those are common adaptor proteins in Ras-MAPK activation (Fujimoto et al., 1996). 
Consequently, a promoted cell cycle progression and accelerated entry into S-phase is 
accomplished by upregulation of G1 cyclins such as cyclin A (CCNA) and cyclin D1 (CCND1) 
transcriptions (Wellmann et al., 1997). 
 
PI3K-Akt and JAK-STAT pathways: On the other hand, the phosphatidylinositol 3-kinase 
(PI3K)-Akt pathway and Janus kinase 3 (JAK3)-signal transducer and activator of 
transcription 3 (STAT3) pathway are vital for, but not limited to, cell survival and phenotypic 
changes. Inhibition of PI3K results in apoptosis of NPM-ALK transformed or ALCL cell lines. 
NPM-ALK recruits the SH2 domain of the PI3K p85 subunit, leading to phosphorylation of 
PKB/Akt (Bai et al., 2000; Slupianek et al., 2001). Activated PKB/Akt phosphorylates 
downstream FOXO3a, which subsequently down-regulates transcription of apoptosis 
promoting genes p27 and BIM, as well as up-regulates expression of cyclin D2 that promotes 
cell cycle progression (Gu et al., 2004). NPM-ALK mediated STAT3 activation provides 
survival signals mainly by enhancing expression of anti-apoptotic protein Bcl-XL (Zamo et al., 
2002; Coluccia et al., 2004). Indeed, gene-targeting of STAT3 in a NPM-ALK transgenic 
mouse model showed that STAT3 is required for cell growth and survival in lymphomagenesis 
in vivo (Chiarle et al., 2005). 
 
In vitro studies in cell culture by chimeric ALK indicated that both MAPK and PI3K 
pathways are involved in neuronal differentiation (Souttou et al., 2001; Piccinini et al., 2002). 
A constitutively active chimeric protein IgG-Fc-ALK, where the Alk extracellular region was 
substituted by the mouse IgG-Fc domain that induces its dimerization, is capable of inducing 
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neuronal differentiation in PC12 cells. This could be abolished by blocking MAPK/ERK 
kinase activity (Souttou et al., 2001). Similar experiment replacing ALK extracellular part 
with that of epidermal growth factor receptor (EGFR) proposed that the phosphorylated 
chimeric EGFR-ALK leads to activation of PI3K, and transformation of NIH 3T3 cells in an 
EGF-dependent manner (Piccinini et al., 2002). 
 
1.1.4. Pharmaceutical inhibitors of ALK and therapeutic approaches 
Pharmaceutical endeavors have been employed to search for treatments of NPM-ALK related 
lymphoma, and been expanded to other ALK related cancer types especially neuroblastoma. 
With increasingly important biomedical relevance, ALK has become very attractive for 
researchers and is considered as a novel target for cancer therapies by small molecule 
inhibitors. Efforts from major pharmaceutical companies and research institutes have lead to 
the development of several promising pro-drugs that are presently in different phases of 
clinical trials (Grande et al., 2011; Carpenter and Mosse, 2012).  
 
The inhibitor NVP-TAE684 was developed by Novartis and is a 5-chloro-2,4-
diaminophenylpyrimidine targeting the NPM-ALK ATP-binding pocket (Galkin et al., 2007). 
TAE684 has been shown to induce cell cycle arrest and apoptosis in ALCL patient cells and 
NPM-ALK expressing BaF3 cells, as well as suppressing lymphomagenesis in mouse models 
in vivo (Galkin et al., 2007). In a systematic test of 602 cell lines derived from a variety of 
human cancers, TAE684 selectively inhibited growth in a small subset of tumor cells, with 
suppression of Akt and ERK1/2 phosphorylation and initiation of apoptotic response 
(McDermott et al., 2008). This subset includes NPM-ALK positive ALCL, NSCLC harboring 
EML4-ALK, and neuroblastoma cells with ALK gene amplification. They are all correlated 
with ALK genetic rearrangements. 
 
Cephalon Inc. has also developed several pyrrolocarbazole (FP)-derived ALK inhibitory 
compounds. CEP-11988, CEP-14083, and CEP-14153 were shown to inhibit interleukin 3 
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(IL-3) - independent proliferation of BaF3 cells expressing NPM-ALK, as well as to block 
proliferation and survival of ALCL derived cell lines (Wan et al., 2006). Later, CEP-28122 
was reported as a highly potent and selective ALK phosphorylation inhibitor leading to 
growth inhibition of ALK positive ALCL, NSCLC and neuroblastoma cells by caspase 3/7 
activation and apoptosis (Cheng et al., 2012). This inhibitor also showed an orally active 
antitumor activity against xenografts in mice, for more than 12 hours inhibition following a 
single intake (Cheng et al., 2012). 
 
Crizotinib (also known as Xalkori or PF-2341066) developed by Pfizer Inc. is the most 
advanced and so far only FDA approved ALK inhibitor for treatment of non-small-cell lung 
cancers (NSCLCs) (Forde and Rudin, 2012). It is an ATP competitor with dual inhibitory 
activities for c-Met and ALK, and is orally bioavailable with cytoreductive antitumor efficacy 
(Zou et al., 2007). It provides significant benefit for patients with ALK positive NSCLC, 
although some patients developed resistance to Crizotinib in their CNS cancer progressions 
for unclear reasons (Camidge and Doebele, 2012; Forde and Rudin, 2012). 
 
Some common features of these developed ALK inhibitors include: capable of selectively 
inhibiting ALK kinase activity with minimum side effect on other RTKs; suppression of Akt, 
STAT and ERK1/2 phosphorylation and inactivation of corresponding signaling pathways; 
often leading to G1 cell cycle arrest; and blocking of proliferation and survival in cancer cells. 
 
1.2. Endogenous functions of non-mutated Alk analyzed in animal models 
In contrast to the wealth of information available for ALK function in human cancers, only 
very little is known about the endogenous normal function of Alk in animals. Most 
importantly, loss-of-function studies for Alk are very rare so far. At present, it is known that 
endogenous Alk expression is found in the nervous system, suggesting possibly important 




1.2.1. Studies on murine Alk 
Non-mutated mouse Alk is highly expressed in the embryonic central nervous system (CNS) 
and peripheral nervous system (PNS) (Iwahara et al., 1997). Studies analyzing mouse Alk 
RNA and protein distribution, showed that Alk is strongly expressed in the diencephalon, 
ventral part of the fourth ventricle neuroepithelium from day 10.5 to 14.5, and slightly later in 
ventricular and subventricular zones of the cortex, midbrain, medulla oblongata and spinal 
cord from day 12.5 (Vernersson et al., 2006). Besides the CNS, Alk is also expressed in the 
developing PNS, including the trigeminal ganglion and nerve, facial ganglion, 
vestibulocochlear ganglion, inferior ganglion of vagus nerve and dorsal root ganglion. In 
other tissues, mouse Alk is expressed in eyes, nasal epithelium, olfactory nerve, tongue, skin, 
stomach and midgut but not hindgut, as well as testis and ovary. Similar expression in the 
developing dorsal root ganglia was also reported in rat (Degoutin et al., 2009). 
 
Alk knockout (KO) mice first generated by the Morris group were stated as viable with a 
normal life span and no gross morphological alterations (Pulford et al., 2004). This was 
independently confirmed by the Palmer and Hallberg groups (unpublished data, mentioned in 
a review by Palmer et al., 2009). A third group independently generated Alk KO mice and 
reported that these animals displayed an age-dependent increase of hippocampal progenitor 
proliferation in adults, altered behavior performances in hippocampal-associated tests, as well 
as increased basal dopaminergic neurochemistry levels selectively in the frontal cortex 
(Bilsland et al., 2008). The observed high level of Alk expression in the developing nervous 
system but generally normal embryogenesis in the knockout mice suggest possible functional 
redundancy of murine Alk by other receptor tyrosine kinases during embryonic neurogenesis. 
 
1.2.2. Chick Alk 
Similar to the situation in mouse, endogenous Alk in chick is also expressed in a subset of 
motor neurons in the developing spinal cord. Its expression coincides with the period of 
programed cell death of spinal motor neurons and muscular synapse formation (Hurley et al., 
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2006). This opens the possibility that neurotrophic factors may mediate the survival of motor 
neurons via Alk. 
 
In the chick PNS, Alk is expressed in sympathetic ganglia (SG) and dorsal root ganglia (DRG) 
as early as stage 19 (Hurley et al., 2006). In DRG, Alk is expressed in mitotically active 
progenitor cells that are immunoreactive for phospho-H3, having no overlap with postmitotic 
neuronal markers Tuj1 or Isl1. In contrast to this, in SG Alk positive cells include both 
mitotically active and postmitotic cells. In another study using primary sympathetic neuron 
cultures from embryonic chick SG, Alk kinase inhibition by NVP-TAE684 or knockdown by 
shRNA lead to reduced proliferation of the cultivated cells (Reiff et al., 2011). On the other 
hand, forced overexpression of human WT ALK or constitutively active mutant ALK both 
caused increased proliferation (Reiff et al., 2011). 
 
1.2.3. Zebrafish Leukocyte tyrosine kinase (Ltk) 
The zebrafish anaplastic lymphoma kinase (alk) ortholog has not been studied so far. 
However, a highly related co-ortholog to ALK, leukocyte tyrosine kinase (LTK), has been 
identified in the zebrafish shady mutant (Lopes et al., 2008). In mammal, LTK (864 aa in 
human) is expressed in haematopoietic cells with unspecified functions (Ben-Neriah and 
Bauskin, 1988). Identified in a large scale mutagenesis screen, the zebrafish shady mutant 
lacks iridophores, which are mirror-like pigment cells that give fish a silver shining. The 
iridophore-less phenotype resembles that of colorless mutants with deficiencies in sox10, 
which is a key gene important for neural crest cell (NCC) development and migration. 
Positional cloning revealed early-stop mutations in the shady mutant ltk locus (Lopes et al., 
2008). Zebrafish ltk, expressed in NCCs and iridophores, encodes a 1530 aa long receptor 
tyrosine kinase, which is much longer in its extracellular region than mammalian Ltk. In 
shady mutants, some NCCs are lost by apoptosis, whereas other NCCs derivatives are not 
affected, including melanophores and xanthophores. These findings suggest that zebrafish ltk 
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functions in fate specification in a subset of NCCs derived from the multipotent premigratory 
NCCs (Lopes et al., 2008). 
 
Another important clue from this study is the sequence relationship between Alk and Ltk. In 
mammals, ALK and LTK can be clearly distinguished by their extracellular parts, in length 
(1030 aa versus 424 aa) and the presence or absence of MAM domains, respectively. A 
phylogenetic analysis by Lopes and colleagues (2008) pointed out that the MAM domain in 
their extracellular parts is a feature of a common Alk/Ltk ancestor, and has been retained in 
zebrafish Ltk and chick Ltk (Lopes et al., 2008). These authors suggested that vertebrate Alk 
and Ltk arose from an ancestral gene that also gave rise to fruit fly Alk/Ltk and C. elegans 
SCD-2 (also known as T10H9.2) genes, which later was duplicated in the vertebrate lineage. 
Importantly, another gene exists in the zebrafish genome. This second gene has higher 
homology to ALK and will be investigated in this thesis. 
 
1.2.4. Fruit fly Alk/Ltk 
The in vivo physiological functions of fruit fly (Drosophila melanogaster) endogenous Alk 
and its ligand Jelly belly (Jeb) have been thoroughly studied (Englund et al., 2003; Lee et al., 
2003; Loren et al., 2003; Bazigou et al., 2007; Cheng et al., 2011). The fruit fly Alk gene 
shares high homology with vertebrate Alk and Ltk, and is expressed in the developing CNS 
and other tissues (Loren et al., 2001). Its ligand Jeb is a secreted protein containing an LDL 
receptor repeat (Weiss et al., 2001). Jeb and Alk are both expressed in the developing visceral 
mesoderm, where they coincide with activated ERK. Mutants for Jeb or Alk show identical 
phenotypes and die as larvae without gut (Loren et al., 2003; Englund et al., 2003; Lee et al., 
2003). Localized Jeb binding to Alk is sufficient to stimulate an Alk-mediated ERK 
phosphorylation and expression of the downstream gene duf, which is required for 
specification of gut muscular founder cells and muscle fusion. Further studies revealed that 
Alk activation is also required for decapentaplegic (Dpp) expression and downstream Mad 
pathway activation between the visceral muscle and the endoderm in gut development, as 
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well as expression of the bHLH transcription factor Hand (Varshney and Palmer, 2006; 
Shirinian et al., 2007). 
 
In addition to gut development, Jeb-Alk signaling also plays a central role in the fly visual 
system (Bazigou et al., 2007). In the developing eye, Alk is expressed in neurons in the optic 
lobe, while Jeb is primarily produced by photoreceptor axons that target these neurons. Jeb-
Alk signaling affects target selection of R1-R6 axons in the lamina and R8 axons in the 
medulla. Impaired Jeb-Alk signaling compromises the expression of guidance factors and 
axon targeting errors (Bazigou et al., 2007). Moreover, in the fly CNS, Alk is reported as an 
efficient protector of neural progenitors (neuroblasts) during nutrient restriction (Cheng et al., 
2011). Alk also activates and maintains PI3K signaling in neuroblasts and protects their 
growth during nutrient restriction, as Jeb is constantly expressed from the surrounding glia 
cells (Cheng et al., 2011). Those well characterized studies demonstrate that the same Jeb-
activated Alk signaling pathway is used for several aspects of embryo development however 
may function through various cellular signaling pathways (ERK or PI3K) in different contexts. 
 
1.3. Factors potentially regulating ALK activity 
1.3.1. Midkine growth factors as putative Alk ligands 
Noteworthy, a Jeb-like protein has not been identified in any vertebrate genome and appears 
to be an invertebrate specific gene. Instead, Midkine (MDK) and Pleiotrophin (PTN) have 
been proposed to bind and activate ALK in cell culture (Stoica et al., 2001 and 2002). 
However, so far there is no in vivo evidence for any direct MDK/PTN-ALK interaction, 
leaving ALK as an orphan receptor in vertebrates. 
 
Murine Mdk (also called retinoic acid-inducible heparin binding protein, RIHB) was initially 
identified in a screen for retinoic acid responsive genes in differentiating embryonic 
carcinoma cells (Kadomatsu et al., 1988), while Ptn (also called heparin binding growth-
associated molecule, HB-GAM) was found as a neurite outgrowth promoting factor for 
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primary cultured neurons, and a mitogenic factor for fibroblasts, respectively (Li et al., 1990). 
These two heparin-binding secreted growth factors form a small family, with a size of 13kDa 
that is rich in basic amino acids and cysteine residues. Various biological activities of Mdk 
and Ptn have been reported (reviewed by Muramatsu, 2002; Kadomatsu and Muramatsu, 
2004). These include anti-apoptotic, angiogenic and neurite outgrowth promoting activity in 
different cell types, stimulation of cell migration, as well as wound healing and tissue repair 
enhancement. The strong expression of murine Mdk and Ptn in embryonic brain and spinal 
cord, as well as in the adult brain, suggest important roles during normal neurogenesis 
(Matsumoto et al., 1994; Fan et al., 2000). The details of these roles remain unknown as the 
corresponding knock-out mice have no obvious early neural phenotype (Nakamura et al., 
1998; Amet et al., 2001). Therefore, functional redundancy of Mdk and Ptn has been 
proposed and consistent with this, double knock-out mice are early embryonic lethal 
(Muramatsu, 2002). Interestingly, the expression of MDK and PTN is also found to be 
frequently up-regulated in various human tumors (reviewed by Muramatsu, 2002; Kadomatsu 
and Muramatsu, 2004) including neuroblastoma (Nakagawara et al., 1995). The MDK level in 
plasma from human neuroblastoma patients is significantly increased and makes MDK a 
promising prognostic marker for neuroblastoma (Ikematsu et al., 2008).  
 
In zebrafish, a teleost specific whole genome duplication resulted in two midkine genes, mdka 
and mdkb, as well as one ptn gene (Winkler et al., 2003), which show mostly non-overlapping 
expression patterns during embryogenesis. mdka is required for spinal cord floor plate 
formation (Schafer et al., 2005), while mdkb regulates specification of neural crest and 
sensory neuron cells (Liedtke and Winkler, 2008). The role of zebrafish ptn remains to be 
analyzed. 
 
Noteworthy, ALK is not the only putative MDK receptor. Receptor protein tyrosine 
phosphatase zeta (RPTPz) (Maeda et al., 1999), and LDL receptor-related protein (LRP) 
(Muramatsu et al., 2000) have also been considered as potential MDK receptor candidates. 
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1.3.2. Receptor protein tyrosine phosphatase zeta (RPTPz) as a negative regulator of Alk 
Receptor protein tyrosine phosphatase zeta (RPTPz) binds to PTN and regulates neuronal cell 
growth in culture (Maeda et al., 1996 and 1998). Later, it was reported that RPTPz also binds 
to MDK (Maeda et al., 1999). Although there are several reports suggesting that both ALK 
and RPTPz could be physiological receptors for MDK and PTN, a recent model furthermore 
proposed that ALK signaling is negatively regulated by RPTPz and is only indirectly 
activated by PTN (Fig. 1; Perez-Pinera et al., 2007). In this model, ALK is activated by 
autophosphorylation after dimerization, whereas RPTPz dephosphorylates and thus inhibits 
ALK. When RPTPz is inactivated by binding to its ligand PTN, autophosphorylated ALK can 
no longer be dephosphorylated by RPTPz, remains activated and induces downstream 
signaling pathways including PI3K, MAPK and STAT3/5. However importantly, this model 
is solely based on in vitro experiments and cell cultures. Whether such an indirect activation 
model is also true in vivo during normal development need to be confirmed. 
 
Receptor protein tyrosine phosphatases are a large family of cell surface proteins which 
usually exist as several alternatively spliced isoforms. RPTPz is reported to have at least three 
main isoforms in mammals: a full length form, a shortened variant lacking part of the 
 
Fig. 1. A possible model of MDK/PTN, ALK and RPTPz interaction and activation. 
(A) ALK is autophosphorylated and activated by dimerization. (B) RPTPz dephosphorylates 
ALK, preventing it from dimerization and activation. (C) When the ligand MDK or PTN binds 
to RPTPz and promotes its dimerization, RPTPz phosphatase activity is inhibited. 
Autophosphorylated ALK can no longer be dephosphorylated by RPTPz, thus remains 
activated. Dashed arrows indicate possible direct binding of MDK/PTN. 
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extracellular spacer domain, and a secreted variant without the cytoplasmic domain (Canoll et 
al., 1996). Multiple RPTPz isoforms are expressed in the Xenopus central nervous system 
(Nagata et al., 2001). Chick RPTPz is reported to be expressed in astrocyte progenitors in the 
developing spinal cord ventricular zone (Ivanova et al., 2004). Rat RPTPz is observed mainly 
on the membrane of migrating neurons and radial glia in vivo, and neurons and astrocytes 
cultured from cerebral, hippocampal, and cerebellar regions (Hayashi et al., 2005). Despite 
abundant expression in the CNS, RPTPz knock-out mice surprisingly show no obvious 
abnormality (Harroch et al., 2000). A more detailed examination, however, revealed that in 
the retina of RPTPz knock-out mice, Müller glia cells are selectively reduced and the 
morphology of their radial processes is disturbed (Horvat-Bröcker et al., 2008).  
 
The endogenous expressions of Midkine, ALK and RPTPz in the vertebrate developing 
nervous system point out possibilities of important functions during normal embryonic 
neurogenesis. However, none of these normal functions has been well studied. Furthermore, 
both Midkine and ALK mis-functions are involved in the development of neuroblastoma, 
suggesting their roles in controlling cell proliferation and survival in neural tissues.  
 
1.4. Vertebrate embryonic neurogenesis 
1.4.1. Structures of the early vertebrate central nervous system  
The early developing central nervous system (CNS) of vertebrates is a tube-like rudiment 
called “neural tube”. It is segmented with about ten neuromeres, and can be divided into three 
portions: the forebrain (prosencephalon), the midbrain (mesencephalon), and the hindbrain 
(rhombencephalon) (Fig. 2) (Kimmel et al., 1995; Gillbert, 2006). The forebrain contains the 
more dorsally located telencephalon, which forms olfactory lobes, hippocampus and 
cerebrum, and the more ventral diencephalon, which gives rise to epithalamus, thalamus and 
hypothalamus. The midbrain forms the optic lobes and tectum. The hindbrain consists of 
seven similarly sized rhombomeres (r1-r7). A part of the first rhombomere (r1) gives rise to 
the cerebellum, while the rest of the hindbrain forms medulla, and the caudalmost hindbrain 
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(chb), also known as r8 (Chandrasekhar et al., 1997; Chandrasekhar, 2004), which is 
connected to the spinal cord. In zebrafish, the otic vesicles, which form most of the inner ear 
structures in future, are located at both sides of r5, with their anterior quarters at r4 and 
posterior quarters at r6 (Whitfield et al., 2002; Nicolson, 2005).  
 
 
1.4.2. Cell proliferation and differentiation in the developing CNS 
In the vertebrate developing CNS, neurons are generated in two ways: First, proliferative 
progenitor divisions are used to expend the progenitor pool and then neurons are generated by 
terminal divisions. Secondly, asymmetric divisions happen where one daughter cell 
repeatedly self-renews as progenitor and the other cell differentiates into a neuron. In the 
zebrafish neural tube, when asymmetric divisions occur, neurons always derive from the more 
apical daughter, whereas the more basal daughter renews the progenitor pool (Alexandre et al., 
2010). This process is mediated by unevenly expressed delta in different daughter cells, 
which is a Notch ligand (Dong et al., 2012). 
 
When neural precursor cells undergo neuronal differentiation, a class of cell surface protein 
Delta is expressed, which binds to and activates the transmembrane protein Notch on the 
neighboring progenitor cells. In a Notch activated cell, transcription of HES genes is switched 
on, which encode a group of basic helix-loop-helix (bHLH) transcriptional repressors. In such 
a way, through juxtaposed cell-to-cell Delta-Notch signaling, lateral inhibition occurs on 
adjacent cells and prevents all cells from differentiating at the same time (reviewed by 
 
Fig. 2. Schematic structures of the early developing vertebrate brain. 
Lateral view of zebrafish brain structures at 24 hours post fertilization (hpf). T,  
telencephalon; D, diencephalon; M, mesencephalon; C, cerebellum; r, rhombomere; chb, 
caudal hindbrain; sc, spinal cord; ov, otic vesicle. Anterior is to the left. 
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Kageyama and Ohtsuka, 1999; Bertrand et al., 2002; Kageyama et al., 2005 and 2008). 
Zebrafish deltaA is expressed in neural precursor cells and excluded from differentiated 
neurons (Haddon et al., 1998; Tallafuss et al., 2009). Functionally, deltaA is important for 
neuron specification (Appel and Eisen, 1998; Mahler et al., 2010).  
 
1.4.3. Basic helix-loop-helix (bHLH) transcription factors in neurogenesis 
HES genes, the mammalian orthologs of the Drosophila Hairy/Enhancer-of-split gene (HES), 
are direct targets of and activated by Notch signaling. Mammalian Hes1, Hes3 and Hes5 are 
highly expressed by neural progenitors in the developing CNS and functionally antagonize 
proneural gene activities (Kageyama et al., 1997; Kageyama and Ohtsuka, 1999). 
Overexpression of HES genes often leads to neurogenesis inhibition and neural stem cell 
maintenance, while inactivation of HES genes results in neurogenesis acceleration and 
premature depletion of neural stem cells (reviewed by Kageyama et al., 2008). The zebrafish 
Hes1 ortholog, her6 is segmentally expressed in the hindbrain and somites during early 
development (Pasini et al., 2001). It is reported that her6 determines neuron identities in the 
zebrafish thalamus (Scholpp et al., 2009).  
 
Activator-type bHLH proteins are encoded by proneural genes. The first proneural genes 
identified were Drosophila achaete-scute complex (asc) and atonal (ato), which are necessary 
and sufficient to initiate neuronal lineage commitment (determination) and differentiation 
from the ectoderm (reviewed by Bertrand et al., 2002; Kageyama et al., 2005). Many 
homologous proneural genes have been identified in vertebrates. The achaete-scute homolog 
family includes: Mash1 and Mash2 in mammals, Cash1 and Cash4 in chick, Xash1 and Xash3 
in Xenopus, as well as Zash1a and Zash1b in zebrafish. atonal-related genes in vertebrates are 
much larger in number and can be grouped as the Atonal family (Math1 and Math5), the 
NeuroD family (Math2, Math3, NeuroD and NeuroD2), and the Neurogenin family (Ngn1, 
Ngn2 and Ngn3) (Guillemot, 1999; Bertrand et al., 2002). Common functions of proneural 
genes include the capacity of promoting neuronal cell fate determination, specifying neuronal 
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subtypes, inducing Notch ligand expression, forcing cell cycle exit, and enhancing neuron 
survival (Guillemot, 1999; Diez del Corral and Storey, 2001; Bertrand et al., 2002; 
Schuurmans and Guillemot, 2002; Ohnuma and Harris, 2003; Ross et al., 2003; Kageyama et 
al., 2005). Functional redundancy of proneural genes for neuronal determination has been 
proposed, and confirmed as the double mutants suffer from impaired neurogenesis and  more 
severe neuron loss than any of the single mutants of  Mash1, Ngn, or Math3 (Casarosa et al., 
1999; Fode et al., 2000; Tomita et al., 2000; Nieto et al., 2001). 
 
There are ambiguous descriptions regarding the properties of cells expressing proneural genes. 
One idea considers them as “transit amplifying cells” that undergo limited rounds of division 
before entering terminal differentiation, in contrast to neural stem cells (Doetsch et al., 2002), 
or as “secondary precursors” with transient proliferation, but being molecularly distinct from 
stem cells (Torii et al., 1999). Another explanation is inspired from the observations that Hes1 
and genes with opposite functions, such as Ngn2 and Dll1 (Delta-like1) are all expressed in an 
oscillatory fashion in neural progenitors. Conditions that induce neuronal differentiation lead 
to the downregulation of Hes1 and sustained up-regulation of Ngn2 and Dll1, which 
ultimately commits cells into differentiation (Shimojo et al., 2008). 
 
Zebrafish has two homologs of mammalian Mash1, namely ascl1a (also called Zash1a) and 
ascl1b (Zash1b), as well as one Math3 homolog neurod4 (also called Zath3) and one Ngn1 
homolog ngn1. Their expression patterns have been described previously (Allende and 
Weinberg, 1994; Korzh et al., 1998; Wang et al., 2003). In hindbrain, their expression is 
segmentally arranged in regions close to rhombomere boundaries, which are most active in 
neurogenesis. In addition, observations of their impaired expression in zebrafish neurogenesis 
mutants, such as acerebellar, no isthmus, spiel-ohne-grensen, cyclops, and mindbomb indicate 
that they are involved in embryonic neurogenesis (Allende and Weinberg, 1994; Wang et al., 
2003; Park et al., 2003). However, how and by which genes their expression and function are 
precisely regulated is unclear.  
17 
 
1.5. Aims of the project 
Despite a wealth of data obtained from ALK gain-of-function studies in human cancers and 
mammalian cell cultures, the endogenous role of ALK during normal development remains 
poorly understood. Furthermore, the physiological ligand(s) for ALK during vertebrate 
embryonic development is/are unknown at the moment, except for in vitro data that suggest 
Midkine growth factors as possible ligands. 
 
Therefore, the first objective of this study was to obtain the full-length alk cDNA sequence 
from zebrafish in order to allow functional studies to address the role of Alk during 
development of the nervous system. This gene sequence was compared with other known 
vertebrate Alk sequences as well as fruit fly Alk and zebrafish ltk. The temporal profile and 
spatial pattern of zebrafish alk expression were analyzed by RT-PCR and whole mount in situ 
hybridization. 
 
In order to analyze overexpression phenotypes in this fish model, the next goal was to 
establish transgenic zebrafish that conditionally overexpress alk under the control of a heat 
shock inducible promoter, as well as a control line. A constitutively active promoter was not 
used since continuously elevated Alk activity is known to pose a high risk of oncogenesis, 
likely leading to early lethality in the analyzed transgenic fish. Overexpression experiments 
using these zebrafish lines were conducted and morphological changes were investigated at 
the molecular and cellular level, i.e. by analyzing intracellular signaling pathways, cell cycle, 
cell proliferation and differentiation in Alk overexpressing embryos. 
 
Moreover, in order to study the endogenous roles of zebrafish alk during normal development, 
loss-of-function studies were performed using several independent approaches: Morpholino 
antisense oligonucleotide mediated gene knock-down, Alk kinase inhibition by a small 
molecule, and expression of a putative dominant-negative form of alk. The alk knock-down 
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phenotypes were compared with phenotypes obtained in zebrafish after knock-down of the 
putative Alk ligand midkine. 
 
Finally, the expression pattern of zebrafish rptpz was analyzed and compared to the 
expression of alk. This is the first report on studying the endogenous role of Alk during CNS 




2. MATERIALS AND METHODS 
2.1. Materials 
2.1.1. Zebrafish strains and husbandry 
Wild type AB strain zebrafish were adopted from Temasek Lifescience Laboratories and 
maintained in the fish facility of the Department of Biological Sciences (DBS). The AB strain 
was exclusively used for gene cloning and transgenic fish generation. Another wild type 
zebrafish strain (DBSWT) inbred for several generations at DBS was additionally used in 
some experiments, and no significant difference from AB wild type was observed in any 
result in this thesis. 
 
Adult fish were fed with freshly hatched brine shrimp and kept on a 14 hours (h) daylight and 
10 h darkness photoperiod cycle in automatic water circulation systems (Aquatic Habitats, 
ZebTEC-Tecniplast). All experiments were performed according to approved protocols (NUS 
IACUC approved protocol No.: 082/10). Zebrafish stages and maintenance followed 
established standards (Kimmel et al., 1995; Westerfield, 1995). Embryos were kept in 30% 
Danieau’s solution (17.4 mM NaCl, 0.21 mM KCl, 0.12 mM MgSO4, 0.18 mM Ca(NO3)2, 1.5 
mM HEPES, pH 7.6) in incubators at 28°C. 1X PTU (0.003% 1-phenyl-2-thiourea) was 
added in the medium to prevent pigmentation. 
 
2.1.2. Morpholino oligonucleotides 
Morpholino oligonucleotides were designed and synthesized by Gene Tools. Delivered 
lyophilized powders were dissolved in distilled water in glass vials, as 3 mM (~25 mg/ml) 
stock solutions. Working solutions were freshly diluted from stocks and heated up at 65°C for 
10 min before injection. The following Morpholinos (MO) were used: 
alk-ATG MO 5’-TCCTCTGCTGCGTTATCACACATTC-3’; targets zebrafish 
alk translation start site; blocks mRNA translation. 
alk-ATG-mismatch MO 5’-TCgTCTcCTGCcTTATgACAgATTC-3’; a mismatch control 
of alk-ATG MO with 5 base substitutions (small letters). 
alk-E3I3 MO 5’-CATTTATGCAGAGCACCTGGTGATG-3’; targets the 
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boundary between zebrafish alk exon 3 and intron 3. 
alk-I3E4 MO 5’-CAAGGCCCCTGCCAGACAGAATGAT-3’; targets the 
boundary between zebrafish alk intron 3 and exon 4. 
alk-Spl MO 1:1 mixture of alk-E3I3 MO and alk-I3E4 MO; prevents splicing 
of intron 3 from zebrafish alk pre-mRNA. 
standard MO 5’-CCTCTTACCTCAGTTACAATTTATA-3’; a random 
sequence control. 
p53 MO 5’-GCGCCATTGCTTTGCAAGAATTG-3’; a control targeting 
the zebrafish p53 gene. 
 
2.1.3. Primers 
Oligonucleotides were synthesized by 1st Base, Singapore. Sequences are listed in Table 1. 
Table 1. List of used primers. 
Primer name Sequence (5’ - 3’) 
For cloning of alk fragments  
ALK001 5’- CAACCTCTCCACTGACAGCA -3’ 
ALK002 5’- ACTTGCTCGGGTCAAAGAGA -3’ 
ALK005 5’- TGATAACGCAGCAGAGGATG -3’ 
ALK006 5’- ATCCACCAAACCGAAGAGTG -3’ 
ALK009 5’- CAAAACCATTGGTCAGCAGC -3’ 
ALK010 5’- TGCTTCAACACCCTCTTGAGAT -3’ 
ALK012 5’- TCTGACAGATGGACACGACTG -3’ 
ALK014 5’- GGCCGTCTGACACGAAACCAG -3’ 
ALK016 5’- CATAGGTCGCAGTCTCAATC -3’ 
ALK301 5’- GCAGCAAGTACAGGCACAAA -3’ 
ALK308 5’- GAGTTTCAAGCGCAGAATGG -3’ 
ALK501 5’- AGTGGTTCACCTCAGCTTGG -3’ 
ALK502 5’- GCAGGGGGTAGAAGAAAAGC -3’ 
ALK011ClaI 5’- CCGATCGATCACAAACCCGTAGAGCAACC -3’ 
ALK504XhoI 5’- TCGCTCGAGATCCTCTGCTGCGTTATCAC -3’ 
For cloning of full length alk and dominant-negative alk  
ALKatgXhoI 5’- CCGCTCGAGCCACCATGTGTGATAACGCAGCAGAG -3’ 
ALK300StopXbaI 5’- TGCTCTAGATTAGGTCATGATGGTGGAGGCT -3’ 
ALK1300F 5’- TGGACGCAGTGTTCTGGCG -3’ 
ALK310 5’- TGCAAAAGTGAGCGCTGATA -3’ 
ALK2000F 5’- TGTGAGTCAGGAGATTGCCA -3’ 
ALK306XbaI 5’- TGCTCTAGATTACAGCACAGTGGCGTTGT -3’ 
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For cloning of rptpz and other fragments  
RPTPz01 5’- GGCGTCCCAGAATACACACT -3’ 
RPTPz02 5’- GCTTTCTGAAGGGTTTGCTG -3’ 
RPTPz03 5’- ACAGACAGCTCCAACCATCC -3’ 
RPTPz04 5’- GTAGGTTCCTGTTCGACCCA -3’ 
RPTPz07 5’- TTACACAGGAGCCCTGAACC -3’ 
RPTPz08 5’- GGTCTTTCCCATGTCACCAC -3’ 
GapdhFOR 5’- GATTGCCGTTCATCCATCTT -3’ 
GapdhREV 5’- TCCATTTCTCACAAACAGAGGA -3’ 
βActin2FOR 5’- ATCGTGATGGACTCTGGTGA -3’ 
βActin2REV 5’- AAGAAGGATGGCTGGAACAG -3’ 
EGFPup4XhoI 5’- TCGCTCGAGGTGAGCAAGGGCGAGGAGCT -3’ 
EGFPdownXbaI 5’- CCGTCTAGATTACTTGTACAGCTCGTCCA -3’ 
 
2.1.4. RNA probes 
Probes used in in situ hybridizations are listed in Table 2. All probes were in antisense 
orientation to their targets, unless specified. 
Table 2. List of used riboprobes. 
Probe Plasmid and source Enzyme Polymerase 
alk N-part pTOPO-alkN1 (cloned in this study) NotI Sp6 
alk N-part sense pTOPO-alkN1 HindIII T7 
alk C-part pTOPO-alkC1 (cloned in this study) HindIII T7 
alk C-part sense pTOPO-alkC1 XhoI Sp6 
ccnd1 prepared by Jan Brocher (Winkler lab) 
her6 prepared by Ram Vinod Roy and Martin Graf (Winkler lab) 
neurog1 prepared by Flora Rajaei (Winkler lab) 
neurod4 pBluescriptSK-zath3 (gift from Korzh lab) BamHI T7 
ascl1a prepared by Martin Graf (Winkler lab) 
ascl1b pBSIISK-zash1b (gift from Korzh lab) BamHI T7 
dla prepared by Jan Brocher (Winkler lab) 
gfap prepared by Martin Graf (Winkler lab) 
rptpz N-part pTOPO-rptpzN1 (cloned in this study) NotI Sp6 
rptpz N-part sense pTOPO-rptpzN1  BamHI T7 
rptpz C-part1 pTOPO-rptpzC1 (cloned in this study) PstI Sp6 
rptpz C-part1 sense pTOPO-rptpzC1  HindIII T7 
rptpz C-part2 pTOPO-rptpzC2 (cloned in this study) NotI Sp6 
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rptpz C-part2 sense pTOPO-rptpzC2 BamHI T7 
mdka pCS2-mdka (Winkler lab) BamHI T7 
mdkb pCS2-mdkb (Winkler lab) BamHI T7 
egr2b pzf-krox20 (Winkler lab) XbaI T3 
shh pCRII-shh (Winkler lab) BamHI T7 
emx pCRII-emx1(Winkler lab) NotI Sp6 




Anti-DIG-AP Fab fragments of sheep anti-digoxigenin antibody, conjugated with 
alkaline phosphatase; diluted 1:2000 for in situ hybridization; from 
Roche. 
Anti-FLU-AP Fab fragments of sheep anti-fluorescein antibody, conjugated with 
alkaline phosphatase; diluted 1:2000 for in situ hybridization; from 
Roche. 
Anti-pH3 Rabbit polyclonal antibody against phospho-Histone H3 (Ser10); 
diluted 1:500 for immunostaining; from Millipore. 
Anti-HuC/D Mouse monoclonal antibody against HuC and HuD; diluted 1:500 
for immunostaining; from Molecular Probes. 
Anti-BrdU Mouse antibody against 5-bromo-2-deoxyuridine (G3G4); diluted 
1:100 for immunostaining; from DSHB, University of Iowa. 
Anti-ERK1/2 Rabbit polyclonal antibody against ERK1/2 (sc-94); diluted 1:500 
for immunostaining, 1:2000 for Western blot; from Santa Cruz. 
Anti-pERK1/2 Rabbit polyclonal antibody against phospho-ERK1/2 
(Thr202/Tyr204); diluted 1:500 for immunostaining, 1:1000 for 
Western blot; from Cell Signaling (#9101). 
Anti-DIG-peroxidase Digoxigenin antibody conjugated with peroxidase; ready-to-use for 
TUNEL with DAB color development; provided in ApopTag® 
Peroxidase In Situ Apoptosis Detection Kit, Millipore. 
Anti-DIG Mouse monoclonal antibody against digoxigenin; diluted 1:500 for 
fluorescent TUNEL; from Roche. 
Anti-GABA Rabbit polyclonal antibody against acetylated tubulin; diluted 





Anti-mouse IgG-Alexa488 Alexa Fluor® 488 goat anti-mouse IgG; diluted 1:1000 for 
fluorescent immunostaining; from Invitrogen. 
Anti-rabbit IgG-Alexa488 Alexa Fluor® 488 goat anti-rabbit IgG; diluted 1:1000 for 
fluorescent immunostaining; from Invitrogen. 
Anti-mouse IgG-Alexa568 Alexa Fluor® 568 goat anti-mouse IgG; diluted 1:1000 for 
fluorescent immunostaining; from Invitrogen. 
Anti-rabbit IgG-Alexa568 Alexa Fluor® 568 goat anti-rabbit IgG; diluted 1:1000 for 
fluorescent immunostaining; from Invitrogen. 
Anti-rabbit IgG-biotinylated Biotinylated goat anti-rabbit IgG; diluted 1:1000 for 
immunostaining with DAB color development; provided in 
VECTASTAIN® Elite ABC Kit, Vector Labs. 
Anti-rabbit IgG-HRP Goat anti-rabbit IgG; conjugated with horseradish peroxidase; 
diluted 1:3000 for Western blot; from Sigma. 
 
2.1.6. Kits 
RNA extraction and clean up RNeasy® Mini Kit, Qiagen 
cDNA synthesis RevertAid™ First Strand cDNA Synthesis Kit, 
Fermentas 
PCR TA cloning PCR Cloning Kit, Qiagen 
TOPO® TA Cloning Kit, Invitrogen 
DNA extraction and clean up Gel/PCR DNA Fragments Extraction Kit, Geneaid 
Plasmid preparation High Speed Plasmid Mini Kit, Geneaid 
Plasmid Midi Kit, Qiagen 
DNA sequencing BigDye® Terminator v3.1 Cycle Sequencing Kit, 
Applied Biosystems 
Capped mRNA synthesis mMESSAGE mMACHINE® SP6 Kit, Ambion 
5’RACE 5’RACE System for Rapid Amplification of cDNA Ends, 
Invitrogen 
TUNEL ApopTag® Peroxidase In Situ Apoptosis Detection Kit, 
Millipore 
Immunostaining VECTASTAIN® Elite ABC Kit, Vector Labs 
 
2.1.7. Equipment and devices 
Micropipette Research® plus 3 Pack, Eppendorf (0.5-10 µl, 10-100 µl, 
100-1,000 µl) 
Water purification Q-POD® Milli-Q system, Millipore 
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PCR thermal cycler Veriti® Thermal Cycler, Applied Biosystems 
T-personal Thermal Cycler, Biometra 
Metal thermal block Themomixer Compact, Eppendorf (fits Eppendorf tubes) 
Dry Bath Incubator, MRC (fits round- or flat-bottom tubes) 
Centrifuges Sorvall Legend Micro 21, Thermo 
Sorvall Legend Micro 21R, Thermo (refrigerated) 
Photometer Biowave II, WPA 
Capillary needle puller PC-10, Narishige 
Microinjector FemtoJet®, Eppendorf 
Water baths JB Aqua Dual, Grant Instruments (for transgenic heat shock 
induction with better temperature control) 
Model-1003, GFL (for other use) 
Electrophoresis and blot 
systems 
PowerPac™ Basic, Bio-Rad 
Wide Mini-Sub® Cell GT, Bio-Rad 
Mini PROTEAN® Tetra Cell, Bio-Rad 
Mini Trans-Blot® Cell, Bio-Rad 
Gel documentation system G:BOX, Syngene 
Microscopes S8 APO stereomicroscope, Leica 
SMZ1000 stereomicroscope, Nikon 
ECLIPSE 90i microscope, Nikon 
LSM 510 Meta confocal microscope, Zeiss 
 
2.2. Molecular biology methods 
2.2.1. RNA extraction 
Total RNA was extracted from zebrafish (AB strain background) embryos or adult tissues 
with a column-based RNeasy® Mini Kit (Qiagen) according to the supplier’s manual. 20-50 
embryos or approximately 20 mg adult tissue were homogenized with a clean pestle with 350 
µl buffer RLT and 3.5 µl β-mercaptoethanol on ice. The Eppendorf tube was centrifuged at 
21,000 x g for 3 minutes (min), and the clear supernatant was transferred into a fresh tube and 
mixed with 350 µl 70% ethanol. The mixture was immediately loaded onto a column, and 
RNA binding was performed by centrifuging at 21,000 x g for 15 seconds (sec). The column 
was washed with 700 µl buffer RW1, then twice with 500 µl buffer RPE, and a prolonged 
centrifugation at 21,000 x g for 2 min at the end. The semi-dried column was loaded with a 
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suitable volume of nuclease-free water (30-100 µl) for dissolving RNA, and eluted by 
centrifuging at 21,000 x g for 1 min. 
 
The extracted RNA was digested with 2 µl DNaseI (Fermentas) at 37°C for 30 min to remove 
residual genomic DNA, followed by a RNA clean-up step using the same kit. 100 µl digestion 
product was mixed with 350 µl buffer RLT and 250 µl ethanol, and loaded onto a new 
column. After washing twice with 500 µl buffer RPE, the purified RNA was eluted from the 
column and collected in water. An additional ethanol precipitation step was also performed 
(2.2.8.). The RNA concentration was determined with a spectrophotometer (Biowave II, 
WPA).  
 
In order to yield more intact long transcripts for cloning of full length zebrafish alk, total 
RNA in this particular case was extracted using the TRIzol method. 50 dechorionated 
zebrafish embryos were homogenized with a clean pestle with 1 ml TRIzol® (Invitrogen) on 
ice. The Eppendorf tube was centrifuged at 12,000 x g and 4°C for 5 min, and the clear 
supernatant was transferred into a fresh tube and left at room temperature for 5 min to permit 
complete dissociation of nucleoprotein complexes. Afterwards, 200 µl chloroform was added, 
and the mixture was vigorously shaken by hand for 30 sec and left at room temperature for 2 
min. Phase separation was performed by centrifuging the tube at 12,000 x g and 4°C for 10 
min, and the colorless upper aqueous phase was transferred into a fresh tube. RNA 
precipitation was done by mixing with 500 µl isopropanol, then inverting the tube several 
times, and leaving the tube at room temperature for 15 min. The tube was centrifuged at 
12,000 x g and 4°C for 20 min, and the resulting pellet was washed with 1 ml 75% ethanol 
and centrifuged at 7,500 x g and 4°C for another 5 min. Finally, the air dried pellet was 






2.2.2. cDNA synthesis 
cDNA was synthesized using the RevertAid™ First Strand cDNA Synthesis Kit (Fermentas) 
according to the supplier’s manual. 1-5 µg of RNA in 11 µl was mixed with 1 µl random 
hexamer primer, and denatured at 70°C for 5min, then chilled on ice. 4µl 5x reaction buffer, 
1µl RiboLock Ribonuclease inhibitor (20 U/µl), and 2µl dNTP (10 mM) were sequentially 
added, and the mixture was incubated at 25ºC for 5 min. The reaction started when 1µl 
RevertAid M-MuLV Reverse Transcriptase (200 U/µl) was added, and it was incubated at 
42ºC for 60 min until stopped by heating to 70ºC for 10 min. In parallel, an identical set of 
reaction without Reverse Transcriptase was performed as -RT control for testing for any PCR 
amplification originating from contaminating genomic DNA. The obtained cDNA or -RT 
products were stored at -20°C. Identical amounts of total RNA were used in cDNA synthesis 
reactions from different stages (1 µg) or different tissues (0.5 µg), and same volumes of their 
resulting cDNA (1 µl) were used as templates for subsequent semi-quantitative RT-PCR, as 
cDNAs were difficult to quantify. The cDNA prepared for cloning of alk full length transcript 
was synthesized with the oligo (dT)18 primer instead, and with extended reaction time (2 
hours). 
 
2.2.3. Polymerase chain reaction (PCR) 
Two DNA polymerases were used in PCR amplifications for different purposes. The Taq 
polymerase (Fermentas) was widely used in RT-PCR cloning of templates for riboprobes, 
semi-quantitative RT-PCR, and colony PCR in this thesis. It results in an overhanging A 
nucleotide in the products, which simplifies subsequent TA cloning. However, Taq has no 
proofreading activity. Therefore, the risk of PCR-introduced mutagenesis is high. Suitable 
amounts of DNA or cDNA were used as template, and mixed with 1 µl of each primers (10 
µM), 2.5 µl of 10x Taq buffer, 2 µl of dNTP (2.5 mM each), 2 µl of MgCl2 (25 mM), and 0.2 
µl of Taq (5 U/µl), in a total volume of 25 µl for each reaction. The reactions were performed 
in thin-walled PCR tubes (Axygen; Thermo) in a thermal cycler. They were started with an 
initial denaturation step at 95°C for 5 min; followed by 30-35 cycles of 30 sec for 
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denaturation at 95°C, 30 sec for annealing at 50-65°C (adjusted according to primer length 
and GC content), and 30 sec to 5 min (1 min per kb as in desired products) of extension at 
72°C; the reaction was finished with a final extension step at 72°C for 10 min. The obtained 
products were run on a gel or stored at -20°C. 
 
For sequence-important PCR such as alk RT-PCR cloning, the high fidelity Phusion™ 
polymerase (Finnzymes) was used, which has a 3’ to 5’ exonuclease activity. In a typical 50 
µl reaction for subsequent restriction digestion and cloning, template cDNA was mixed with 2 
µl of each primers (10 µM), 10 µl of 5x Phusion buffer (contains 1.5 mM MgCl2 at final 
concentration), 4 µl of dNTP (2.5 mM each), and 0.5 µl of Phusion (2 U/µl). The reactions 
were started with an initial denaturation step at 98°C for 2 min; followed by 35 cycles of 10 
sec for denaturation at 98°C, 20 sec for annealing at 55-65°C (adjusted according to primer 
length and GC content), and 30 sec to 3 min (30 sec per kb as in desired products) of 
extension at 72°C; the reaction was finished with a final extension step at 72°C for 10 min. 
 
Phusion polymerase generates blunt ends in the products. In order to perform TA cloning into 
pDrive or pTOPO vector using these products, an additional A-adding reaction was carried 
out. 0.75 µl of 4.25 µl master mix (2.5 µl of 10x Taq buffer, 1 µl of 50 mM MgCl2, 0.5 µl of 
100 mM dATP, and 0.25 µl of Taq), was added to 3.25 µl purified PCR products, and 
incubated at 72°C for 20 min. This 4 µl product after the A-adding reaction was used for TA 
cloning as described earlier for Taq derived PCR products. 
 
2.2.4. TA cloning 
PCR products with overhanging A nucleotides were cloned into the pDrive vector using the 
PCR Cloning Kit (Qiagen), or into the pCRII-TOPO vector using the TOPO TA Cloning Kit 
(Invitrogen). A reaction mixture, consisting of 1 µl pDrive vector, 4 µl PCR product, and 5 µl 
2x Ligation Master Mix, was incubated at 16°C for 1 h. Alternatively, a mixture consisting of 
0.5 µl pCRII-TOPO vector, 4 µl PCR product, 1 µl Salt Solution, and 0.5 µl water, was 
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incubated at room temperature for 10 min. The ligation products were then transformed into 
prepared EZ chemically competent cells (2.2.9.) by heat shock method (2.2.10.), and spread 
on LB agar (1.5%) plates, which contained 50 μg/ml ampicillin and pre-spread 80 µl X-gal 
(20 mg/ml) and 40 µl IPTG (100 mM) for blue/white selection. Only white or light blue 
colonies were picked for subsequent PCR colony screening. 
 
2.2.5. Restriction digestion of DNA 
For subcloning of DNA fragments from cloning vectors (pDrive and pTOPO) into the 
expression vector (pCS2), or for direct cloning of PCR products into pCS2 vector with 
primer-introduced restriction sites, digestions with restriction enzymes (Fermentas) were 
carried out. PCR products were first purified with the PCR Clean Up method with Gel/PCR 
DNA Fragments Extraction Kit (Geneaid), and then double digested by two restriction 
enzymes in a compatible buffer, or sequentially with an additional PCR Clean Up step in 
between. Typically, 3 µg plasmid or PCR product, and 2-5 µl (no more than 5% of the 
reaction volume) restriction enzyme(s) (10 U/µl) was/were used in a 50-100 µl digestion 
reaction. Each digestion was incubated at 37°C for 4 h. The digestion products were run on a 
gel and extracted. 
 
In digests for plasmid linearization, which were used as templates for RNA transcription, 10 
µg of plasmid DNA were single digested with 5 µl restriction enzyme (10 U/µl) in a 200 µl 
reaction, at 37°C overnight. The digestion products were purified by phenol/chloroform. 
 
2.2.6. Agarose gel electrophoresis and gel extraction 
PCR or digestion products were separated by size on a 1% agarose (Invitrogen) gel in an 
electrophoresis device (Bio-Rad) in 1x TAE buffer. When the fragment size needed to be 
determined, a DNA or RNA ladder (Fermentas) was run on the same gel. The agarose gel was 
pre-stained with SYBR® Safe (Invitrogen), visualized and analyzed using UV light in a 
G:BOX gel system (Syngene). For DNA extraction, the desired DNA bands were excised 
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from the gel with a clean scalpel, and dissolved in 500 µl DF buffer at 60°C for 10 min. The 
rest of the purification procedure was done according to the Gel Extraction method with the 
Gel/PCR DNA Fragments Extraction Kit (Geneaid). The concentration of the purified product 
was determined with a photometer (Biowave II, WPA). 
 
2.2.7. Phenol / chloroform purification of DNA/RNA 
For DNA purification, 200 µl phenol/chloroform/isoamyl alcohol (25:24:1, TE saturated, 
pH8.0) was added to 200 µl of DNA solution, and mixed by vortexing. The mixture was 
centrifuged at 21,000 x g for 5 min, and then the upper aqueous phase was transferred into a 
fresh tube. 200 µl chloroform was added, and mixed by vortexing. The mixture was 
centrifuged again at 21,000 x g for 5 min, and then the upper aqueous phase was transferred 
into a fresh tube for ethanol precipitation. 
 
For RNA purification, 100 µl phenol (water saturated, pH4.7) and 50 µl chloroform/isoamyl 
alcohol (24:1) were added to 100 µl of RNA solution, and mixed by vortexing. The mixture 
was centrifuged at 21,000 x g for 5 min, and then the upper aqueous phase was transferred to 
a fresh tube. 100 µl chloroform/isoamyl alcohol (24:1) was added, and mixed by vortexing. 
The mixture was centrifuged again at 21,000 x g for 5 min, and then the upper aqueous phase 
was transferred into a fresh tube for ethanol precipitation. 
 
2.2.8. Ethanol precipitation 
The DNA or RNA solution was mixed with 1/10 volume of 3M NaOAc (pH5.2) and 2.5 
volumes of ice-cold ethanol. The mixture was then incubated at -80°C for at least 30 min to 
facilitate nucleic acid precipitation. After centrifuging at 21,000 x g and 4°C for 30 min, the 
pellet was washed with 70% ethanol and centrifuged at 21,000 x g and 4°C for another 10 





2.2.9. Preparation of competent bacteria 
Chemically competent bacterial cells were generated and prepared as follows, using the EZ 
strain (Qiagen) provided in the pDrive PCR cloning kit. A 10 ml 37°C overnight pre-culture 
was inoculated in LB medium with EZ seed cells and 50 µg/ml tetracycline. On the next day, 
the culture was expanded into 400 ml LB medium without antibiotics, and grown until an 
optical density of OD600= 0.3-0.4 was obtained at 37°C. The culture was centrifuged in 50 ml 
Falcon tubes at 3,000 rpm and 4°C for 10 min. The pellet was resuspended with 1/40 volume 
of the culture in ice-cold TSS buffer (10% PEG-3000, 3% DMSO, 40 mM MgCl2) and 
immediatedly aliquoted into 100 μl portions in pre-cooled Eppendorf tubes. The aliguots were 
snap froozen in liquid nitrogen and stored at -80°C. 
Luria-Bertani (LB) medium (per liter): 10 g tryptone, 5 g yeast extract, 10 g NaCl, pH 7, 
autoclaved at 121°C for 15 min.   
 
2.2.10. Ligation and transformation 
Double digested and purified DNA fragments and plasmid vectors were linked together by 
ligation reactions at their sticky ends. The inserts and vectors were mixed at 2:1 to 6:1 molar 
ratios (insert: vector; the smaller the insert in size, the more in molarity), and 50-100 ng total 
DNA was used together with 0.5 µl T4 DNA ligase (New England Biolabs) and 1 µl T4 
buffer in a 10 µl ligation reaction. The reaction was incubated at 16°C for 2h, then at 4°C 
overnight. 
 
1 µl circular plasmids or 5 µl ligation products was gently pipetted into 100 µl chemical 
competent bacterial cells thawed on ice, and incubated on ice for 30 min. The bacteria were 
then heat shocked at 42°C for 45 sec and immediately transferred back to ice for another 2 
min. After transformation, 400 µl room-temperature LB medium was added and the mixture 
was shaken at 37 °C for 10 min (ampicillin selection) or 1 h (kanamycin selection). The 
bacterial culture was then concentrated by centrifuging at 4,000 rpm for 1 min and 
resuspending in 100 µl remaining medium. The resuspension was plated on a LB agar (1.5%) 
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plate containing antibiotics, and grown at 37 °C for 12-16 h. Colonies were picked, and a 
colony PCR was performed using 1 µl of colony suspension as template. Those positive 
colonies were inoculated in LB medium with antibiotics. 
 
2.2.11. Plasmid DNA preparation 
Plasmid mini-preparation from 5 ml bacteria culture was carried out with the High Speed 
Plasmid Mini Kit (Geneaid), and plasmid midi-preparation from 100 ml bacteria culture was 
carried out with the Plasmid Midi Kit (Qiagen), according to the supplier’s manuals. 
 
2.2.12. DNA sequencing 
DNA sequencing was performed with the BigDye® Terminator v3.1 Cycle Sequencing Kit 
(Applied Biosystems). A 10µl half-diluted reaction consisted of 50 ng template, 1.6 pmol 
primer, 1 µl of 5x BigDye Sequencing Buffer, and 2 µl of 2.5x BigDye Reaction Premix. The 
reactions were started with an initial denaturation step at 96°C for 1 min; followed by 25 
cycles of 15 sec of denaturation at 96°C, 10 sec of annealing at 50°C (for Sp6, T3 and T7 
primers) or 60°C (for gene specific primers), and 4 min of extension at 60°C. After the 
reaction, the product was precipitated with 10 µl water, 2 µl EDTA (125 mM), 2 µl NaOAc 
(3M, pH5.2), and 50 µl ethanol, at room temperature for 30 min. Subsequently, the tube was 
centrifuged at 21,000 x g and 4°C for 45 min, and the pellet was then washed with 100 µl 70% 
ethanol and centrifuged again at 21,000 x g and 4°C for 15 min. After discarding the 
supernatant, the pellet was air-dried and stored at -20°C until the run on the capillary 
sequencer. Samples were run on the DNA sequencer ABI 3730 XL (Applied Biosystems) in 
the DNA Sequencing Laboratory of DBS. The results were analyzed by software FinchTV 
Version 1.4. 
 
2.2.13. In vitro RNA transcription for riboprobe 
In order to detect RNA expressions using whole mount in situ hybridization, digoxigenin 
(DIG) or fluorescein (FLU) labelled riboprobes in their antisense sequence were generated by 
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in vitro transcription. The transcription template plasmids were linearized by a restriction 
enzyme at the end of the gene sequence, preventing transcription of the vector sequence. 1 µg 
linearized plasmid DNA was used as template, together with 4 µl 5x transcription buffer, 2 µl 
10x DIG/FLU-NTP mix (Roche), 0.5 µl RiboLock RNase inhibitor (Fermentas), and 1 µl 
RNA polymerase (20 U/µl, Fermentas), in a total reaction volume of 20 µl. The reaction was 
incubated at 37ºC for 2 h. 1 µl DNaseI (Fermentas) was added after the reaction, for another 
15 min at 37ºC to remove the DNA templates. The transcription product was then purified 
using the RNeasy clean up kit (Qiagen) and ethanol precipitation. After purification, the 
product was dissolved in 25 µl nuclease-free water, and 1 µl was tested on a gel. The rest of 
the product was mixed with 76 µl HybMix and stored at -20ºC. 
 
2.2.14. Capped mRNA synthesis 
In order to produce functional capped mRNA with poly(A) tails, full-length cDNAs were 
cloned into the expression vector pCS2. The following plasmids were used: pCS2-NPMALK 
(from Dr. Robert Kelsh, University of Bath, UK); pCS2-mouseAlk (sub-cloned from pTTP-
mAlk, from Dr. Bengt Hallberg and Dr. Ruth Palmer, Umeå University, Sweden); pCS2-alk 
and pCS2-alkATG-egfp (cloned in this study); pCS2-mdka and pCS2-mdkb (Winkler lab 
stock); pCS2-mdkaG and pCS2-mdkbG (cloned by Lim Jack Wee, National University of 
Singapore, Singapore). The plasmids were linearized with NotI, and the capped mRNAs were 
in vitro synthesized using the mMESSAGE mMACHINE® SP6 Kit (Ambion). 
 
A 20 µl reaction contained 1 µg linearized template DNA, 2 µl 10x transcription buffer, 10 µl 
NTP/CAP mix, and 2 µl Sp6 Enzyme mix. The reaction was incubated at 37ºC for 2 h, then 1 
µl TURBO DNase (2 U/μl) was added for another 30 min at 37ºC to remove the DNA 
templates. The reaction was stopped by adding 7.5 µl Ammonium Acetate Stop Solution. The 
product was purified by phenol/chloroform extraction, followed by RNeasy clean up using the 
kit (Qiagen), and ethanol precipitation. After purification, capped mRNA was dissolved in 20 
µl nuclease-free water and stored at -80ºC for further use. 
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2.3. Zebrafish alk, rptpz cloning and sequence analysis 
2.3.1. Cloning of alk 5’UTR and 3’UTRs  
In order to obtain the translation start site and 5’UTR sequences of zebrafish alk, Rapid 
Amplification of cDNA Ends (RACE) was carried out using a 5’RACE System Kit 
(Invitrogen), in combination with several rounds of nested PCRs using primers AAP, AUAP 
(provided in the kit) and gene specific primers (GSP). Primer sequences are listed in 2.1.3. 
5’RACE cDNA synthesis by GSP1 (ALK010), S.N.A.P. column purification of cDNA, and 
TdT tailing of cDNA were performed according to the kit manual and protocol. In the 
subsequent nested PCRs by Taq, the first round product using AAP and GSP2 (ALK012) was 
1/10 diluted as template for the second round of PCR using AUAP and GSP3 (ALK014). This 
resulted in two bands on the gel, which were both cut and sequenced. Sequencing revealed 
that the lower band was a part of the higher band, which is normally seen in RACE. To 
validate the obtained alk 5’UTR sequence, RT-PCR from regular cDNA, and by high fidelity 
Phusion polymerase, was carried out using a newly designed UTR primer (ALK009) and a 
coding sequence primer (ALK016). This resulted in a 544 bp (216 bp of 5’UTR) amplicon 
that was cloned into pDrive. Moreover, based on the sequence in the Ensembl database 
(ENSDARG00000095833, Zv9), the alk 3’UTR sequence was also similarly amplified by 
Phusion, using a coding sequence primer (ALK301) and a UTR primer (ALK308). This 
resulted in a 653 bp (139 bp of 3’UTR) amplicon and was cloned into pDrive.  
 
2.3.2. Cloning of alk fragments and generation of an alkATG-egfp construct  
Two zebrafish alk fragments were first PCR amplified from AB strain wild type 48 hpf cDNA 
using Taq, and TA-cloned into the pTOPO vector in order to produce riboprobes for in situ 
hybridization. An 880 bp amplicon representing the alk N-terminal part (amplified by primers 
ALK005 and ALK006) was cloned as pTOPO-alkN1. This construct was used to generate a 
pair of antisense and sense sequence alk N-part riboprobes (2.1.4.), which were used to obtain 
the in situ hybridization images shown in this thesis. Another 679 bp amplicon representing 
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the alk C-terminal part (by primers ALK001 and ALK002) was cloned as pTOPO-alkC1, and 
alk C-part antisense and sense riboprobes were also generated. 
 
For semi-quantitative RT-PCR determining alk RNA transcript levels at different 
developmental stages and in adult tissues, primers ALK501 and ALK502 were used, which 
were located in alk exons 1 and 4 respectively. This primer pair resulted in a 467 bp amplicon 
in the alk N-terminal part. Same amounts of cDNAs, as well as -RT products, which were 
derived from same amounts of RNAs (2.2.2.) were used as templates in Taq PCR reactions. 
Primer pairs for gapdh fragments (378 bp; primers GapdhFOR and GapdhREV, in exons 11 
and 12) and beta actin (350 bp; primers βActin2FOR and βActin2REV, both in exon 4) were 
used in parallel PCR amplifications as loading controls. Same primers and PCR settings were 
also used in the experiment testing the efficiency of alk splice blocking MOs (Spl-MO). 
cDNAs and -RT products from WT or alk Spl-MO injected embryos at 24 hpf were used as 
templates. The resulting 467 bp band in WT and 756 bp band (containing intron 3) in Spl-MO 
injected samples were gel extracted and sequenced to compare with expected amplifications. 
 
To test the efficiency of the alk translation blocking MO (ATG-MO), an artificial target 
construct was generated. alk ATG-MO binds to 2 nt in the alk 5’UTR and 23 bp in its coding 
sequence including the ATG. Therefore, a fragment including this target site around the alk 
ATG was PCR amplified using Phusion from pDrive-alk-5UTR (with primers ALK011ClaI 
and ALK504XhoI), which contained 107 bp of the alk 5’UTR and the first 24 bp in its coding 
sequence. An egfp fragment was PCR amplified by Phusion (with primers EGFPup4XhoI and 
EGFPdownXbaI) from pUAS-egfp (Winkler lab stock), which had the egfp full coding 
sequence except an ATG. These two parts were digested with ClaI plus XhoI, and XhoI plus 
XbaI, respectively, and ligated into the pCS2 vector digested with ClaI plus XbaI. The 
resulting pCS2-alkATG-egfp construct generated a hybrid capped mRNA, which consisted of 
alk 5’UTR and the ATG-MO target site, a 6 bp XhoI linker site, in-frame with the egfp coding 
sequence. This construct was verified by sequencing. 
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2.3.3. Cloning of full length and dominant-negative alk  
Total RNA extracted with the TRIzol method from 4 dpf AB strain wild type embryos (2.2.1.) 
was used to generate oligo (dT)18 primer synthesized cDNA for full length zebrafish alk 
cloning (2.2.2.). A full length alk coding sequence, as well as a truncated sequence encoding a 
putative dominant-negative form of alk (dnalk), which lacks the corresponding C-terminal 
tyrosine kinase sequence, was first cloned by nested PCRs with the LongRange PCR Kit 
(Qiagen). However, sequences among different transformants showed several single 
nucleotide changes, suggesting a possibility of PCR polymerase introduced mutations. 
Therefore, the high fidelity Phusion polymerase was used in further cloning. However, the 
same nested PCR settings failed to amplify full length alk, probably due to lower efficiency of 
Phusion for long PCR products. Therefore, a two-step amplification and ligation strategy was 
used, taking the advantage of a unique endogenous PagI restriction site in the alk sequence (nt 
2300-2305). 
 
alk part A was PCR amplified from the same cDNA by Phusion with primers ALKatgXhoI 
and ALK300StopXbaI, and cloned into pDrive-alk-partA. This part corresponded to alk nt 1-
2307, and the designed dominant-negative alk with a Stop codon included in the down primer. 
This insert was sub-cloned into pCS2 by XhoI and XbaI digestions and ligation, as pCS2-
dnalk. The rest of the alk sequence was cloned as part B (alk nt 1993-4167), which has a 
small overlap with part A. Part B was amplified by Phusion in nested PCRs: Primers 
ALK1300F and ALK310 were used in the 1st round of PCR, and the resulting product was 
1/50 diluted as the template for the 2nd round with primers ALK2000F and ALK306XbaI. The 
end product was cloned into pDrive as pDrive-alk-partB. Parts A and B together represented 
the full length alk 4167 bp coding sequence, i.e. the same as the one directly obtained by 
LongRange in overall sequence, but without any PCR introduced mutation in all eight 
transformants that were analyzed by sequencing. Because of the internal PagI restriction site 
(alk nt 2300-2305), the artificial Stop codon no longer existed in the insert when pDrive-alk-
partA was digested by XhoI and PagI. Similarly, pDrive-alk-partB was digested by PagI and 
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XbaI. The two digested fragments were ligated together with XhoI and XbaI digested pCS2, 
to form a pCS2-alk construct containing the full length zebrafish alk. pCS2-dnalk and pCS2-
alk sequences and orientations were verified again by sequencing. Since a single sequencing 
reaction usually results in an about 600 bp reliable read-out, sequencing of alk was performed 
as following: Vector primers (Sp6 and T3) were used in the initial runs, then fragment-by-
fragment alk primers were designed and continuously used, and all pieces were eventually 
combined. Sequences were verified on both sense and antisense strands. Primers used in 
sequencings are not listed. 
 
For generation of heat shock inducible transgenic fish, a pHS plasmid was used for further 
sub-cloning. It contains an artificial bidirectional inducible promoter consisting of 
multimerized minimum heat shock elements (HSE), as well as I-SceI sites flanking the 
expression cassette (Bajoghli et al., 2004). Slightly modified from the original pHS-GFP 
(kindly provided by Dr. Thomas Czerny, University of Veterinary Medicine, Austria), gfp 
was replaced with cfp on the non gene-of-interest side by NcoI and KpnI, from a pECFP-N1 
plasmid (done by Yin Jun, Winkler lab). On the gene-of-interest side, alk or dnalk from 
pCS2-alk or pCS2-dnalk (released by XhoI and XbaI digestions) was sub-cloned into the 
modified pHS-CFP (digested with XhoI and SpeI), resulting in pHS-CFP-alk or pHS-CFP-
dnalk, respectively. XbaI and SpeI generate compatible sticky ends for ligation. 
 
2.3.4. Sequence analysis 
Nucleic acid and protein sequences were analyzed with softwares FinchTV and Vector NTI. 
Sequence alignments and phylogenetic trees were generated by AlignX (a module of Vector 
NTI), and protein transmembrane helices were predicted by TransMembrane prediction using 
Hidden Markov Models (TMHMM Server V2.0, Center for Biological Sequence Analysis at 




The following Alk nucleic acid or protein sequences from 18 species with their accession 
numbers in GenBank or Ensembl databases were used in sequence alignment analysis: human 
(Homo sapiens; NM_004304.4); mouse (Mus musculus; NM_007439.2); rat (Rattus 
norvegicus; NM_001169101.1); cattle (Bos taurus; XM_616782.4); horse (Equus caballus; 
XM_001500568.3); dog (Canis lupus familiaris; XM_540136.3); gray short-tailed opossum 
(Monodelphis domestica; XM_001380617.1); dolphin (Tursiops truncates; 
ENSTTRP00000007868); chicken (Gallus gallus; XM_419364.3); turkey (Meleagris 
gallopavo; XM_003203724.1); zebra finch (Taeniopygia guttata; XM_002195764.1); 
zebrafish (Danio rerio; obtained in this study); fugu (Takifugu rubripes; 
ENSTRUP00000025266.1); tetraodon (Tetraodon nigroviridis; ENSTNIP00000011762.1); 
stickleback (Gasterosteus aculeatus; ENSGACP00000016962.1); cod (Gadus morhua; 
ENSGMOP00000016063.1); coelacanth (Latimeria chalumnae; ENSLACP00000016684.1); 
and fruit fly (Drosophila melanogaster; NM_144343.2). 
 
2.3.5. Cloning of rptpz fragments  
Three zebrafish rptpz fragments were PCR amplified from AB strain wild type 24 hpf cDNA 
using Taq, and TA-cloned into the pTOPO vector in order to produce riboprobes for in situ 
hybridization. An 888 bp amplicon reflecting the rptpz N-terminal part (with primers 
RPTPz07 and RPTPz08) was cloned as pTOPO-rptpzN1. This construct resulted in a pair of 
antisense and sense sequence rptpz N-part riboprobes, which were used and corresponding in 
situ hybridization images are shown in this thesis. Two other amplicons in the rptpz C-
terminal parts were also cloned as pTOPO-rptpzC1 (1218 bp, with RPTPz01 and RPTPz02) 
and pTOPO-rptpzC2 (606 bp, with RPTPz03 and RPTPz04), and their antisense and sense 
riboprobes were also generated (2.1.4.).  
 
2.4. Microinjection into zebrafish embryos 
Microinjection needles were prepared by pulling glass capillaries (GC100F-10, 1.0 mm O.D. 
x 0.58 mm I.D., Harvard Apparatus) with a vertical needle puller (Narishige), set as step 1, 
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heater level at 55.8. Male and female fish matings were set up the night before the injection 
day with a plastic divider, which was removed to allow spawning of synchronized fertilized 
eggs in the morning. Eggs were harvested and briefly rinsed with fish medium. An injection 
mold was prepared using a plastic former with ridges in 1.5% agarose gel, to form grooves 
holding the eggs during the injection procedure. Morpholino oligonucleotide solutions were 
heated up to 65 °C for 10 min before injection to improve dissolution. 
 
Injection needles were back loaded with Microloaders (Eppendorf) with working solutions. 
Solutions were injected into one- or two-cells staged embryos, leaving a small droplet (about 
0.5 nl) in the yolk just below the cells. This was performed with an air-pressured 
microinjector (FemtoJet, Eppendorf) and a micromanipulator (World Precision Instruments) 
using a stereomicroscope. In the special case of injection for generating transgenic fish, the 
solution was injected at the early one-cell stage and directly into the cell, allowing genomic 
integration as early as possible. Recombinant Midkine proteins were injected at the 1000 cells 
stage (3 hpf) directly into the blastula, allowing distribution of proteins in the extracellular 
space among cells as cell surface growth factors. After injection, embryos were kept in 30% 
Danieau’s solution in 28°C incubators until they reached the desired developmental stages. 
 
2.5. Generation of transgenic fish 
The heat shock inducible transgenic zebrafish lines were generated in the AB strain 
background by co-injection of plasmid and I-SceI meganuclease as reported in other studies 
(Thermes et al., 2002; Bajoghli et al., 2004). Plasmids pHS-CFP-alk, pHS-CFP-dnalk, and 
pHS-CFP were used for generation of the alk:HSE:cfp, the dnalk:HSE:cfp, and the HSE:cfp 
lines, respectively. 600 ng plasmid, 1 µl I-SceI (5 U/µl; New England Biolabs), and 1 µl 10x 
I-SceI buffer were mixed in a total volume of 10 µl reaction, and incubated at room 
temperature for 1 h before injection. The solution was injected into early one-cell staged wild 
type embryos and directly into the cell. On the next day between 24-31hpf, injected embryos 
were heat shocked at 39°C for 1.5 h in a petri dish floating in a water bath (Grant Instruments). 
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The fish medium was changed with fresh medium after the heat shock. On the following day, 
heat shocked embryos were screened under the fluorescent stereo binocular microscope with 
a CFP filter. Only those embryos with strong levels of CFP in patches over the entire body 
were selected as F0 candidates and further raised to adulthood. Candidates were grown to four 
months when sexual maturation occurred, and then crossed to WT AB fish, with one week 
intervals between crossings. Their progenies were heat shocked and screened similarly for 
CFP signals. F0 candidates did not give rise to any CFP positive progenies, in more than 200 
screened embryos from at least three independent spawnings, were considered as negatives. 
F0 fish that gave rise to CFP positive progenies were kept as transgenic positive F0 founders 
with successful germ line transmission, and their CFP positive progenies were raised as F1. 
The F2 or F3 embryos, progenies of F1 or F2, were used in the experiments described in this 
thesis. See details in 4.1. for transgenic lines. 
 
2.6. Whole mount in situ hybridization and immunostaining 
2.6.1. Embryo fixation and dehydration 
Embryos at the desired stages were fixed in 4% paraformaldehyde (PFA) / PBST (1 M NaCl, 
19.5 mM KCl, 59 mM Na2HPO4, 11 mM KH2PO4, 0.1% Tween-20) at 4ºC overnight. After 
fixation, embryos were washed in PBST for 5 min and manually dechorionated. Subsequently, 
they were washed three times for 5 min each, in PBST, then 5 min in methanol, and finally 
stored in fresh methanol at -20ºC. 
 
2.6.2. Whole mount in situ RNA hybridization 
Fixed embryos were rehydrated in a gradient of washing steps: 75% methanol/PBST, 50% 
methanol/PBST, 25% methanol/PBST, and finally PBST. Each washing lasted 5 min. 
Embryos were then subject to proteinase K (5 µg/ml in PBST, Fermentas) treatment. 
Treatment time depended on the stages of embryos: no treatment for embryos before 18 hpf; 4 
min for embryos at 24 hpf; 10 min for embryos at 48 hpf. Proteinase K digestion was stopped 
by replacing with glycine solution (2 mg/ml in PBST), and then refixation in 4% PFA/PBST 
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for at least 20 min. Afterwards embryos were washed in PBST again for five times, 5 min 
each. 
 
Before hybridization, embryos were pre-hybridized in HybMix (50% formamide, 5x SSC, 
150 µg/ml heparin, 5 mg/ml torula RNA, 0.1% Tween) for 1 h in a 65ºC water bath. In the 
meantime, DIG/FLU labelled riboprobes were diluted in HybMix, and denatured by heating 
them to 80 ºC for 10 min then immediately chilling on ice. Probes and embryos were 
hybridized at 65ºC overnight. On the next day, embryos were washed at 65ºC sequentially 
with SSCT buffer I (50% formamide, 2x SSC, 0.1% Tween) for two times, 30 min each; 
SSCT buffer II (2x SSC, 0.1% Tween) for 30 min; and SSCT buffer III (0.2x SSC, 0.1% 
Tween) for two times, 30 min each. At last, embryos were brought back into PBST at room 
temperature.  
 
Before antibody incubation, a blocking step was performed by incubating embryos in block 
solution (5% sheep serum/PBST) at room temperature for 1 h. Afterwards embryos were 
incubated in anti-DIG/FLU-AP antibody Fab-fragments (coupled with alkaline phosphatase, 
1:2000 in PBST, Roche) at room temperature for 2 h. Six times of washing in PBST, 20 min 
each, were carried out after antibody binding. During one of the washings, embryos were 
washed at 4ºC overnight. For color development, embryos were first equilibrated in pre-
staining buffer (0.1 M NaCl, 0.05 M MgCl2, 0.1% Tween, 0.1 M Tris-HCl pH9.5) for two 
times, 5 min each. Then they were incubated in staining solution (0.1 M NaCl, 0.1% Tween, 
0.1 M Tris-HCl pH9.5, 1:50 diluted NBT/BCIP stock from Roche) in the dark, allowing color 
development. Staining was stopped by washing in PBST for several times. 
 
2.6.3. Two-color whole mount in situ hybridization 
Fixed embryos were rehydrated, proteinase K digested, and pre-hybridized identical to the 
one color in situ hybridization (2.6.2.). Two probes, separately labelled with DIG and FLU, 
were added to the hybridization mix, and embryo staining was continued with SSCT buffer 
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washing and sheep serum blocking steps as in 2.6.2. Anti-FLU-AP antibody Fab-fragments 
were first incubated with embryos and samples afterwards were subjected to PBST washing. 
Red color was first developed by equilibrating embryos in red staining buffer (RSB; 0.1% 
Tween, 0.1 M Tris-HCl pH8.2) for two times, 5 min each, then incubating in red staining 
solution (dissolving one Fast Red tablet from Roche in 2 ml RSB) in the dark until sufficient 
color developed, and stopping staining by PBST washing. To remove the first antibody, 
embryos were incubated in an acidic removal solution (0.1% Tween, 0.1 M glycine-HCl 
pH2.2) for two times, 10 min each, and subsequently washed in PBST for four times, 10 min 
each. The second antibody binding with anti-DIG-AP Fab-fragments was then performed as 
described for one color in situ hybdidization (2.6.2.). The second blue color was also similarly 
developed by NBT/BCIP staining. 
 
2.6.4. Whole mount immunostaining 
Fixed embryos were rehydrated in a gradient of washing steps: 75% methanol/PBST, 50% 
methanol/PBST, 25% methanol/PBST, and then three times of washing in PBST. Each wash 
step lasted 5 min. After that, embryos were blocked in PBDT (1% BSA, 2.5% sheep serum, 1% 
DMSO, 0.5% TritonX100 in PBST) at room temperature for 1 h, and then incubated in 
primary antibody diluted in PBDT (see 2.1.5. for antibodies used) at 4°C overnight. On the 
next day, embryos were washed at room temperature in PBSTT (PBST with 0.1% TritonX100) 
for six times, 30 min each, and then subjected to either the diaminobenzidine (DAB) staining 
method or fluorescence detection. 
 
DAB method: Immunostainings with DAB color development were performed with the 
VECTASTAIN® Elite ABC Kit (Vector Labs). Washed embryos were incubated in 
biotinylated secondary antibody diluted in PBDT at 4°C overnight, and then washed at room 
temperature in PBSTT for six times, 30 min each. Next, embryos were incubated in ABC 
solution (one drop of solution A and one drop of solution B mixed in 2.5 ml PBS, pre-
incubated for 30 min before use) at room temperature for 1 h, and then washed in PBSTT for 
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four times, 30 min each. Subsequent color development was achieved using FAST™ 3,3’-
Diaminobenzidine tablets set (Sigma). Embryos were pre-incubated in DAB solution (one 
DAB tablet dissolved in 5 ml water) for 30 min, and then stained in DAB/Urea/H2O2 solution 
(one DAB tablet and one Urea/H2O2 tablet dissolved in 5 ml water) from 30 sec to a few 
minutes. Color development was stopped by washing in PBST several times. 
 
Fluorescence: Fluorescent immunostainings were achieved with four Alexa Fluor® dyes 
(488 or 568) coupled secondary antibodies (Invitrogen), either against mouse or rabbit IgG 
(see 2.1.5. for antibodies used). Washed embryos were incubated in fluorescence labelled 
secondary antibodies diluted in PBDT, depending on the origin of used primary antibodies 
and the fluorescence desired, at room temperature for 1.5 h in dark, and then washed in 
PBSTT for six times, 30 min each, in dark. Samples were imaged under fluorescence without 
long storage. 
 
2.6.5. TUNEL assay 
DNA fragmentation in apoptotic cells was detected using the terminal deoxynucleotidyl 
transferase (TdT)-mediated dUTP nick end labeling (TUNEL) assay, with the ApopTag® 
Peroxidase In Situ Apoptosis Detection Kit (Millipore). Fixed embryos were rehydrated in a 
gradient of washing steps: 75% methanol/PBST, 50% methanol/PBST, 25% methanol/PBST, 
and then three times of washing in PBST. Each wash step lasted 5 min. Endogenous 
peroxidases were quenched by incubating embryos in 3% H2O2/PBST for 10 min, and 
washing in PBST for two times, 1 min each. Embryos were then equilibrated in Equilibration 
Buffer at room temperature for 20 min, and subsequently incubated in Reaction Solution (30% 
TdT enzyme in Reaction Buffer) at 37°C for 1 h. The reaction was stopped by washing in 
Stop/Wash solution at room temperature for 10 min, and then washing in PBST for three 
times, 5 min each. After the TdT reaction, the DIG-labelled UTPs were detected with either 




DAB method: Embryos were incubated in an anti-DIG-peroxidase antibody (provided in the 
kit) at 4°C overnight. On the next day, they were washed in PBST for three times, 5 min each, 
and then continued with DAB color development as described in 2.6.4. 
 
Fluorescence: Embryos were blocked in PBDT at room temperature for 1 h, and then 
incubated in an anti-DIG primary antibody (1:500 diluted in PBDT; from Roche) at 4°C 
overnight. On the next day, they were washed at room temperature in PBSTT for six times, 30 
min each. Next, embryos were incubated in an anti-mouse IgG-Alexa568 secondary antibody 
(1:1000 diluted in PBDT; from Invitrogen) at room temperature for 1.5 h in dark, and then 
washed in PBSTT for six times, 30 min each in dark.  
 
2.6.6. BrdU incorporation and detection 
Cells undergoing DNA synthesis were detected by analyzing incorporation of a thymidine 
analogue into DNA, 5-bromo-2-deoxyuridine (BrdU; Dolbeare, 1995). This labelling 
technique was used to detect the cells at S-phase according to modified protocols. Living 
dechorionated embryos were incubated in fish medium containing 10 mM BrdU (Sigma) with 
15% DMSO for 15 min on ice allowing BrdU incorporation, and then washed shortly for 
several times in fish medium before fixation. Without further incubation, embryos were fixed 
and dehydrated as described in 2.6.1. After rehydration (2.6.4.), embryos were treated in 2 M 
HCl at 37°C for 1 h to expose the DNA, and then washed in PBST for five times, 5 min each. 
The BrdU positive nuclei were subsequently detected by fluorescent immunostaining as 
described in 2.6.4., using an anti-BrdU primary antibody (1:100 diluted in PBDT; from 
DSHB, University of Iowa) and an anti-mouse IgG-Alexa488 secondary antibody (1:1000 
diluted in PBDT; from Invitrogen).  
 
2.7. SDS-PAGE and Western blot analysis 
For quantitative investigation of ERK and phospho-ERK protein levels, Western blots were 
conducted. Proteins were prepared from WT or NPM-ALK mRNA injected embryos at 11 hpf, 
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as well as from transgenic negative siblings (Sib) or positive embryos (Tg+) at 22 hpf in 
alk:HSE:cfp lines. Early staged zebrafish embryos contain big amounts of yolk proteins, 
which affect polyacrylamide gel electrophoresis (PAGE) and subsequent blotting (Link et al., 
2006). Therefore, a deyolking step was first performed. 20-50 dechorionated embryos were 
transferred into 1 ml Deyolking Buffer (55 mM NaCl, 1.8 mM KCl, 1.25 mM NaHCO3) in an 
Eppendorf tube on ice and pipetted several times with a 100 µl tip to dissociate yolk sacs 
from embryos. Subsequently, the tube was shaken at 1,000 rpm at room temperature for 2 min 
on a Themomixer (Eppendorf), and then gently spun at 300 x g for 30 sec to pellet the 
embryos. After removal of supernatant, embryos were similarly washed in 1 ml Washing 
Buffer (110 mM NaCl, 3.5 mM KCl, 2.7 mM CaCl2, 10 mM Tris-Cl pH8.5). Freshly prepared 
2 mM Phenylmethanesulphonyl fluoride (PMSF; Sigma) was added into Deyolking Buffer 
and Washing buffer as a proteinase inhibitor. Protein lysis was done in RIPA buffer (50 mM 
Tris-HCl pH8.0, 150 mM NaCl, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate, with 
freshly added 2 mM PMSF). 2-5 µl RIPA buffer per embryo was added, and a 10 µl tip was 
used to gently pipette the cell mass on ice. When no observable solid remained in the solution, 
the same volume of 2x SDS-PAGE loading buffer (125 mM Tris-HCl pH6.8, 4% SDS, 20% 
glycerol, 0.2% bromophenol blue, with freshly added 10% β-mercaptoethanol) was added. 
The samples were heated up at 95°C for 5 min to denature proteins, and stored at -20°C 
thereafter.  
 
SDS denaturing gels (1 mm thick), with a 5% polyacrylamide stacking part (pH6.8) and a 10% 
resolving part (pH8.8), were prepared and run in electrode buffer (25 mM Tris base, 190 mM 
glycine, 0.1% SDS, pH8.3), using the Mini PROTEAN® Tetra Cell system (Bio-Rad) 
according to the supplier’s manual. The PageRuler™ Prestained Protein Ladder (Fermentas) 
was used for protein size determination. Proteins were electrophoretically transferred from gel 
to nitrocellulose membranes (0.2 µm; Bio-Rad) in electrode buffer with 10% ethanol, using 
the Mini Trans-Blot® Cell (Bio-Rad) at 200 mA for 1h. The transferred membranes were 
washed in glass jars with TBST (150 mM NaCl, 10 mM Tris-Cl pH7.4, 0.1% Tween), and 
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blocked in 5% BSA/TBST at room temperature for 1 h. After that, membranes were 
incubated in anti-ERK or anti-pERK primary antibody diluted in 1% BSA/TBST at 4°C 
overnight, washed in TBST, and then in an anti-rabbit IgG-HRP secondary antibody (Sigma) 
diluted 1:3000 in 5% non-fat milk/TBST at room temperature for 1.5 h. HRP signal was 
detected using the SuperSignal West Pico Chemiluminescent Substrate (Thermo) on a 
Amersham Hyperfilm (GE Healthcare) in a dark room. 
 
2.8. Treatment of zebrafish embryos with an Alk small molecule inhibitor  
The Alk inhibitory small molecule, CEP-26939 (Cephalon), was dissolved in dimethyl 
sulfoxide (DMSO; Sigma) as a 4 mM stock. A further dilution in Danieau’s solution as 40 
µM CEP-26939 with 1% DMSO was used as for treatment of embryos, whereas 1% DMSO 
was used as a negative control in parallel experiments. Living embryos were manually 
dechorionated and incubated in either treatment or control medium, in petri dishes coated 
with 1% agarose. Embryos were treated from 24 hpf to 60 hpf, with changes of fresh medium 
every 12 h, and fixed at 60 hpf. 
 
2.9. Microscopy and image acquisition  
2.9.1. Live imaging 
For imaging living embryos with a stereo binocular microscope (Nikon SMZ1000), embryos 
were anesthetized with 0.01% Tricaine (Sigma), immobilized in 3% methylcellulose in petri 
dishes and positioned with a pair of forceps. Fluorescent light was generated by Intensilight 
C-HGFI (Nikon), with a GFP or CFP filter, respectively. 
 
2.9.2. Sample preparation and microscopy 
For fixed embryos after whole mount in situ hybridization or immunostaining, single-plane 
focused images were taken with a Nikon ECLIPSE 90i microscope at high resolution. 
Embryos were dehydrated in a 70% glycerol/PBST to 100% glycerol gradient and finally flat-
mounted in 100% glycerol, to improve optic transparency. The yolk was manually removed 
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with forceps and needles in glycerol. Manual sections were cut by a scalpel. Samples were 
orientated in a drop of glycerol on glass slides (Continental Lab Products) and covered with 
cover slips (VFM No.1.5, CellPath). One or two cover slips on each sides of the sample were 
placed, forming a “bridge” with the cover slip on top, preventing the sample from being 
pressed. Alexa-488 fluorescence was excited and detected with a GFP-B filter, and Alexa-568 
with a TRITC filter. Images were acquired using the software NIS-Elements BR 3.0 (Nikon). 
 
2.9.3. BODIPY staining 
BODIPY® Dyes are fluorescent dyes staining lipid structures including cell membranes, 
often used as counterstains to cytoplasmic GFP (Cooper et al., 2005). Modified from 
established protocols (Cooper et al., 2005; Godinho, 2011), BODIPY-TR (Texas-Red) 
(Molecular Probes, Invitrogen) was used here to stain cell membranes for cell counting. Prior 
to imaging, parts of the embryo, such as the hindbrain in this experiment, were dissected with 
a scalpel and stained in 20 µM BODIPY-TR/PBST for 1h at room temperature. Samples were 
then washed in PBST for three times, 10 min each, and processed for imaging without long 
storage. Samples were protected from light during staining and washing steps.  
 
2.9.4. Confocal microscopy 
Confocal microscopic images were taken with a Zeiss LSM 510 Meta laser scanning 
microscope. Samples were dissected and mounted in glycerol on glass slides. Alexa-488 
fluorescence was excited with an Argon multi-line gas laser at 488 nm, and detected through 
a 505-530 nm band-pass filter. Alexa-568 and BODIPY-TR fluorescence were excited with a 
Helium Neon gas laser at 543 nm, and detected through a 560 nm long-pass filter. All images 
were scanned by multi-channel mode. 
 
2.9.5. Image processing, cell counting and statistical analysis 
Images were processed with Zeiss LSM Image Browser Version 4.2, ImageJ 1.43u, and 
Adobe Photoshop CS3 software. Cells were counted manually in confocal Z-projections or 
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3D projections. Each sample was counted three times, and the average was determined. 
Statistical analysis was done with the GraphPad Prism 5 software. Unpaired two-tailed 
Student’s t-test was used in comparisons between treated and control groups. Bar graphs were 





3.1. Cloning of a full length zebrafish alk sequence 
A zebrafish anaplastic lymphoma kinase (alk) sequence has been predicted in the NCBI 
database (GenBank: XM_686872.2) as a 4164 base pairs (bp) transcript coding for a 1387 
amino acids (aa) protein. In the Ensembl genome database, which is a joint project between 
EMBL, EBI and the Wellcome Trust Sanger Institute, zebrafish alk has been recently 
annotated on chromosome 17: 47,709,444 - 47,826,608 (ENSDARG00000095833, Zv9), but 
this sequence represents an incomplete transcript encoding C-terminal and intracellular part of 
the protein and its 3’-untranslated region (UTR), lacking the N-terminus and translation 
initiation site. It appears that up to the writing of this thesis the corresponding part of genome 
where the remaining alk sequence locates has not been covered by the zebrafish genome 
sequencing project (Zv9) yet. However, the existing sequences from these two sources 
(XM_686872.2 and ENSDARG00000095833) are matching with each other in the 
overlapping region, with only a few nucleotide substitutions which probably reflect single 
nucleotide polymorphisms (SNP). Their encoding protein sequences are 100% identical. 
 
To identify the missing zebrafish alk N-terminal end sequence with its 5’UTR, I conducted a 
5’-Rapid Amplification of cDNA Ends (RACE) reaction. Based on the obtained 5’UTR 
sequence  and the already known sequences present in the databases described above, new 
primers were designed to amplify a 544 bp fragment containing alk 5’UTR and its coding 
sequence start site, as well as a 653 bp fragment containing alk coding sequence end and its 
3’UTR. These were done by regular RT-PCR to confirm their genuineness. Zebrafish alk has 
a minimum confirmed length of 216 bp 5’UTR and a 139 bp 3’UTR. Next, the full length 
zebrafish alk coding sequence was successfully cloned and sequenced. This sequence has a 
4167 bp coding region and no alternative splice isoforms were observed. This transcript 
encodes an 1388 amino acids (aa) protein with an almost 100% identical match with the 
zebrafish alk sequences available in NCBI and Ensembl databases, except an additional 
Glutamine (Q1280) in a 13 Q repeat located at the most C-terminal end after the tyrosine 
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kinase domain, and a Serine (S309) to Alanine (A309) replacement in a 4 S repeat located in 
the middle of its N-terminus (Fig. 3). These differences reflect possible polymorphism 
between zebrafish wild type strains, because the zebrafish genome sequencing project in 
Wellcome Trust Sanger Institute uses the Tübingen strain, while the AB strain was used in 
my study. Nevertheless, these changes are very unlikely to have any impact on the protein 
function, given their amino acid identity and locations. 
 
Zebrafish (Danio rerio) Alk was compared with human ALK (Homo sapiens, NM_004304.4), 
mouse Alk (Mus musculus, NM_007439.2) and chicken Alk (Gallus gallus, XM_419364.3) 
in their translated protein sequences (Fig. 3). Zebrafish Alk has a highly conserved tyrosine 
kinase (TK) domain (aa 795-1062), 89.6% identical to the human ALK TK domain (1116-
1383). However, the N-terminus of zebrafish Alk (1-708) only shares 25.3% identity with its 
human counterpart (1-1029) and seems to be shorter. Similarly, chicken Alk also has a 
conserved TK domain (970-1237) that is 95.5% identical to human, but a shorter N-terminus 
(1-883) with 53.3% identity to human ALK. In a more comprehensive alignment involving 17 
vertebrates from human to fish, and fruit fly (Drosophila melanogaster), the TK domain 
appeared as the most conserved part among all Alks in different animals. On the contrary, the 
Alk N-terminus seems to exhibit much more variety (See detailed analysis of alignments in 
4.2.). This indicates that the N-terminus of Alk has undergone extensive divergence during 
vertebrate evolution. 
 
Despite the difference in its N-terminus, zebrafish Ale still shares significant similarity with 
human ALK in its functional domains (Fig. 3). The LDLa motif (human: 437-473) and the 
second MAM domain (human: 475-637) could be identified in zebrafish Alk with 54.1% and 
38.2% similarities, respectively. The G-rich domain (human: 816-940) and the 
transmembrane domain (human: 1030-1058) were also highly similar in zebrafish Alk with 
69.6% and 79.3% similarities, respectively. In the tyrosine kinase domain, three residues that 
are known to be most frequently mutated in human ALK gain-of-function neuroblastoma, 
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F1174, F1245 and R1275 (Chen, et al., 2008; Mosse et al., 2008), are identical in zebrafish 
Alk (F853, F924 and R954 respectively). These three residues are conserved in all 18 species 
analyzed in 4.2. without exception (alignment not shown), indicating that they are critical for 
Alk kinase function. Moreover, within the activation loop of its kinase domain, ALK contains 
a YXXXYY motif in which the three tyrosines Y1278, Y1283 and Y1284 are phosphorylated 
upon signal activation by dimerization and autophosphorylation (Palmer et al., 2009). These 
tyrosines are also present in zebrafish Alk. In fact, this motif always presents as YRASYY in 
all vertebrate Alks, and as a slight modification, YRSDYY, in fruit fly. The above analyzed 
sequence features strongly point out that this identified sequence is the ortholog of human 
ALK in zebrafish.  
 
Furthermore, using the newly obtained zebrafish alk 5’ DNA sequence to BLAST against 
NCBI database again, a BAC clone in linkage group 17 (DKEYP-47F9, GenBank: 
BX663528.10) was identified containing multiple sequence stretches matching the isolated 
cDNA sequence including the 5’UTR. Thus, this BAC obviously contains the zebrafish alk 
genomic sequence where its N-terminus locates. Therefore, a detailed sequence alignment 
was carried out, which revealed the arrangement of the first few introns and exons in 
zebrafish alk (See in 3.4.1.). All of these sequence data provided the first insight into a 
potential functionally conserved receptor tyrosine kinase ortholog, zebrafish anaplastic 
lymphoma kinase (alk).  This allowed further functional studies in this model organism. 
Riboprobes were designed based on the available sequences to perform in situ hybridization 
expression studies. Full length zebrafish alk transcript was used in over-expression 
experiments, and knowledge about its 5’UTR and first intron-exon boundaries sequences 
were utilized for the design of translation blocking or splicing preventing Morpholino 





               1                                                                   70 
Hs ALK     (1) MGAIGLLWLLPLLLSTAAVGSGMGTGQRAGSPAAGPPLQPREPLSYSRLQRKSLAVDFVVPSLFRVYARD 
Mm Alk     (1) MGAAGFLWLLPPLLLAAASYSGAATDQRAGSPASGPPLQPREPLSYSRLQRKSLAVDFVVPSLFRVYARD 
Gg Alk     (1) ---------------------------------------------------------------------- 
Dr Alk     (1) ---------------------------------------------------------------------- 
 
               71                                                                 140 
Hs ALK    (71) LLLPP--SSSELKAGRPEARGSLALDCAPLLRLLGPAPGVSWTAGS--PAPAEARTLSRVLKGGSVRKLR 
Mm Alk    (71) LLLPQPRSPSEPEAGGLEARGSLALDCEPLLRLLGPLPGISWADGASSPSPEAGPTLSRVLKGGSVRKLR 
Gg Alk     (1) -------------------------------------------------------------MGGQEGCLG 
Dr Alk     (1) ---------------------------------------------------------------------- 
 
               141                                                                210 
Hs ALK   (137) RAKQLVLELGEEAILEGCVGPPG-EAAVGLLQFNLSELFSWWIRQGEGRLRIRLMPEKKASEVGREGRLS 
Mm Alk   (141) RAKQLVLELGEETILEGCIGPPEEVAAVGILQFNLSELFSWWILHGEGRLRIRLMPEKKASEVGREGRLS 
Gg Alk    (10) SAEGFKYSAGVEPGSRKWDPKVEVSLASGEQARPFRQFGFLVITLGSSFLNSRIWVE-------R----S 
Dr Alk     (1) ---------------------------------------------------------------------- 
 
               211                                                       ^^^^^^^^^280 
Hs ALK   (206) AAIRASQPRLLFQIFGTGHSSLESPTNMPSPSPDYFTWNLTWIMKDSFPFLSHRSRYGLECSFDFPCELE 
Mm Alk   (211) SAIRASQPRLLFQIFGTGHSSMESPSETPSP-PGTFMWNLTWTMKDSFPFLSHRSRYGLECSFDFPCELE 
Gg Alk    (69) ----E------AVLLLTGLSSLDLPTSSPPLPPGLSSWNLTWIMRDTSPFFSHRGRHIFDCNFETPCELE 
Dr Alk     (1) --------------------------------------------------------------------MC 
 
               281^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^350 
Hs ALK   (276) YSPPLHDLRNQSWSWRRIPSEEASQMDLLDGPGAERSKEMPRGSFLLLNTSADSKHTILSPWMRSSSEHC 
Mm Alk   (280) YSPPLHNHGNQSWSWRHVPSEEASRMNLLDGPEAEHSQEMPRGSFLLLNTSADSKHTILSPWMRSSSDHC 
Gg Alk   (129) YSFSSKDQESPNKAWLRVSAEDISQLNIPGGPERDHSENTPKGSFLFLNASES--PVILSPWLRSSSDQC 
Dr Alk     (3) DNAAEDDPKMAEGAGFVSDGQSCPSVRSQEGVEAPQAGDGPPG---------AT-LTDYSPLQALCRPRC 
 
               351^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^420 
Hs ALK   (346) TLAVSVHRHLQPSGRYIAQLLPHNEAAREILLMPTPGKHGWTVLQGRIGRPDNPFRVALEYISSGNRSLS 
Mm Alk   (350) TLAVSVHRHLQPSGRYVAQLLPHNEAGREILLVPTPGKHGWTVLQGRVGRPANPFRVALEYISSGNRSLS 
Gg Alk   (197) VVQVAVYKFFQQSGEYIARILPIDGSSSEILTEQNPEKRGWELLQRRVGHREKPFRISLEYIAKGNKSIA 
Dr Alk    (63) LFLVLTLLVFS-------------------------LLFSWAVVHLSLAARSKPFRISSSYSQPGEIETA 
 
               421^^^^^^^^^         !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! ^^^^^^^^490 
Hs ALK   (416) AVDFFALKNCSEGTSPGSKMALQSSFTCWNGTVLQLGQACDFHQDCAQGEDESQMCRKLPVGFYCNFEDG 
Mm Alk   (420) AVDFFALKNCSEGTSPGSKMALQSSFTCWNGTVLQLGQACDFHQDCAQGEDEGQLCSKLPAGFYCNFENG 
Gg Alk   (267) AVDSFAMKNCTTGAASVSKMALEGSFSCWNGTSIRLGQACDFIRDCTEGEDEGAMCRKLPSGFYCSFEEG 
Dr Alk   (108) TYDPRYSTNCTTRSS--QNVTLRGRYHCRGGREINVSQLCDFSIDCPQGDDEGEHCRQFLNGSYCSFGRE 
 
               491^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^560 
Hs ALK   (486) FCGWTQGTLSPHTPQWQVRTLKDARFQDHQDHALLLSTTDVPASES-ATVTSATFPAPIKSSPCELRMSW 
Mm Alk   (490) FCGWTQSPLSPHMPRWQVRTLRDAHSQGHQGRALLLSTTDILASEG-ATVTSATFPAPMKNSPCELRMSW 
Gg Alk   (337) DCGWMEGSAASRASPWRIGSLEYNRFPSVADYALILDTNKAPAGAS-TVMTSATFPTPLRNSPCELRMSW 
Dr Alk   (176) DCGWQPVQGRGPQWRAHPSIPQSLRSSCPSPGALLAIDSQPKGQRGSAQVRSPLFFYPLRNAPCMVKFWV 
 
               561^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^630 
Hs ALK   (555) LIRGVLRGNVSLVLVENKTGKEQGRMVWHVAAYE-GLSLWQWMVLPLLDVSDRFWLQMVAWWGQGSRAIV 
Mm Alk   (559) LIRGVLRGNVSLVLVENKTGKEQSRTVWHVATDE-GLSLWQHTVLSLLDVTDRFWLQIVTWWGPGSRATV 
Gg Alk   (406) LIRGVLLGNISLVLVENKTGKELSRTFWHSANSE-GLGIWQWLILPLPDILDRFWFQIIASWERGSNAVI 
Dr Alk   (246) CGS--SNGALSLWITENSTGPEGQRSLWNSTSEANMGKGWKLITLPLFGLVDLFYLQFSADISSSAGIAF 
 
               631^^^^^^^^^^^                                                     700 
Hs ALK   (624) AFDNISISLDCYLTISGEDKILQNTAPKSRNLFERNP------NKELKPGENSPRQTPIFDPTVHWLFTT 
Mm Alk   (628) GFDNISISLDCYLTISGEEKMSLNSVPKSRNLFEKNP------NKESKSWANISGPTPIFDPTVHWLFTT 
Gg Alk   (475) AFDNVSLSLDCFLTINGE-KITRSSTPDSSNLLTSRRGLNNFGWEQKLLGNLQLSTAPISGPADHWLFTT 
Dr Alk   (314) AVDNFTLSMECFLETNGEFPPVAPISPTQALFTQSNE--------NIKTTTTLYGGPGASTESVKWIFHT 
 
               701                                                                770 
Hs ALK   (688) CGASGPHGPTQAQCNNAYQNSNLSVEVGSEGPLKGIQIWKVPATDTYSISGYGAAGGKGGKNTMMRSHGV 
Mm Alk   (692) CGASGPHGPTQAQCNNAYQNSNLSVVVGSEGPLKGVQIWKVPATDTYSISGYGAAGGKGGKNTMMRSHGV 
Gg Alk   (544) CGASGAYGPTQSQCNDAYRNSNLSVIVGAEGILQGIQIWRVPATNTYSISGYGAAGGKGGKNTMVRSHGV 
Dr Alk   (376) CGATGQDGPTPTQCSNSYRNTNVNVTVGTKGPFKGIQMWQVPETRKYRITAYGAAGGRS-VLAVHKSHGV 
 
               771                                                       $$$$$$$$$840 
Hs ALK   (758) SVLGIFNLEKDDMLYILVGQQGEDACPSTNQLIQKVCIGENNVIEEEIRVNRSVHEWAGGGGGGGGATYV 
Mm Alk   (762) SVLGIFNLEKGDTLYILVGQQGEDACPRANQLIQKVCVGENNVIEEEIRVNRSVHEWAGGGGGGGGATYV 
Gg Alk   (614) SVLGIFDLQKDDTLYILVGQQGEDACPSTNDVIQKVCIGENNVIEEEIRVNRSVNEWAGGGGGGGGATYI 
Dr Alk   (445) YMTGDFLLQKDELLYILVGQEGEDACPNMVPTMDRICR------EQ-QGPSINKTQLKGGGGGGGGGTYV 
 
               841$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$910 
Hs ALK   (828) FKMKDGVPVPLIIAAGGGGRAYGAKTDTFHPERLENNSSVLGLNGNSGAAGGGGGWNDNTSLLWAGKSLQ 
Mm Alk   (832) FKMKDGVPVPLIIAAGGGGRAYGAKTETFHPERLESNSSVLGLNGNSGAAGGGGGWNDNTSLLWAGKSLL 
Gg Alk   (684) FKMENGEPVPLIIAAGGGGRAYRAKTDTFHPERLENDSSVPGLNGNSGAAGGGGGWNDNTSFLWSGKSLL 





               911$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$                        980 
Hs ALK   (898) EGATGGHSCPQAMKKWGWETRGGFGGGGGGCSSGGGGGGYIGGNAASNNDPEMDGEDGVSFISPLGILYT 
Mm Alk   (902) EGAAGGHSCPQAMKKWGWETRGGFGGGGGGCSSGGGGGGYIGGNAASNNDPEMDGEDGVSFISPLGILYT 
Gg Alk   (754) EGATGGRSCPQAMKKWGWETRGGFGGGGGGCSSGGGGGGYIGGNAAEDNDPEMDGEDGVSFINPIGTLYT 
Dr Alk   (577) LGGQGG----EPCQAMGWKTRGGFGGGGGACTAGGGGGGYRGGSAWHDNDPRKDGDDGTSYISPDGEMYL 
 
               981                                                             1048** 
Hs ALK   (968) PALKVMEGHGEVNIKHYLNCSHCEVDECHMDPESHKVICFCDHGTVLAEDGVSCIVSPTP------EPHL 
Mm Alk   (972) PALKVMEGHGEVNIKHYLNCSHCEVDECHMDPESHKVICFCDHGTVLADDGVSCIVSPTP------EPHL 
Gg Alk   (824) PALKVTEGHGEVDIRLHLNCSHCEMDECRVDLETQKVICFCEPGTDLAEDGVSCIAEPT--------VHL 
Dr Alk   (643) EPLKGMEGNGEVIINPVQNCSHCESGDCHETSEG--MVCYCDEELTLAPDGVSCINSTELPLLPAQPSLS 
 
               ***************************                                       1120 
Hs ALK  (1032) PLSLILSVVTSALVAALVLAFSGIMIVYRRKHQELQAMQMELQSPEYKLSKLRTSTIMTDYNPNYCFAGK 
Mm Alk  (1036) PLSLILSVVTSALVAALVLAFSGIMIVYRRKHQELQAMQMELQSPEYKLSKLRTSTIMTDYNPNYCFAGK 
Gg Alk   (886) PLSLVLSVVTSALVAALILAFSGIMIVYRRKHQELQAMQMELQSPEYKLSKLRTSTIMTDYNPNYCFAGK 
Dr Alk   (711) HLALGLSVGTSALIAALLLAVSGVMIMYRRKHTELQSIQLELQSPDCKLSKLRASTIMTDYNPNYCFGGK 
 
               1121          ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~1190 
Hs ALK  (1102) TSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII 
Mm Alk  (1106) TSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII 
Gg Alk   (956) TTSISDLKEVPRKNISLIRGLGHGAFGEVYEGQVAGIPSDPTPLQVAVKTLPEVCSEQDELDFLMEALII 
Dr Alk   (781) TASVNDLKEVPRRNISLTRGLGHGAFGEVYEGLAVGIPGEPSPMQVAVKTLPEVCSEQDELDFLMEALII 
 
               ~~#~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~1260 
Hs ALK  (1172) SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 
Mm Alk  (1176) SKFNHQNIVRCIGVSLQALPRFILLELMAGGDLKSFLRETRPRPNQPTSLAMLDLLHVARDIACGCQYLE 
Gg Alk  (1026) SKFNHQNIVRCIGVSLQALPRFILLELMAGGDLKSFLRETRPRPNQLSSLSMLDLLHVAHDIACGCQYLE 
Dr Alk   (851) SKFSHQNIVRCIGVSLQALPHFILLELMAGGDLKSFLRETRPRLEHPSSLTMVDLLNIARDIARGCQYLE 
 
               ~~~#~~~~~~~~~~~~~~~~~~~~~~~~~~~~~#~~+~~~++~~~~~~~~~~~~~~~~~~~~~~~~1330 
Hs ALK  (1242) ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 
Mm Alk  (1246) ENHFIHRDIAARNCLLTCPGAGRIAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 
Gg Alk  (1096) ENHFIHRDIAARNCLLTCRGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 
Dr Alk   (921) ENQFIHRDIAARNCLLTCKGPGRVAKIGDFGMARDIYRASYYRKGGRAMLPVKWMPPEAFMEGIFTSKTD 
 
               1331~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~1400 
Hs ALK  (1312) TWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 
Mm Alk  (1316) TWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 
Gg Alk  (1166) TWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTNGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILE 
Dr Alk   (991) TWSFGVLLWEIFSLGYMPYPSRSNQEVLEFVTNGGRMDPPKNCPGPVYRIMTQSWQHQPEDRPNFSTILE 
 
               ~~1403                                                            1470 
Hs ALK  (1382) RIEYCTQDPDVINTALPIEYGPLVEEEEKVPVRPKDPEGVPPLLVSQQAKREEERSPAAP---------- 
Mm Alk  (1386) RIEYCTQDPDVINTALPIEYGPVVEEEEKVPMRPKDPEGMPPLLVSPQP-AKHEEASAAP---------- 
Gg Alk  (1236) RIEYCTQDPDVINTALPVEYGPSIEEEEKVAIRPEDPEGIPPLLVSSHQDKKDDKQTLPS---------- 
Dr Alk  (1061) RIDYCLQDPDVVNVPLPVEYGPIPEEEERVPMRPEDPSAPSLLVSPQGTEDVPSATHSAQSKKDGEAIHM 
 
               1471                                                              1540 
Hs ALK  (1442) ---------PPLPTTSSGKAAKKPTAAEISVRVPRGP------AVEGGHVNMAFSQSNPPSELHKVHGSR 
Mm Alk  (1445) ---------QPAALTAPGPSVKKPPGAGAGAGAGAGAGPVPRGAADRGHVNMAFSQPNPPPELHKGPGSR 
Gg Alk  (1296) ---------PPPLPSAITAGKALGKAGSLELSVPGKVQAAS----GGGHINMAYAQSNPPSELHKSRGSR 
Dr Alk  (1131) ANLSTDSKLPPVPPSQPHPHHHLQTPVVTAPVPASKPSSTTSNAQDGGHVNLGFMQAHSSEKESRNR--- 
 
               1541                                                              1610 
Hs ALK  (1497) NKPTSLWNPTYGSWFTEKPTKKNNPIAKKEPHDRGNLGLEGSCTVPPNVATGRLPGASLLLEPS------ 
Mm Alk  (1506) NKPTSLWNPTYGSWFTEKPAKKTHPPPGAEPQARAGAAEGGWTGPGAGPRR---AEAALLLEPS------ 
Gg Alk  (1353) NKPTNLWNPTYGSWFAEKQASKNKPLLEKEMPERENLGHEGNCTVGPNIVTGRLPGSSLLLEPS------ 
Dr Alk  (1198) -KPTNLWNPTYGSWFLQQQQKRQQVQAQRQTSG-PRIPGEGQEQVGRTVTVAEALGLQQQHKQQQYQQQL 
 
               1611                                                              1680 
Hs ALK  (1561) ----------------------------------SLTANMKEVPLFRLRHFPCGNVNYGYQQQGLPLEAA 
Mm Alk  (1567) ----------------------------------ALSATMKEVPLFRLRHFPCGNVNYGYQQQGLPLEAT 
Gg Alk  (1417) ----------------------------------SLTASVKEVPLFRLRHFPCGNVNYGYQQQGLPLEAS 
Dr Alk  (1266) QRQQQQQQQQQQQQQGLCRPLLPPPPPPAPTPLLLDSATLAPVPLYRLRRFPCGNIGYGYQEQGLPMEPM 
 
               1681                                             1733 
Hs ALK  (1597) TAPGAGHYEDTILKSKNSMNQPGP----------------------------- 
Mm Alk  (1603) AAP-----GDTMLKSKNKVTQPGP----------------------------- 
Gg Alk  (1453) TPPCATSYEDPALRNKNHISQQGP----------------------------- 






3.2. Zebrafish alk is expressed during embryonic neurogenesis and enriched in the 
nervous system 
As a first step of a zebrafish alk functional study, RNA transcript levels were determined by 
RT-PCR at developmental stages from 6 hours post fertilization (hpf) to 72 hpf, as well as in 
different tissues from adult fish. alk expression initiates at a time point between 6 hpf and 12 
hpf, and continuously increases up to 72 hpf with a significant shift at 48 hpf (Fig. 4A). The 
starting point of alk expression shortly after gastrulation corresponds to the stage when 
segmentation and neurulation begins in zebarfish at 10 hpf (Kimmel et al., 1995). It was 
reported that the neurogenesis peak in the zebrafish hindbrain, when the neuron to progenitor 
ratio change is highest, happens between 24 hpf and 48 hpf (Lyons et al., 2003). The increase 
of alk RNA levels from 12 hpf to 48 hpf therefore coincides with the zebrafish neurogenesis 
time line. 
 
In adult tissues, alk is enriched in brain, with some low level expression in heart, caudal fin, 
as well as testis, but not in liver (Fig. 4B). beta-actin was used as a loading control for tissue 
RT-PCR and gapdh was used in RT-PCR for embryonic stages. This was because 
significantly higher levels of gapdh were detected in heart and liver (data not shown), 
possibly due to high energy turn-over in those organs. The enrichment of alk in adult brain 
suggests that it may function also in adulthood such as adult neurogenesis and neural 
regeneration, which is prominent in zebrafish (Grandel et al., 2006). 
 
Fig. 3. Sequence alignment of four vertebrate Alks. (on page 51-52) 
Identical residues: foreground white, background black; Conservative changes: foreground 
white, background grey; Similar changes: foreground black, background grey; Non-similar 
changes:  foreground black, background white. ^^^^: MAM domains; !!!!: LDLa motif; $$$$: 
G-rich domain; ****: transmembrane domain; ~~~~: tyrosine kinase domain; #: most 
frequent human ALK gain-of-function neuroblastoma mutation residues (F1174, F1245 and 
R1275 as in human); +: tyrosine residues essential for phosphorylation upon activation. Hs: 
Homo sapiens, human (NM_004304.4); Mm: Mus musculus, mouse (NM_007439.2); Gg: 
Gallus gallus, chicken (XM_419364.3); Dr: Danio rerio, zebrafish (this study). 
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To gain insight into the spatial control of alk expression during embryonic development, 
whole mount in situ hybridization was done using an antisense alk riboprobe comprising a N-
terminal sequence (nt 6-885) in embryos at 24 hpf, 48 hpf and 72 hpf (Fig. 4C-O). Another 
antisense probe was designed corresponding to the alk C-terminal sequence (nt 3393-4071) 
and showed identical patterns (data not shown), thus further confirming the correct identity of 
the cloned alk full length sequence. Moreover, a sense sequence probe was used as negative 
control, which showed no staining (Fig. 4F’-O’). As early as 24 hpf, alk transcripts were 
broadly expressed in the entire developing central nervous system (CNS), i.e. the neural tube 
(Fig. 4C,F). In addition, at 48 hpf, distinct expression domains with elevated levels emerged 
in the midbrain and hindbrain (Fig. 4D,G), which remained stable at 72 hpf (Fig. 4E,H). More 
detailed images were acquired by cross-sectioning 24 hpf embryos at forebrain (Fig. 4I), 
midbrain (Fig. 4J), and hindbrain levels in rhombomeres 2 (Fig. 4K) and 5 (Fig. 4L), as well 
as 48 hpf embryos at forebrain (Fig. 4M), midbrain (Fig. 4N), and rhombomeres 5 levels (Fig. 
4O). These sections showed that alk is expressed in the entire neural tube, with higher 
expression in ventral regions than dorsal regions of the forebrain (Fig. 4I) and midbrain (Fig. 
4J). In the hindbrain, those regions with higher expression are where differentiated neurons 






Fig. 4. Expression of zebrafish alk. 
(A) RT-PCR of cDNA at different stages. gapdh is used as loading control. (B) RT-PCR of cDNA 
from different adult tissues. beta-actin is used as loading control. (C-E) Lateral views of whole 
embryos at 24 hpf (C), 48 hpf (D) and 72 hpf (E), with dorsal up and anterior to the left. (F-H) 
Dorsal high magnification views of head regions at 24 hpf (F), 48 hpf (G) and 72 hpf (H). 
Anterior to the left. (I-L) Cross sections of embryos at 24 hpf, at forebrain (I), midbrain (J), 
rhombomere 2 (K) and rhombomere 5 (L) levels, corresponding to positions indicated by 
lines in (C). (M-O) Cross sections of embryos at 48 hpf at forebrain (M), midbrain (N), and 
rhombomere 5 (O), corresponding to positions indicated by lines in (D). (F’-O’) Respective 
negative controls using a sense probe. Scale bars: C-H, 200 µm; I-O, 100 µm. 
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3.3. Gain-of-function studies in zebrafish by overexpressing alk 
3.3.1. Overexpression of alk and NPM-ALK by mRNA injection 
As a first experiment testing alk over- and mis-expression, full length capped zebrafish alk 
mRNA (650 ng/µl) was injected into zebrafish embryos at the one-cell stage. Mouse Alk (650 
ng/µl) and human oncogenic NPM-ALK (50 ng/µl) were used as positive controls (Fig. 5). 
The fusion protein NPM-ALK is a known highly oncogenic version of Alk. Its expression in 
zebrafish caused a developmental arrest in a majority of embryos (46/49, 93.9%) at 
gastrulation. These embryos developed protrusions (Fig. 5B) at a stage when uninjected wild 
type embryos reached the 6-10 somites stage (12-14 hpf, Fig. 5A). The majority of zebrafish 
alk (45/50, 90%, Fig. 5D) or mouse Alk injected embryos (38/38, 100%, Fig. 5E) developed 
an overall abnormal embryo structure when compared to uninjected wild type embryos at 24 
hpf (Fig. 5C). Although these embryos did not show a phenotype as severe as that in NPM-
ALK injected embryos, disruptions of normal morphology were apparent all over the embryo 
including the developing brain. In some embryos, protrusions could also be seen but at less 
frequency than in NPM-ALK injected embryos. None of the embryos injected with either of 
the three mRNAs continued with development and survived the second day. 
 
 
Fig. 5. Human NPM-ALK, zebrafish alk and mouse Alk mRNA injections into zebrafish. 
(A,B) Wild type embryo (A) or embryo injected with human NPM-ALK mRNA (B) at 10 somite 
stage (14hpf). Arrowheads point to protrusions. (C-E) Wild type embryo (C), zebrafish alk 
mRNA (D) or mouse Alk mRNA (E) injected embryo at 24hpf. All images show lateral views 
with anterior to the left. 
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These mRNA injection experiments provided a first hint that over- and mis-expressed 
zebrafish alk has a severe impact on development and leads to abnormal morphology, in a 
similar fashion as mouse Alk or human oncogenic and constitutively active NPM-ALK. The 
used mRNAs were immediately translated after injection, and is stable for several hours until 
being degraded. To avoid early-lethal effects of the potentially oncogenic activity during 
gastrulation and achieve temporal control mis-expression, a heat shock inducible alk 
transgenic was next generated for functional analysis. 
 
3.3.2. Overexpression of alk in heat-shock inducible transgenic fish 
Numerous studies in fish models have been reported using heat shock inducible promoters in 
transgenic approaches to study gene function (Halloran et al., 2000; Molina et al., 2000; 
Scheer et al., 2002; Grabher and Wittbrodt, 2004; Hardy et al., 2007; Placinta et al., 2009). 
Most of those transgenic methods expressed green fluorescent protein (gfp) or other genes of 
interest (GOI) under the control of an hsp70 promoter upon heat shock induction at 37°C - 
40°C. A major problem in those reported studies were high levels of background “leaking” 
expression especially in the eyes (Blechinger et al., 2002) due to endogenous hsp70 promoter 
activity. Moreover, a second potential drawback is the transgenic selection tag, usually a 
fluorescent protein fused in frame to the GOI. This might compromise the GOI’s endogenous 
structure and hence activity and function. 
 
To eliminate these disadvantages, Bajoghli et al. (2004) reported an artificial bidirectionally 
inducible promoter consisting of eight multimerized minimal heat shock elements (HSE). 
This modified architecture lacking any other regulatory elements present in the original 
promoter largely improved specificity and reduced background activity. Combined with the I-
SceI meganuclease method for transgenesis, which elevates genome integration efficiency 
(Thermes et al., 2002), this construct performed extraordinary well in generating stable 
transgenic Medaka (Oryzias latipes) as it was originally described (Bajoghli et al. 2004). 
However, this method using minimal HSE (from Medaka) has not been well tested in 
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zebrafish yet. To use this transgenic system, several preliminary experiments need to be 
conducted to verify whether it also works in zebrafish. Unlike tissue specific promoter, heat 
shock inducible promoter will ideally trigger the expression of transgene in every cell but not 
a tissue restricted manner; however, it could control the timing of overexpression. 
Considering possible oncogenic defects of overexpressed alk, this is the right choice of 
method. 
 
In order to keep the background alk expression at minimum level in the transgenics, I 
generated several stable transgenic zebrafish lines using similar heat shock inducible 
constructs (Fig. 6A,B). Compared to the original construct, a small modification was 
introduced by replacing gfp with cyan fluorescent protein (cfp). Stable lines were established 
by injecting DNA constructs and I-SceI meganuclease into one cell staged embryos (F0), 
 
Fig. 6. Heat shock inducible transgenic zebrafish lines. 
(A,B) Diagrams illustrating transgenic cassettes for control line (A) and alk overexpression 
lines (B). The construct reported by Bajoghli et al. contains eight repeat heat shock elements 
(HSE) with bidirectional promoter activity. This construct was engineered in such a way that 
alk and cfp were put on each side (B), or just cfp in the control line (A). (C-E) 24hpf embryos 
from the control line (HSE:cfp, C), first alk overexpression line (alk:HSE:cfp1, D), and second 
alk overexpression line (alk:HSE:cfp2, E). All embryos received a 1.5 hour 39.5°C heat shock 
at 10.5 hpf. Bright field images on top and images of the same embryos in CFP channel 
below. Inserts are representative transgenic positive embryos in each line. Arrows point to 
transgenic negative siblings in each line. They are morphologically normal and not visible in 
the CFP channel.  
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selecting those with strong mosaic cfp expression upon heat shock, and screen their progenies 
for genome integration and germ line transmission (See details in 2.5. and 4.1.). Lines from 
four positively identified independent F0 founders were established as stable alk 
overexpressing lines, two of which having strong CFP levels. These lines (alk:HSE:cfp1 and 
alk:HSE:cfp2; Fig. 6D,E) were used in the following experiments. Most of the following 
experiments were done in line alk:HSE:cfp1, or repeated in both lines for some cases. The 
obtained findings were always identical in both lines demonstrating reproducibility of the 
results. In addition, one CFP control line was established that lacked any alk sequence and 
showed comparable CFP level to the alk lines (Fig. 6C). F1 or F2 transgenic positive fish 
were used in inbreeding crossings. Their F2 or F3 progenies had between 20-40% embryos 
showing no CFP signal after heat shock and were considered as transgenic negative 
individuals (arrows in Fig. 6). These embryos were labelled as transgenic negative siblings 
(Sib), and were used as negative controls within each line. This distribution of positive and 
negative siblings suggested that the majority of parental fish were heterozygous for the 
transgene. No CFP signal was ever observed in embryos without heat shock in all three lines. 
 
Notably, after a 1.5 hour heat shock at 39.5°C at 10.5 hpf stage, all of the transgenic positive, 
alk expressing embryos in both lines (inserts in Fig. 6D,E) showed morphological 
abnormalities similar to those of alk mRNA injected embryos (Fig. 5D). On the other hand, 
transgenic positive embryos in the CFP control line (insert in Fig. 6C) did not show any 
morphological defect, suggesting that the overexpressed CFP had no unspecific side effect. 
Those transgenic negative siblings were normal in all of the three lines, indicating also that 
the heat shock treatment used here did not affect embryogenesis.  
 
While the CFP signals were found to be decreasing over the days following the heat shock in 
a similar manner for all of three lines (data no shown), the same stabilities for Alk expression 
had to be confirmed. In the absence of suitable antibody, in situ hybridizations were done 
detecting exogenous alk mRNA overexpressed by the transgene at different time points after a 
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heat shock at 24 hpf (Fig. 7). In this experiment the heat shock was not done at 10.5 hpf as 
before, because embryos with early expression of alk were severely affected and did not 
survive long enough. A similarly late heat shock at 24 hpf was also used in screening of 
transgenic lines for maintenance. Fig. 7 shows that exogenous alk RNA was ectopically 
expressed at high levels across the entire embryo, as soon as 1 hour after heat shock (Fig. 7A). 
alk transcripts were degraded over time and appeared as reduced and patchy staining at 6 
hours after heat shock (Fig. 7B), and eventually restored to endogenous alk level at 22 hours 
after heat shock (Fig. 7C). The transgene could be reactivated by another heat shock (Fig. 7D). 
Similar to the situation with CFP, a proportion of embryos showed no exogenous alk RNA 
(arrows in Fig. 7), consistent with the presence of transgene negative siblings. Considering a 
delay for protein translation, protein stability and the fact that ectopic alk transcripts were 
evident for at least 6 hours, one can deduct that the heat shock in my experimental system 
efficiently triggers over- and mis-expression of alk for about 10 hours after the induction. 
 
 
Fig. 7. In situ hybridization to detect overexpressed alk in alk:HSE:cfp transgenic zebrafish. 
A heat shock was performed at 24 hpf. All in situ hybridizations were done using an alk 
antisense RNA probe, at 1 hour after heat shock (HS) (A), 6 hours after HS (B), 22 hours after 
HS (C), and shortly after a second HS performed at 48 hpf (D). Inserts show representative 
transgenic positive embryos. As soon as 1 hour after heat shock, high levels of exogenous alk 
RNA could be detected in the entire embryo. Reduced staining and patches at 6 hours after 
HS indicated RNA degradation, and staining almost completely disappeared at 22 hours after 
HS. A second HS could re-activate transcription of overexpressed alk. Arrows points to 
transgenic negative siblings where no exogenous alk was detected. Endogenous alk 
expression was not detected because of short staining time. 
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3.3.3. Overexpression of alk increases cell proliferation and affects neurogenesis in the 
hindbrain 
In the experiments described above, I showed successful alk over-expression in heat shock 
induced transgenic lines for about 10 hours upon induction. Affected embryos showed 
morphological abnormalities (Fig. 6D,E), This was neither due to the heat shock procedure or 
overexpressed CFP, as demonstrated by two negative controls, transgenic negative siblings 
and HSE:cfp embryos, respectively. 
 
To investigate the induced changes at a molecular level, embryos that were heat shocked at 
10.5 hpf were studied by several markers using immunostaining or RNA in situ 
hybridizations at 24 hpf (Fig. 8; Fig. 9). The region comprising rhombomeres r4 to r6 in the 
hindbrain were examined in detail using confocal microscopy and single plane analysis, since 
this region could be landmarked using the position of the otic vesicles. The first defect 
noticed in alk positive transgenics (Tg+) embryos was the loss of the 4th ventricle, which is 
normally a T-shaped opening in hindbrain (asterisks in Fig. 8A,B,D,H). Instead, several small 
hole-like cavities were observed (arrows in Fig. 8F,G,I,K, with high magnification in I’). This 
indicated a possible early neural tube defect, since the 4th ventricle, like the other ventricles in 
the brain, is formed by the descending neuroepithelium, which proliferates and differentiates 
at the same time (Kimmel et al., 1995). 
 
It is known that during zebrafish hindbrain embryonic neurogenesis, most neurons are not 
generated by classic stem cell-like asymmetric divisions but through a terminal neurogenic 
division (Lyons et al., 2003). From 15 to 48 hpf, cell divisions are gradually shifting from 
expanding the progenitor population to generating pairs of neurons. Asymmetric division 
persists through the process but only contributes to a portion of newly formed neurons. Before 
and around 24 hpf the majority of cell divisions in the CNS are proliferative (one cell divides 
into two progenitor cells), also with some asymmetric contribution (one cell gives rise to one 
progenitor and one neuronal precursor). The cell divisions occur almost exclusively at the 
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apical most ventricular surface (Lyons et al., 2003; Dong et al., 2012). Dividing cells in M-
phase can be labelled by a phospho-histone 3 (pH3) antibody. Using this approach, 
proliferating cells were observed at the apical surface as expected in control siblings (Fig. 
8A,D,H). The same pattern was also observed in the Tg+ embryos of the HSE:cfp control line 
(Fig. 8B). In contrast, in all of the Tg+ embryos of the alk:HSE:cfp1 line, pH3 positive cells 
were found localized in a completely randomized manner, sometimes located in clusters (Fig. 
8E-G). To rule out any possible positional effect of the inserted transgene, alk:HSE:cfp2 Tg+ 
embryos were carefully examined and showed the same results (Fig. 8I-K).  
 
 
Fig. 8. Overexpression of alk increases cell proliferation and affects neurogenesis. 
(A,B) Confocal sections of embryos of the HSE:cfp line. Sib (A) and Tg+ (B) showed no 
difference in number and distribution of both pH3 and HuC/D positive cells. (C) Statistics of 
pH3 cell numbers in a 50 µm confocal stack of the hindbrain. Mean ± SEM, N=10 embryos in 
each group. Sib and Tg+ in HSE:cfp line were not significantly different (p=0.84). Sib and Tg+ 
in both alk:HSE:cfp lines were highly significantly different (***p<0.001). Unpaired two tailed 
t-test. (D-G) Confocal sections of embryos of the alk:HSE:cfp1 line. Sib (D) and Tg+ (E-G, from 
three different embryos) had different neural tube shapes. Dividing cells (pH3, green) and 
neurons (HuC/D, red) in Tg+ embryos (E-G) were both misplaced, losing their normal 
patterns. (H-K) Identical defects observed in the alk:HSE:cfp2 line. (I’) High magnification of 
the boxed area in (I). Asterisks: the 4th ventricle. Arrowheads: mis-located neurons. Arrows: 
small cavities in the neural tube. Sib, transgenic negative siblings. Tg+, transgenic positive 
embryos. All images are sections perpendicular to neural tube. Scale bars: 50 µm. 
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In the next step, pH3 positive cells were counted  using confocal microscopy of 20 continuous 
optical sections representing a 50 µm thick area within r4 - r6 (Fig. 8C). In the HSE:cfp 
control line, total pH3 cells in the transgenic negative Sib group (25.60 ± 0.81, mean ± SEM, 
N=10 embryos) showed no difference to the Tg+ group (25.40 ± 0.54, N=10) (p=0.84, 
unpaired two tailed t-test), suggesting that overexpressed CFP had no influence on cell 
proliferation. In contrast, in the alk:HSE:cfp1 line, the Sib (25.30 ± 0.84, N=10) and Tg+ 
(36.50 ± 2.16, N=10) samples showed a highly significant difference (p<0.001), with 44% 
more pH3 cells in the Tg+ group. Similarly, also in the alk:HSE:cfp2 line, Sib (25.50 ± 0.69, 
N=10) and Tg+ (39.10 ± 1.87, N=10) were different with high significance levels (p<0.001), 
and 53% more pH3 positive cells in the Tg+ group. Moreover, both Tg+ groups from the two 
alk:HSE:cfp lines showed significantly more proliferating cells than Tg+ of the HSE:cfp 
control line (p<0.001, 44% and 54% more). These statistical comparisons among the six 
analyzed groups clearly demonstrate that overexpressed alk, but not CFP, dramatically 
elevates cell proliferation in the hindbrain, as increased numbers of dividing cells were 
observed. 
 
A HuC/D (also named Elav3/4) antibody was used to analyze postmitotic neurons. These are 
deposited as two clusters at each side of the basal and lateral regions of the neural tube in the 
hindbrain (Fig. 8A,D,H). This pattern was not affected in HSE:cfp Tg+ embryos (Fig. 8B), 
indicating that ectopic CFP has no effect on neuronal differentiation. On the contrary, in Tg+ 
embryos of both alk:HSE:cfp lines, mis-located differentiated neurons were found in the 
central part of the neural tube at positions where they never occur in controls (arrowheads in 
Fig. 8E-G,I-K). Exact neuron numbers could not be determined, since these cells were tightly 
clustered in normal embryos. However, the confocal analysis of the 60 samples described 
above suggested less HuC/D positive differentiated neurons in the alk:HSE:cfp Tg+ groups. 
This is consistent with the idea of decreased neurogenic divisions coinciding with increased 




DNA synthesis in cells at S-phase was revealed by 5-bromo-2-deoxyuridine (BrdU) labelling 
and a BrdU antibody (Fig. 9A-D). Under control conditions, cells in S-phase occupy domains 
in between the ventricular surface division zones and areas rich in postmitotic neurons, in a 
pattern complementary to pH3 and HuC/D positive cells (Fig. 9A). In contrast, in alk:HSE:cfp 
Tg+ embryos, S-phase cells were no longer restricted to their normal positions but randomly 
scattered throughout the complete neural tube (Fig. 9B-D). 
 
Elevated proliferation can be a consequence of mis-regulation in cell cycle progression. One 
of the best studied cell cycle regulators, cyclin D is known to promote cell proliferation by 
regulating cyclin dependent kinases CDK4 and CDK6 (Musgrove et al., 2011). It has 
oncogenic activity when overexpressed and is found overexpressed in many cancers 
(Musgrove et al., 2011), including ALK positive neuroblastomas (Chiarle et al., 2008). During 
zebrafish retinal neurogenesis, cyclin D1 (ccnd1) expression is down-regulated in 
differentiating neurons (Yamaguchi et al., 2005; Bessa et al., 2008; Ochocinska and 
Hitchcock, 2009). In several mutants or morphants (Morpholino knock-down animals) with 
proliferation defects, where cells fail to exit the cell cycle and differentiate, ccnd1 is 
 
Fig. 9. Overexpression of alk affects cell cycle. 
(A-D) Confocal sections of embryos of the alk:HSE:cfp1 line, with BrdU labelled cells in S-
phase. In Sib (A), BrdU positive cells occupy a region between dividing cells and neurons 
exited the cell cycle, in a pattern complementary to pH3 and HuC/D (Fig. 8A,B,D,H). In Tg+ 
(B-D), BrdU positive cells were randomly located. Smaller dimension of the samples in (A-D) 
might be due to HCl treatment in the experiment procedure. (E-H) Manual sections of 
embryos by in situ hybridization showed expanded ccnd1 expressions in Tg+ (F-H) in 
comparison to Sib embryos (E). Sib, transgenic negative siblings. Tg+, transgenic positive 
embryos. All images are sections perpendicular to neural tube. Scale bars: 50 µm. 
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constantly expressed at high levels (Yamaguchi et al., 2005; Ochocinska and Hitchcock, 2009; 
Ko et al., 2011). In my study, normal ccnd1 expression was observed in two stripes in the 
dorsal hindbrain in alk:HSE:cfp1 control Sib (Fig. 9E). In contrast, in alk:HSE:cfp1 Tg+ 
embryos, ccnd1 was severely expanded into other regions, or even the entire neural tube (Fig. 
9F-H). This finding is consistent with ccnd1 up-regulation found in cancers and retinal 
neurogenesis mutants with over-proliferation described in previous reports (Yamaguchi et al., 
2005; Chiarle et al., 2008; Ochocinska and Hitchcock, 2009; Ko et al., 2011). This suggests 
that overexpression of alk promotes more cells to re-enter the cell cycle after a completed cell 
division that were destined to exit the cell cycle and differentiate. Consequently, this could 
lead to reduced numbers of differentiated neurons.  
 
In summary, overexpression of alk in my transgenic lines by heat shock induction at 10.5 hpf 
results in at least two specific defects, not observed in control embryos subjected to heat 
shock or after CFP overexpression: 1). Loss of the normal spatial pattern of neurogenesis, 
which in control is found, from apical to basal (middle to lateral), as M-, S-phase to 
postmitotic cells. This was evident by pH3, BrdU, and HuC/D staining. 2). Elevated 
proliferation reflecting increased proliferative cell division over neurogenic division, which 
was evident by increased numbers of pH3 positive cells and up regulated ccnd1 expression. 
 
3.3.4. Overexpression of alk ectopically activates MAPK signaling in the CNS 
Human ALK related cancers are characterized by showing activation of three major signaling 
pathways: 1.) the Ras-extracellular signal regulated kinase (ERK) / mitogen activated protein 
kinase (MAPK) pathway; 2.) the Janus kinase 3 (JAK3)-STAT3 pathway; and 3.) the PI3K-
Akt pathway (reviewed by Chiarle et al., 2008; Palmer et al., 2009). Among these three 
pathways, proliferation is mainly stimulated by ALK-activated ERK1 (also known as 
MAPK3, p44) and ERK2 (also known as MAPK1, p42) phosphorylation, with up regulation 
in CCND1 expression (reviewed by Chiarle et al., 2008). Transcription of CCND1 is also 
often up-regulated through the receptor tyrosine kinase RTK-Ras-MEK-ERK pathway during 
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oncogenic activation (reviewed by Musgrove et al., 2011). The MAPK family is highly 
conserved in vertebrates including zebrafish (Krens et al., 2006a and 2006b), and zebrafish 
ERK1/2 were reported for their important function during embryogenesis including 
proliferation (Krens et al., 2008; Le et al., 2008). Moreover, Drosophila Alk functions during 
visceral mesoderm development through ERK activation (Englund et al., 2003; Lee et al., 
2003; Loren et al., 2001 and 2003). Therefore, I next tested whether the MAPK pathway is 
the intracellular signaling cascade that responds to alk overexpression in my experiments. 
Phosphorylation of ERK1/2 (pERK) was investigated using a pERK antibody, as well as total 
ERK using an ERK antibody (Fig. 10). 
 
 
Fig. 10. MAPK signaling is activated as a response to alk overexpression. 
(A,A’) A 24 hpf wild type embryo without heat shock. Endogenous pERK signals 
(arrowheads) were observed mostly in the caudal most hindbrain and spinal cord, but rarely 
in other parts of the CNS. (B,B’,C,C’) Both Sib (B,B’) and Tg+ embryos (C,C’) of the HSE:cfp 
control line were normal and no additional pERK was observed. (D,D’,E,E’) Total ERK was 
ubiquitously distributed in both Sib (D,D’) and Tg+ (E,E’) embryos of the alk:HSE:cfp1 line. 
(F,F’,G,G’) Ectopic pERK (arrows) was found in Tg+ (G,G’) of the alk:HSE:cfp1 line. (H,H’,I,I’) 
Identical results were observed in the second alk:HSE:cfp2 line. (A’-I’) Cross sections from 
embryos in r5 at positions indicated by black lines in (A-I). Sib, transgenic negative siblings. 
Tg+, transgenic positive embryos. ERK, total ERK1/2. pERK, phosphorylated-ERK1/2. Scale 
bars: 50 µm. (J) Western blots showing more pERK protein in NPM-ALK mRNA injected 
embryos than in WT at 11 hpf. Each lane represents protein content from five embryos of a 
20-50 embryo pool. (K) Western blots showing increased pERK levels in Tg+ than Sib 
embryos at 22 hpf in both alk:HSE:cfp lines. Each lane was equal to proteins from five 
embryos of a 20-50 embryo pool, posterior parts of the embryos were cut off to eliminate 
endogenous pERK originating from the spinal cord and tail bud. 
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In 24 hpf WT embryos without heat shock, endogenous pERK could only be found in the 
caudal most hindbrain and spinal cord (Fig. 10A), as well as strongly in the tail bud (image 
not shown). There were only few individual pERK positive cells in the hindbrain and other 
brain regions anterior to it (Fig. 10A). This distribution was normal in both Sib and Tg+ 
embryos of the HSE:cfp line, with no additional pERK signals observed (Fig. 10B,C). In 
cross sections at the level of r5, usually no pERK positive cells could be seen (Fig. 
10A’,B’,C’). This demonstrated that neither heat shock nor overexpression of CFP was 
capable of activating ERK phosphorylation. In another control experiment, total ERK amount 
and distribution were compared between Sib and Tg+ embryos of the alk:HSE:cfp line and no 
difference was observed (Fig 10D,D’,E,E’). In contrast, in Tg+ embryos of both alk:HSE:cfp 
lines, the pERK was strongly increased and ectopic activation was found across the complete 
CNS (Fig 10G,G’,I,I’). To determine this difference in a more quantitative fashion, Western 
blot analysis was used to detect total ERK and pERK. Embryos at 11 hpf injected with human 
oncogenic NPM-ALK mRNA were used as positive control, and showed more pERK than the 
WT control with similar levels of  total ERK protein (Fig. 10J). Similar to this, also Tg+ 
embryos of both alk:HSE:cfp lines at 22 hpf exhibited higher pERK levels than their Sib 
controls, while total ERK protein levels were not affected (Fig. 10K). Taken together, 
overexpression of alk causes up-regulation of pERK levels while total ERK levels remain 
unchanged. This ectopic activation of MAPK signaling in the CNS is consistent with the 






3.3.5. Overexpression of alk at later stages leads to similar defects but with less severity 
In our alk overexpression model, exogenous alk was triggered by heat shock at 10.5 hpf. At 
this stage gastrulation has been completed and neurulation is about to start. Therefore, 
overexpressed alk had minimal effect on early aspects of embryogenesis but had an impact 
mainly on neurogenesis as soon as it started. Noteworthy, endogenous alk expression initiates 
between 6 to 12 hpf, so 10.5 hpf was used to match this endogenous alk pattern. However, 
overexpression of alk at 10.5 hpf was embryonic lethal. For screening and maintaining these 
lines (Sib and Tg+ individuals could not be distinguished without heat shock induction), late 
staged heat shock was used after 24 hpf. Tg+ embryos of the alk:HSE:cfp lines were generally 
normal in morphology up to 48 hpf, but usually showed a much lower survival rate 
(approximately 20%) in the first month, compared to WT or HSE:cfp positive fish with 
normally 50-80% survival.   
 
Therefore, 24 hpf heat shocked embryos of the alk:HSE:cfp1 line were analyzed at 31 hpf 
using pH3 and HuC/D double fluorescent immunostaings (Fig. 11A-C) as described before. 
The Tg+ embryos had a generally normal neural tube shape with correct pH3 and HuC/D 
distribution patterns. Interestingly, clustered pH3 positive cell colonies were seen in 2 out of 
10 Tg+ embryos (Fig. 11B), and mis-located neurons were also found in 5 out of 10 Tg+ 
samples analyzed (Fig. 11C). Similar pH3 cell counting in a 50 µm thick area within r4 - r6 
revealed that the Tg+ group (53.70 ± 1.61, mean ± SEM, N=10) showed significantly more 
pH3 cells (14.5% more) than the Sib group (46.90 ± 1.57, N=10) (p<0.01, unpaired two tailed 
t-test) (Fig. 11D). These results suggest that heat shock at 24 hpf leads to similar proliferation 




In another experiment, 30 - 60 embryos per group were given their first heat shock at 39°C 
for 2 hours at 24 hpf, with subsequent repeated heat shocks every day (Table 3). Until 7 days 
post fertilization (dpf), some larvae (18/34 in 1st experiment, 3/48 in 2nd experiment) in the 
alk:HSE:cfp Tg+ groups were dead or severely deformed (Fig. 11E), but the remaining were 
generally normal in morphology. After careful examination, tissue protrusions were observed 
in the Tg+ larvae. Between 30-40% of specimen (Table 3) developed these structures in the 
heads (Fig. 11F), fins (Fig. 11K), and most often in the notochords (Fig. 11G-J). A small 
fraction in the control groups (2.3% in alk:HSE:cfp Sib; 4.7% in HSE:cfp Sib) also developed 
such structures but these were restricted to the notochord and no severely deformed larvae 
were observed. These notochord deformations could thus reflect unspecific side effects of the 
daily repeated heat shock. This chronic alk overexpression experiment mimicked somatic 
acquired mutations in human patients leading to ALK over-activation at late stages.  
 
Fig. 11. Late stage overexpression of alk leads to proliferation defects. 
(A-C) Confocal sections of 31hpf alk:HSE:cfp1 embryos double immunostained with pH3 
(green) and HuC/D (red). Tg+ (B,C) had an overall normal morphology of hindbrain as 
compared to Sib (A), but clustered pH3 positive cells (circled area in B) and mis-located 
neurons could be observed (arrowhead in C). (D) Statistics of pH3 cell numbers in a 50 µm 
thick confocal stack of the hindbrain. Mean ± SEM, N=10 embryos in both groups. Sib and 
Tg+ of the alk:HSE:cfp1 line were significantly different (**p<0.01). Unpaired two tailed t-
test. Sib, transgenic negative siblings. Tg+, transgenic positive embryos. Scale bars in (A-C): 
50 µm. (E) A 7 dpf severely deformed Tg+ larva subjected to repeated heat shocks. (F-K) 
Protrusions in 7 dpf Tg+ larvae were visible in head (F), notochord (G-J) and fins (K). Arrows 





In summary, alk overexpression triggered at late stages caused similar defects as early heat 
shock but to a much less severity. It did not affect the entire embryo but rather caused defects 
in a more locally restricted fashion.  
  
Table 3. Embryos subjected to repeated heat shocks and analyzed at 7 dpf. 




 Sib Tg+ Sib Tg+ Sib Tg+ 
Total  63  47  26  34  44  48  
Normal  60  47  25  5  43  26  
Dead or severely deformed  0  0  1  18  0  3  




3.4. Alk loss-of-function studies in zebrafish  
3.4.1. Morpholino knock-down of alk results in increased apoptosis in the CNS  
Morpholino antisense oligos (MO, Gene Tools) are commonly used in fish to achieve gene 
knock-down, by either blocking mRNA translation or preventing pre-mRNA splicing. Here, a 
zebrafish alk translation blocking MO (ATG-MO) was designed based on the newly acquired 
N-terminal sequence and directed against its translation initiation site (2 bp in 5’UTR and 23 
bp in coding sequence including ATG, Fig. 12A). A corresponding 5 bp mismatch MO 
(ATGmismatch-MO or ATGmis-MO) served as negative control. A pair of splicing blocking 
MOs spanning the exon 3/intron 3 (E3I3-MO) and intron 3/exon 4 (I3E4-MO) junctions were 
used in addition as an independent approach to confirm reproducibility of the results (Fig. 
12A).  
 
To test alk ATG-MO efficiency, an artificial construct was cloned (Fig. 12B), which 
comprised 107 bp of the alk 5’UTR and the first 24 bp of its coding sequence in frame with 
an egfp sequence lacking its own ATG. Capped alkATG-egfp mRNA was produced and 
injected at 50 ng/µl into WT embryos. Strong EGFP signal could be detected (Fig. 12D) 
compared to non-injected WT embryos at 8 hpf (70% epiboly stage; Fig. 12C). When this 
mRNA was co-injected with alk ATG-MO, the EGFP signal was almost completely 
suppressed (Fig. 12E), indicating efficient blockage of EGFP translation. On the other hand, 
when alk ATGmismatch-MO was co-injected, EGFP was visible, however slightly weaker, 
indicating that the ATGmismatch-MO despite five nucleotide substitutions could still have 
some blocking activity (Fig. 12F). Notably, for preventing translation of this overexpressed 
artificial alkATG-egfp mRNA, all used MOs were injected at a 2.5 times higher concentration 
(5 mg/ml) into embryos, in contrast to what used in following functional studies (2 mg/ml) to 
block endogenous alk translation. Importantly, however, this experiment showed that the alk 




To achieve efficient splice blocking and avoid any possible alternative splicing, the two splice 
MOs (E3I3-MO and I3E4-MO) were co-injected at 2 mg/ml each (4 mg/ml in total MO). 
Such combination is named alk Spl-MO in the following text. These MOs were designed to 
prevent splicing of intron 3 (Fig. 12A), resulting in a 289 bp insertion leading to frame shift 
with nine possible STOP codons (Fig. 12G). This insertion should thus result in a 
nonfunctional protein product, only consisting of amino acids encoded by the first 3 exons 
(620 bp) compared to the endogenous protein encoded by full length alk (4167 bp). To test 
this, RT-PCRs were used with a primer pair located in exon 1 and exon 4 (Fig. 12A). The 
correctly spliced product was expected to be 467 bp, while the wrongly spliced product with 
insertion should be 756 bp. The result from Spl-MO injected embryos at 24 hpf showed a size 
 
Fig. 12. alk MO efficiency test experiments. 
(A) A schematic diagram showing alk first few exon-intron arrangement and MO binding 
sites. Numbers show exon/intron size in basepairs. (B) An artificial construct, egfp in frame 
with alk ATG site, was used to test ATG-MO binding efficiency. (C-F) Injections of this mRNA 
in combinations with MOs resulted in different EGFP translation levels. Embryos were at 8 
hpf, with bright field images on top and fluorescent images below. This mRNA could be 
translated and show EGFP signal (D), and co-injected alk ATG-MO blocked its translation (E). 
alk ATGmismatch-MO did not block its translation (F). Embryos indicated with asterisks in 
(C) and (E) were taken from the group shown in (D), indicating sufficient fluorescent 
excitation. (G) A diagram showing the incorrect product with insertion of intron 3, when alk 
pre-mRNA splicing is prevented by the splicing MOs. (H) RT-PCR were used to test splicing 
MO efficiency by primers indicated in (A). In Spl-MO injected 24 hpf embryos, the PCR 
product showed an about 300 bp size increase (2nd lane) when compared to uninjected wild 
type (1st lane), indicating insertion of intron 3. -RT controls (3rd and 4th lanes, without reverse 
transcriptase in cDNA synthesis) were both clear, confirming no product from genomic DNA 
amplification. gapdh used as loading control. 
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increase as expected (Fig. 12H). Both bands in WT and Spl-MO lanes were gel extracted and 
sequenced, which confirmed the expected intron retention.  
 
alk ATG-MO (2 mg/ml) or Spl-MO (4 mg/ml) were injected into zebrafish embryos at the 
one- or two-cells stage, and apoptosis was examined at 22 hpf using a transferase mediated 
dUTP nick end labeling (TUNEL) assay. This showed increased apoptosis in the CNS (Fig. 
13C,F) when compared to uninjected WT (Fig. 13A). Neither a standard control MO 
(GeneTools, Std-MO with random sequence, 2 mg/ml) nor the alk ATGmismatch-MO (2 
mg/ml) resulted in increased apoptosis (Fig. 13B, E), suggesting that the increased apoptosis 
was specific to alk deficiency. It was recently reported that knock-down approaches using 
MO and short interfering RNAs (siRNA) in some cases cause unspecific off-target effects, 
often leading to neural apoptosis by p53 activation (Robu et al., 2007). Thus, co-injection 
with a p53 MO is suggested as an additional control to test if off-target apoptosis effect could 
be attenuated, when p53 translation is completely blocked (Langheinrich et al., 2002).  
 
 
Fig. 13. Increased apoptosis in alk morphants revealed by TUNEL assay. 
Embryos were at 22 hpf. Images show lateral views on top with anterior to the left, and 
dorsal views on head region in lower row with anterior to the top. WT (A) or Std-MO 
injected (B) embryos had few scattered TUNEL positive cells. In alk ATG-MO (C) or Spl-MO 
injected (F), TUNEL positive cells increased in number, while ATGmismatch-MO injected (E) 
looked normal. Co-injections with p53-MO (D,G) failed to attenuate the apoptosis defect 
indicating specificity of the effect. Scale bars: 100 µm. 
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Therefore, a widely used p53 MO (provided by Gene Tools as standard) was co-injected (8 
mg/ml) with alk MOs. This failed to attenuate apoptosis defects caused by alk-ATG MO (Fig. 
13D) or alk-Spl MO (Fig. 13G) indicating that the alk MO knock-down effects are specific. 
Thus, alk knock-down promotes apoptosis in the CNS independent of activation of p53 
pathway, and the observed apoptosis is not caused by MO off-target effects. 
 
3.4.2. Morpholino knock-down of alk does not affect cell division in the hindbrain 
In embryos overexpressing alk, an increase in the number of dividing cells in M-phase was 
observed suggesting elevated proliferation. Next, I tested whether the knock-down of alk 
affects proliferation.  Anti-pH3 and TUNEL double fluorescent immunostaining was 
conducted (Fig. 14). In both alk ATG-MO or Spl-MO injected embryos, pH3 positive cells 
were at their normal location, although more apoptotic cells were observed as TUNEL 
positive dots (Fig. 14B,C). The size of the neural tube also looked smaller after alk knock-
down when compared to WT (Fig. 14A). Counting of pH3 positive cells in a 50 µm thick area 
within the r4 - r6 hindbrain region (Fig. 14D) showed that neither alk ATG-MO (23.80 ± 0.86, 
mean ± SEM, N=5 embryos) nor alk Spl-MO (24.60 ± 0.93, N=5) resulted in significantly 
different cell numbers when compared to WT (25.00 ± 0.84, N=5) (Unpaired two tailed t-test, 
p=0.35, p=0.76, respectively). In contrast, within the same samples, counting of TUNEL 
positive cells (Fig. 14E) showed that both alk ATG-MO (40.60 ± 2.93, N=5) and alk Spl-MO 
(44.00 ± 4.56, N=5) injected embryos had highly significantly different numbers compared to 
WT (5.40 ± 1.44, N=5) (p<0.001 in both). These findings suggest that alk deficiency may not 
affect dividing cells in M-phase, but causes increased apoptosis. Since the majority of cell 
divisions at this stage represent proliferative neural progenitors, the increased apoptosis 
observed in alk morphants very unlikely affects progenitor cells, but rather affects other cell 





3.4.3. Morpholino knock-down of alk impairs neuronal differentiation 
To study the effect of an alk knock-down on neuronal differentiation, expression of several 
established neuronal markers was analyzed in alk morphants and compared to control 
embryos. As direct targets of Notch signaling, Hes genes (Hes1 and Hes5 in mammals) are 
highly expressed in undifferentiated neural progenitors and essential for maintaining their 
stem cell identity in the CNS (reviewed by Kageyama et al., 2008). Here, expression of the 
zebrafish homolog of Hes1 (Pasini et al., 2001), hairy-related 6 (her6) was studied first by in 
situ hybridization. No change in its expression was detected in alk morphants (Fig. 15a1-a4; 
sections at r2 and r5 in Fig. 16a1-a4) suggesting that proliferating undifferentiated neural 
progenitors are not affected by alk knock-down. 
 
 
Fig. 14. Knock-down of alk does not affect cell division in the hindbrain. 
(A-C) Confocal sections of 22 hpf embryos double fluorescent immunostained with pH3 
(green) and TUNEL (red). Compared to WT (A), both alk ATG-MO injected (B) or alk Spl-MO 
injected (C) embryos had their pH3 positive cells at normal location, although more TUNEL 
positive cells could be seen. Notice that the size of neural tube in (B,C) was smaller than in 
(A). (D) Statistics of pH3 cell numbers in a 50 µm thick confocal stack of hindbrain. Neither 
alk ATG-MO nor alk Spl-MO was significantly different from WT. (E) Statistics of TUNEL 
positive dots numbers in the same samples. Both alk ATG-MO and alk Spl-MO were different 
from WT with high significance (***p<0.001). Mean ± SEM, N=5 embryos in each group. 
Unpaired two tailed t-test. Scale bars: 50 µm.  
76 
 
On the other hand, proneural gene expression is usually up-regulated in differentiating neural 
cells. Proneural genes become activated when Notch-Hes signaling is switched off. High and 
continuous expression of proneural genes, that often act redundantly, determines neuronal 
fates by inducing Notch ligand expression, forcing cell cycle exit and initiating neuronal 
differentiation, as well as promoting neuron survival. Expression of different proneural gene 
combinations restrict lineages to define the neuron type to be generated (reviewed by Diez del 
Corral and Storey, 2001; Bertrand et al., 2002; Kageyama et al., 2005). To study the effect of 
alk knock-down on differentiation of neuronal precursors, several zebrafish proneural genes 
were investigated in the following. Neurogenin 1 (neurog1, also named neurod3) expression 
seemed unchanged, or only slightly reduced, in alk morphants (Fig. 15b1-b4; Fig. 16b1-b4). 
However, expression of the ortholog of Drosophila atonal, zebrafish neurogenic 
differentiation 4 (neurod4, also named zath3) was significantly reduced, including in the 
hindbrain (Fig. 15c1-c4; Fig. 16c1-c4). The achaete-scute complex like (ascl or ash) genes 
belong to another family of proneural genes that sometimes act independently from atonal-
related genes (neurog/neurod family) in vertebrates. Zebrafish ascl1a (also named zash1a) 
and ascl1b (also named zash1b) are both orthologs of mammalian ascl1. Both, ascl1a and 
ascl1b expression was reduced in alk morphants (Fig. 15d1-d4,e1-e4; Fig. 16d1-d4,e1-e4). 
Moreover, delta A (dla), one of the Notch ligands highly expressed in differentiating neurons, 
was also reduced (Fig. 15f1-f4; Fig. 16f1-f4). Importantly, all of the genes mentioned above 
that were affected in alk morphants (neurod4, ascl1a, ascl1b and dla) were expressed 
normally in alk ATGmismatch-MO injected embryos. This suggests that impaired 
neurogenesis, as evident by reduced proneural gene expression, is specific for the MO knock-
down of alk. Finally, a glia marker, glial fibrillary acidic protein (gfap) was studied and no 
change in its expression was observed in alk morphants (Fig. 15g1-g4; Fig. 16g1-g4). Of note, 
at this stage a subtype of glia, which are called radial glia with neural stem cell features at 




Fig. 15. Knock-down of alk impairs neuronal differentiation. 
In situ hybridizations of neuronal marker genes on wild type embryos (a1-g1), alk ATG-MO 
injected embryos (a2-g2), alk Spl-MO injected embryos (a3-g3), and alk ATGmismatch-MO 
injected embryos (a4-g4). All images show dorsal views of head region with anterior to the 
left. (a1-4) her6 expression was unchanged in all groups. (b1-4) neurog1 expression was 
unchanged or only slightly reduced in alk ATG-MO (b2) or Spl-MO (b3) injected embryos. (c1-
4) neurod4 expression was strongly reduced in several regions including the hindbrain in alk 
ATG-MO (c2) or Spl-MO (c3) injected embryos. alk ATGmismatch-MO injected embryos (c4) 
showed no significant difference when compared to WT (c1). (d1-4, e1-4, f1-4) Similarly, 
ascl1a (d2,d3), ascl1b (e2,e3), and dla (f2,f3) expression was reduced in alk ATG-MO or Spl-
MO injected morphants. alk ATGmismatch-MO injected embryos (d4,e4,f4) showed no 
difference when compared to WT (d1,e1,f1). (g1-4) Glia marker gfap expression was 
unchanged in all groups. Scale bars: 100 µm. Lines at r2 and r5 indicate levels of cross 






Fig. 16. Knock-down of alk impairs neuronal differentiation (sections). 
Manual cross sections at the level of r2 (a1-g1) and r5 (a3-g3) in WT embryos, or r2 (a2-g2) 
and r5 (a4-g4) in alk Spl-MO injected morphants. (a1-4) her6 expression was unchanged 
between WT and alk morphants. (b1-4) neurog1 expression was unchanged or only slightly 
reduced in morphants (b2,b4). (c1-4) neurod4 expression was significantly reduced at both r2 
(c2) and r5 (c4) levels in morphants. (d1-4, e1-4, f1-4) Similarly, ascl1a (d2,d4), ascl1b (e2,e4), 
and dla (f2,f4) expression in alk morphants was reduced. (g1-4) Glia marker gfap expression 
was unchanged. Scale bars: 50 µm. 
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Since the progenitor marker expression was unchanged and also cell proliferation was not 
affect, this indicates that progenitor cells are not affected in alk morphants and that the 
observed increase in apoptosis does not originate from these progenitors. On the other hand, 
reduced proneural gene expression in differentiating neuronal precursors could explain the 
identity of the apoptotic cells. 
 
3.4.4. Inhibiting Alk activity by a small molecule recapitulates alk morphant defects 
In the experiments described above on alk deficiency, two independent MO sets repeatedly 
and specifically promoted apoptosis and reduced proneural gene expression in the CNS by 
affecting the survival of neuronal precursors after they have exited their progenitor phase. 
MO targeted gene knock-down is known to decrease in efficiency over time by “dilution” 
through rounds of cell divisions and limited stability of the synthetic oligonucleotides. Given 
the gradually increasing expression of zebrafish alk after 24 hpf (Fig. 4A), it is unlikely that 
the MO used in above experiments can achieve the same efficiency at later stages, for 
example 48 hpf when neuronal differentiation starts to slow down. Over the last years, 
screens for pharmaceutical inhibitors to treat cancers caused by human NPM-ALK or other 
mutated ALK identified several promising small molecule inhibitors. CEP-28122, an ALK 
phosphorylation inhibitor identified by Cephalon Inc., was reported to lead to growth 
inhibition in a variety of cultivated human ALK-activated cancer cell lines, including 
neuroblastoma, through caspase 3/7 activation and apoptosis (Cheng et al., 2012). It also 
showed a potent and selective antitumor activity against xenografts in mice, showing more 
than 12 h inhibition following a single intake (Cheng et al., 2012). In collaboration with 
Cephalon Inc., I tested a similar ALK inhibitory small molecule, CEP-26939, as another 





Dechorionated embryos were treated in fish medium containing 40 µM CEP-26939 with 1% 
DMSO starting from 24 hpf with medium changes every 12 h, and fixed at 60 hpf for 
examination of her6, neurog1, neurod4 and ascl1b expression by in situ hybridizations, as 
 
Fig. 17. Inhibition of Alk activity by the small molecule inhibitor CEP-26939 phenocopies 
alk morphant defects. 
(A,C,E,G,I) 60 hpf embryos treated in 1% DMSO from 24 hpf were used as negative controls. 
(B,D,F,H,J) 60 hpf embryos treated in 40 µM CEP-26939 from 24 hpf. (A,B) Inhibitor treated 
embryos showed more apoptotic cells in mid- and hindbrain (B) when compared to DMSO 
treated embryos (A). (C,D) No significant change was observed for her6 expression in 
inhibitor treated embryos. (E,F) Neurog1 was only slightly reduced in inhibitor treated (F) 
compared to DMSO treated embryos (E). (G,H,I,J) Both neurod4 and ascl1b expression 
domains in mid- and hindbrain were almost completely absent in inhibitor treated embryos 
(H,J). All images show dorsal views with the plane of focus on mid- and hindbrain, with 
anterior to the left. Numbers in each image indicate individuals similar as that shown as 
representatives and total numbers of embryos investigated. Scale bars: 100 µm. 
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well as apoptosis by TUNEL. Negative controls were incubated in 1% DMSO, which was 
used as solvent for the inhibitor, and investigated in parallel (Fig. 17). Increased apoptosis in 
the CNS of inhibitor treated embryos was detected by TUNEL staining (Fig. 17A,B). This 
was confirmed by Acridine Orange staining in living animals at 48 hpf (data not shown). 
Similar to the situation in the MO experiments, no difference in her6 expression was seen 
between inhibitor treated and DMSO treated controls (Fig. 17C,D). Some reduction in 
neurog1 expression was observed with no major change in its overall pattern (Fig. 17E,F). In 
contrast, expression of neurod4 and ascl1b, the two genes most strongly impaired in the MO 
targeting experiments, was almost completely absent in the mid- and hindbrain in CEP-26939 
treated embryos (Fig. 17G,H,I,J). In parallel, in all of the regions where reduction of neurog1, 
neurod4 or ascl1b expressions was observed, apoptotic cells were increased (Fig. 17A,B). 
Therefore, the use of this ALK inhibitory small molecule confirmed that alk deficiency leads 
to increased apoptosis and reduced proneural gene expression identical to what was 
previously described using alk MOs. 
 
3.4.5. Morpholino knock-down of alk reduces the number of differentiated hindbrain 
neurons  
Reduced proneural gene expression observed in the previous experiments suggested the 
presence of compromised neuronal differentiation and survival. To test to what degree alk 
deficiency would affect the final step of neurogenesis, i.e. the formation of differentiated 
neurons, a pan-neuronal marker HuC/D (Kim et al., 1996; Park et al., 2000) was studied in alk 
morphants. In the hindbrain of 31 hpf embryos, the areas where postmitotic neurons are 
located and express HuC/D were significantly smaller in alk morphants (Fig. 18B,B’,C,C’) 
when compared to WT (Fig. 18A,A’) or ATGmismatch-MO injected embryos (Fig. 18D,D’), 
whereas the proliferative ventricular and subventricular zones appeared normal in size. As a 
technical challenge, differentiated neurons are usually tightly clustered with each other, 
making cell counting difficult. Therefore, a lipid dye, BODIPY-Texas Red, was used in co-
staining to highlight cell membranes and allow cell counting (Fig. 18E). In WT, in average 
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92.25 (± 2.94, mean ± SEM, N=12 sections from 6 embryos) HuC/D positive neurons could 
be counted per confocal single plane representing a 5 µm optical section. In contrast, only 
50.50 (± 3.43, N=12 sections from 6 embryos) neurons could be counted in the alk ATG-MO 
injected group, and only 46.36 (± 2.64, N=14 sections from 7 embryos) neurons in the alk 
Spl-MO injected group. Both reductions were highly significantly different from WT 
(p<0.001, unpaired two tailed t-test). In contrast, the alk ATGmismatch-MO injected group 
(85.14 ± 2.71, N=14 sections from 7 embryos) was not significantly different from WT 
(p=0.088). In conclusion, alk ATG-MO or alk Spl-MO injected embryos show a reduction in 
the number of differentiated neurons to 54.7% or 50.3% when compared to WT, respectively. 
 
 
Fig. 18. Knock-down of alk reduces the number of differentiated neurons in the hindbrain. 
(A-D) Confocal sections of 31 hpf embryos at the level of r5 immunostained with the pan-
neuronal marker HuC/D (green) and co-stained with bodipy-Texas Red (TR, red) labelling cell 
membranes. The HuC/D channel (green) is separately shown in (A’-D’). Arrowheads point to 
emerging neurons in the ear, indicating that all sections were at the same position. In both 
alk ATG-MO (B,B’) or alk Spl-MO (C,C’) injected embryos, the areas of postmitotic neurons 
were smaller than in WT (A,A’) or alk ATGmismatch-MO injected embryos (D,D’), while the 
proliferative ventricular and subventricular zones were normal in size. (E) Statistics of HuC/D 
cell numbers on sections. Both alk ATG-MO and alk Spl-MO groups were highly significantly 
different from WT (***p<0.001), whereas the change in alk ATGmismatch-MO group was not 
significant (p=0.088). Mean ± SEM, N=12 in WT and ATG-MO, N= 14 in Spl-MO and 
ATGmismatch-MO. Unpaired two tailed t-test. Scale bars: 50 µm. 
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As alk deficiency reduces the expression of several proneural genes simultaneously, I next 
tested whether the knock-down of alk specifically affects a certain subtype of neurons. An 
anti-gamma amino butyric acid (GABA, a major inhibitory neurotransmitter) antibody was 
used as a second neuronal marker in addition to HuC/D, which only detects GABAergic 
interneurons (Bernhardt et al., 1992; Yu et al., 2011). In both alk ATG-MO or alk Spl-MO 
injected 31 hpf embryos, there were less GABA immunoreactive neurons in the hindbrain 
(Fig. 19A-C). On average, WT embryos had 45.30 (± 0.97, mean ± SEM, N=10 embryos) 
GABA positive cells. This number was reduced to 28.70 (± 1.73, N=10) in alk ATG-MO or 
25.83 (± 1.94, N=6) in alk Spl-MO injected embryos (Fig. 19D). Both numbers were highly 
significantly different from WT (p<0.001, unpaired two tailed t-test). Thus, alk ATG-MO or 
alk Spl-MO injected embryos have only 63.4% or 57.0% GABAergic interneurons in 
hindbrain compared to WT, respectively. 
 
 
Fig. 19. Knock-down of alk reduces the number of GABAergic interneurons in the 
hindbrain. 
(A-C) Z-projections of dorsal view confocal stacks including all GABA immunoreactive 
neurons in the hindbrain of 31 hpf embryos immunostained with a GABA antibody. Anterior 
to the left. Both alk ATG-MO (B) or alk Spl-MO (C) injected embryos had less GABAergic 
neurons than WT (A). (D) Statistics of GABA positive cells in hindbrain. Both alk ATG-MO and 
alk Spl-MO groups were highly significantly different from WT (***p<0.001), Mean ± SEM, 
N=10 in WT and ATG-MO, N= 6 in Spl-MO. Unpaired two tailed t-test. Scale bars: 100 µm. 
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Taken together, the quantitative analysis using two neuronal markers (HuC/D and GABA) 
showed that alk deficiency in both MO sets resulted in a reduction of approximately 50% for 
all neurons, and about 40% for GABAergic interneurons in the hindbrain, in a reproducible 
manner. These appear to be the consequences of impaired neuronal differentiation and 
survival as described in the previous context. Additionally, the similar extent of reduction in a 
more general fashion rather than affecting a specific neuron type supports the idea that alk 
functions more generally in a wide range of neurons, rather than a specific neuron type, 
during early neurogenesis. 
 
3.4.6. Interfering with alk function by a putative dominant negative approach 
In addition to MO mediated knock-down and a chemical inhibitor, also a putative dominant 
negative zebrafish alk (dnalk) form, which lacks the intracellular signaling tyrosine kinase 
domain, was used to interfere with alk function in transgenic fish. Similar approaches have 
been described using  dominant negative versions of the insulin-like growth factor receptor 
(Schlueter et al., 2007), which is also a receptor tyrosine kinase. Hypothetically, dnAlk should 
interfere with endogenous Alk function by competitively binding to its ligand without 
activating the downstream signaling pathway. 
 
For this, a heat shock inducible transgenic zebrafish line (dnalk:HSE:cfp) was generated (Fig. 
20A), similar to the approach described in 3.3.2. This resulted in the successful 
overexpression of dominant negative alk mRNA upon heat shock induction (Fig. 20B). When 
embryos were heat shocked at 10.5 hpf and analysed at 24 hpf, in both transgenic negative 
siblings (Sib, Fig. 20E) and transgenic positive embryos (Tg+, Fig. 20F), apoptosis was 
elevated, when compared to WT without heat shock (Fig. 20C). Importantly, the pattern of 
apoptosis was clearly different from that observed in alk morphants (Fig. 20D). The similar 
apoptosis patterns found in both heat shocked Sib and Tg+ embryos suggests that this is due 
to the heat shock but not an interference with Alk function as evident in the alk ATG-MO 
situation. Moreover, no reduction of ascl1b expression in the heat shocked Tg+ was obvious 
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(Fig. 20H) when compared to Sib (Fig. 20G). Also, no changes in neurog1 and neurod4 
expression, and no effect on the numbers of pH3 positive cells was observed when the kinase-
deficient Alk variant was expressed (data not shown).   
 
Therefore, it seems unlikely that this particular Alk variant acts in a dominant negative 
fashion. Apoptosis was promoted by heat shock treatment, but not in a specific pattern as 
observed in alk morphants or inhibitor treated embryos. Also, impaired neurogenesis was not 
obvious in a similar way as what was observed in embryos after MO knock-down or small 
molecule inhibition. Although biochemistry data are still missing confirming that the 
overexpressed dnAlk proteins were stable and competing with endogenous Alk, my findings 
strongly suggest that this truncated, kinase-deficient zebrafish Alk variant did not act as a 
dominant negative form, in contrast to several other RTK variants. This opens the possibility 
that zebrafish Alk, other than similar RTKs, might not necessarily need to bind to an 
extracellular ligand but instead might exert its biological function by interacting with partners 
through its intracellular part. 
  
 
Fig. 20. Interfering with alk function by a putative dominant negative approach. 
(A) Transgenic cassette of the dnalk:HSE:cfp line. (B) In situ hybridization on 28 hpf 
transgenic embryos (2 hours after heat shock) detecting dnalk overexpression by an alk N-
terminus probe. Insert shows a transgenic positive embryo (Tg+). (C,D) Fluorescent TUNEL 
staining on 24 hpf WT (C) or alk ATG-MO injected embryo (D) without heat shock. (E,F) 
Fluorescent TUNEL staining on 24 hpf transgenic negative sibling (E) or transgenic positive 
embryo (F) in the dnalk:HSE:cfp line. (G,H) In situ hybridization detecting ascl1b expression 




3.5. Characterization of possible regulatory interactors in the alk pathway 
3.5.1. Expression of zebrafish rptpz, a possible negative regulator of alk 
Mammalian receptor protein tyrosine phosphatase beta/zeta (RPTPz) has been reported as a 
negative regulator of ALK (Perez-Pinera et al., 2007). Its expression has been reported in the 
mammalian nervous system (Hayashi et al., 2005; Fukazawa et al.; 2008). I therefore decided 
to study the RPTPz ortholog in zebrafish. When BLAST using the human RPTPz longest 
isoform (GenBank: NM_002851.2), a predicted zebrafish mRNA (GenBank: XM_679636.2.) 
sharing highest similarity was found. Based on this, I cloned an 888 bp zebrafish rptpz 
fragment sharing 59.0% aa identity (73.2% similarity) with a human RPTPz N-terminal 
counterpart, as well as two fragments (1218 bp in C1 and 606 bp in C2) similar to human 
RPTPz C-terminal parts (See details in 2.3.5.). C1 shares 64.3% aa identity (76.8% similarity), 
and C2 shares 75.2% aa identity (84.2% similarity) with human counterparts. Further attempts 
of PCR amplification in other regions resulted in no success. These three fragments together 
are still far beyond the full length human RPTPz (6948 bp in its coding sequence). 
 
Zebrafish rptpz expression pattern was next studied by in situ hybridizations as shown in Fig. 
21 using a probe with the zebrafish rptpz 888 bp N-part sequence. Other two probes using the 
C-parts sequences showed identical results (images not shown), further confirming that all of 
the three fragments are from the same gene transcript. The detected expression in zebrafish 
nervous system (Fig. 21) also indicated that this is the mammalian RPTPz ortholog in 
zebrafish. Three control probes using sense sequence of N, C1, and C2 parts resulted in no 
staining (images not shown). rptpz expression was found at 18 hpf (Fig. 21A). In the 
hindbrain, it started within the anterior four rhombomeres (r1-r4, Fig. 21B). In the trunk, it 
was expressed in the spinal cord, except floor plate (FP) and roof plate (RP), as well as in 
neural crest cells (NCC) (Fig. 21C,D). At 24 hpf, more rptpz expression domains were 
identified in the head, such as telecephalon (TC), fore-midbrain boundary (FMB), all seven 
rhombomeres (r1-r7), and otic vesicles (OV) (Fig. 21E,H,I). In the hindbrain, rptpz was found 




Fig. 21. Expression of zebrafish rptpz. 
(A) Lateral overview of rptpz expression in 18 hpf embryos. (B) Two color in situ 
hybridization with egr2b (red, markers r3 and r5) showed that rptpz expression at 18 hpf 
starts within the anterior four rhombomeres (r1-r4). (C) Dorsal view of trunk region of 18 hpf 
embryos. (D) Two color in situ hybridization with shh (red, in floor plate and notochord) in 
18 hpf embryos, level of cross section are indicated by a line in (A). Dashed circle demarcates 
the spinal cord. rptpz is expressed in the spinal cord except the floor plate (FP) and roof 
plate (RP), as well as in neural crest cells (NCC). (E)  Lateral overview of rptpz expression in 
24 hpf embryos. (F) Two color in situ hybridization with egr2b (red, markers r3 and r5) on 24 
hpf embryos, magnified dorsal view at hindbrain. rptpz expression is more prominent in the 
rhombomere centers than in the boundaries. (G) Two color in situ hybridization with shh 
(red, marks floor plate and notochord) on 24 hpf embryos, level of cross section indicated by 
a line in (E). rptpz is expressed in neurogenic regions in the hindbrain but not in regions rich 
in postmitotic neurons (asterisks). (H,I) Lateral view (H) and dorsal view (I) of 24 hpf 
embryos in head region. rptpz is strongly expressed in telecephalon (TC), fore-midbrain 
boundary (FMB), all seven rhombomeres (r1-r7), and otic vesicles (OV), but not in the mid-
hindbrain boundary (MHB). (J,K) Dorsal view of head region in 24 hpf embryos showing 
mdka (J) and mdkb (K) expression. (L) Dorsal view of head region rptpz expression in 48 hpf 
embryos. r1-7, rhombomere 1-7; NCC, neural crest cells; RP, roof plate; FP, floor plate; NC, 
notochord; TC, telecephalon; FMB, fore-midbrain boundary; MHB, mid-hindbrain boundary; 




posterior three rhombomeres (Fig. 21H,I). Interestingly, when its expression in the hindbrain 
was compared to those of zebrafish midkine-a (mdka) and midkine-b (mdkb), which encode 
possible antagonist of RPTPz but activators of ALK (Perez-Pinera et al., 2007), some overlap 
in the mosaic patterns was observed (Fig. 21J,K). At 48 hpf, rptpz expression was found to be 
reduced in the spinal cord (image not shown), but maintained at high levels in certain regions 
of the brain (Fig. 21L). 
 
In summary, zebrafish rptpz has a very dynamic, temporally as well as spatially restricted 
expression pattern in the developing nervous system, suggesting a possible regulatory role in 
neurogenesis. Interestingly, rptpz shows a higher expression in the central compartments than 
in the rhombomere boundaries (Fig. 21F), and its expression is excluded from the mid-
hindbrain boundary (MHB; Fig. 21H,I), roof plate and the floor plate (Fig. 21D), as well as 
basal regions in the hindbrain rich in postmitotic neurons (Fig. 21G). Boundary cells in 
vertebrate embryonic developing CNS, including zebrafish, are known as less neurogenic, 
slower in proliferation and do not give rise to neurons as frequently as progenitors within the 
compartments (Amoyel et al., 2004; Cheng et al., 2004; Kageyama et al., 2008). Similar 
features also apply to cells in the roof plate and the floor plate. The lack of rptpz expression in 
these regions in addition to its high expression levels in regions of neurogenic active suggests 
a possible link to neurogenesis. Noteworthy, alk is expressed more widespread than rptpz and 
it is tempting to speculate that zebrafish Rptpz as a putative Alk antagonist limits the 
activation of Alk to certain areas in the CNS, in a manner dependent of the presence of an 
activating ligand. Midkine growth factors have previously been implicated as ligands for 





3.5.2. An in vivo structure-function analysis of zebrafish Midkine proteins, the putative 
ligands for Alk  
Mammalian Midkines have been proposed as putative ligands for ALK and RPTPz in cell 
culture (Maeda et al., 1999; Stoica et al., 2002). Midkine is a heparin-binding growth factor 
which has a diversity of biological activities (reviewed by Muramatsu, 2002; Kadomatsu and 
Muramatsu, 2004). Zebrafish has two midkine genes, mdka and mdkb, as a result of teleost 
specific whole genome duplication (Winkler et al., 2003). With mostly non-overlapping 
expression patterns during embryogenesis, mdka and mdkb are both involved in zebrafish 
embryonic development (Schäfer et al., 2005; Liedtke and Winkler, 2008). Based on 
structural data provided by our collaborators, zebrafish Midkine wildtype proteins and mutant 
variants were expressed in Escherichia coli. Purified recombinant proteins (0.1 mM) were 
injected into embryos at the blastula stage in order to functionally validate conclusions made 
from structural analysis, as well as to investigate the consequence of overexpressing Midkines. 
(This part is as collaboration with Prof. Yang Daiwen’s laboratory. More detailed data can be 
found in Lim Jackwee’s Ph.D. thesis, National University of Singapore.) 
 
WT Mdka and Mdkb proteins resulted in clearly distinguishable morphological forebrain 
patterning defects (Fig. 22). At 24hpf, PBS injected control embryos were always normal 
(100 % ± 0.0 %, mean ± STDDEV, n=135). On the other hand, a majority of Mdka injected 
embryos exhibited cyclopia (85.3 % ± 16.2 %, n=192), evident as partial or complete fusion 
of both eyes (Fig. 22G,H). Mdkb injected embryos in contrast showed reduced eye size or 
complete loss of eyes on one or both sides of the embryo (95.3% ± 5.2 %, n=167). 
Importantly and different from Mdka injected embryos, the distance between the eye 
rudiments in Mdkb injected embryos remained unchanged (Fig. 22M,N). These 
morphological differences became more prominent at 4 days post fertilization (Fig. 22I,J,O,P). 
Interestingly, when human MDK was injected, zebrafish embryos exhibited a combination of 





To investigate the observed phenotypic defects in more detail, emx and mab21l2 expression 
domains were analyzed by in situ hybridization at 22 hpf. emx is a homeobox-containing gene 
expressed in the dorsal telencephalon of the forebrain (Fig. 22E,K,Q). Interestingly, emx 
expression levels remained unchanged in Mdka injected embryos, but the shape of the domain 
was slightly altered (41/42). In contrast, Mdkb injected embryos showed a clear reduction or 
almost complete absence of the emx expression domain (37/38). mab21l2, a marker expressed 
in the presumptive eye fields, exhibited a fusion of the normally separated eye primordia in 
Mdka injected embryos (34/44), while the mab21l2 domains were separated but often smaller 
in Mdkb injected embryos (35/38) (Fig. 22F,L,R). These data suggest that Mdka and Mdkb 
proteins have distinct activities during early steps of embryonic brain patterning, preceding 
neurogenesis, when overexpressed in embryos. 
 
NMR spectroscopy by our collaborators revealed both zebrafish Mdka or Mdkb protein 
structure as N- and C-half domains linked by a 7-residue hinge. We next tested whether their 
biological activities affecting embryonic patterning as observed above are due to their N- or 
C-half domains. N-halves and C-halves of Mdka and Mdkb were also injected into zebrafish 
 
Fig. 22. Distinct forebrain defects in zebrafish embryos upon midkine overexpression. 
PBS injection into zebrafish embryos at blastula stage had no effect on head development as 
evident by normal phenotype at 24 hpf (A,B) and 4 days post fertilization (dpf; C,D) and in 
situ hybridization using forebrain marker emx (E; dorsal telencephalon; *) and eye field 
marker mab21l2 (F; arrowhead; note that mab21l2 is also expressed in optic tectum). In 
contrast, Mdka injection resulted in cyclopia defects (G–L), while Mdkb injection lead to 
smaller yet separated eye fields or absence of eyes in injected embryos (M–R). 
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embryos. All injected embryos had normal morphology at 24 hpf, even at a higher dose (0.3 
mM, three times more). Furthermore, embryos simultaneously co-injected with individual 
Mdka N- and C-half domains showed normal phenotype, as did embryos co-injected with 
Mdkb N- and C-half domains. These data suggest that full length Midkine proteins are 
required to induce the forebrain and eye defects. In the next step, chimeric zebrafish NaCb 
and NbCa proteins were injected, which comprised of the N-half domain of Mdka combined 
with C-half domain of Mdkb (NaCb), as well as the vice versa orientation (NbCa). Unlike 
wild type midkine, these chimeric proteins always lead to much more complicated brain 
patterning defects, which were difficult to interpret on a morphological basis as “Mdka-like” 
or “Mdkb-like”. Therefore, emx expression was analyzed as a more informative marker. 
Surprisingly, reduced emx expression similar to Mdkb injected embryos, was detected in only 
33.3 % (13/39) of NaCb injected embryos and only 48.4 % (15/31) of the NbCa injected 
group. This suggests that both NaCb and NbCa variants may retain some partial activities of 
full length Mdkb, however, to a significantly reduced extent. Taken together, these data show 
that zebrafish Mdka and Mdkb function as individual units without interchangeable domains 
and require their unique N- and C-half domains to achieve full biological activity. 
 
The replacement of the charged hinge region linking N- and C-half domains with non-polar 
7xGly residues clearly abates heparin-binding in vitro without affecting protein folding 
(shown by our collaborators). In order to confirm this activity change in vivo, those polyG 
variants as well as their mRNAs were assessed on embryos. Embryos injected with MdkaG 
proteins exhibited cyclopia with a frequency and extent very similar to that observed with 
wild type Mdka (77.4% vs. 85.3%). In contrast, the number of embryos injected with MdkbG 
proteins displaying smaller eye size was strongly reduced when compared to embryos 
injected with wild type Mdkb (6.5% vs. 95.3%). To confirm this finding obtained by protein 
injection, capped mRNAs encoding the corresponding proteins were synthesized in vitro and 
injected into embryos at the early 1-2 cell stage. Consistent with the data obtained from 
protein, injection of mdkbG mRNA resulted in clearly lower frequencies of embryos with 
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reduced eye size, when compared to those injected with mdkb mRNA (22.1% vs. 85.3%). For 
mdkaG mRNA, a slight reduction was also noticed in the frequency of induced cyclopia when 
compared to mdka mRNA (57.7% vs. 87.2%). These data suggest that the conserved hinge 
region is essential for Mdkb in vivo activity, while it is dispensable for Mdka activity in 
inducing patterning defects upon overexpression. 
 
In summary, other than the situation for zebrafish Alk, overexpression of its putative ligands 
zebrafish Mdka, Mdkb, and their respective variants affected the earliest steps of embryonic 
patterning preceding neurogenesis. This opens the possibility that these early effects are 






This thesis is the first study reporting the isolation and functional characterization of zebrafish 
alk. It also represents the first comprehensive in vivo study of endogenous Alk function in a 
vertebrate animal model. It revealed that zebrafish alk is expressed in the developing nervous 
system and has several functions during early neurogenesis.  
 
4.1. Transgenic fish for ALK research 
In order to establish stable transgenic zebrafish lines expressing alk, embryos co-injected with 
constructs and I-SceI meganuclease were preselected after an initial heat shock. Only 
embryos having high levels of CFP signal were raised and screened as F0 candidates. In this 
study, a total of four alk:HSE:cfp lines were established from four independent F0 founders 
out of 28 candidates (14.3%). Similarly, three dnalk:HSE:cfp lines from three founders out of 
26 candidates (11.5%), and one HSE:cfp line from one founder out of 28 candidates (3.6%) 
were obtained. The rest of F0 candidates did not give rise to any positive F1 progeny when 
about 200 embryos were screened for each candidate. This indicated that no germ line 
transmission occurred, although transient expression was observed in F0 individuals. A 
transgene transmission frequency to F1 of up to 30.5% was reported in medaka (Thermes et 
al., 2002). It is unclear why the transgenic frequencies were lower in zebrafish in this study 
using the same I-SceI maganuclease approach.  
 
I observed a lower survival rate in the first month when raising the alk:HSE:cfp positive F0, 
F1 and F2 fish (approximately 20%), when compared to WT or HSE:cfp positive control fish 
(normally 50-80%). High levels of expression and distribution of the transgene are favourable 
for better germ line integration and high transgenic efficiency. However, in the case of alk, 
high expression levels or copy numbers severely compromised the survival of the larvae. The 
pattern of transgenic CFP expression was mosaic in F0, but ubiquitously found in all cells 
across the entire embryo in F1 and F2, suggesting the transgenes had been integrated into the 
genome (images not shown). 
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Table 4. Summary of transgenic lines. 
CFP intensity: * as weakest and ***** as strongest, under same heat shock conditions. 
The germ line transmission rate in F1 from a given F0 founder reflects the mosaicism of the 
F0 germline (transgenic insertion at one-cell stage = 50%; two-cells = 25%; four-cells = 
12.5%). This was reported to be nearly 50% in I-SceI meganuclease injected medaka 
(Thermes et al., 2002) and 10%-45% in zebrafish (Soroldoni et al., 2009). In the present work, 
the transmission rate when crossed with WT was between 11.5% and 26.2%, with an average 
of about 15% (Table 4). This indicates that in most of the transgenic F0 founders, integrations 
happened at the two- or four-cell stage. 
 
F0 F1 
 Gender CFP positive CFP intensity 
alk:HSE:cfp1 ♂ 23.1% (3/13) **** 
alk:HSE:cfp2 ♂ 18.3% (101/553) ***** and * 
alk:HSE:cfp3 ♂ 26.2% (68/260) ** 
alk:HSE:cfp4 ♀ 12% (38/316) *** 
dnalk:HSE:cfp1 ♂ 15.3% (98/641) *** 
dnalk:HSE:cfp2 ♀ 11.5% (18/156) ***** 
dnalk:HSE:cfp3 ♂ 20.9% (55/263) ** 
HSE:cfp ♂ 18.4% (116/629) **** 
  
Transgenic lines originating from different F0 founders also had different levels of transgenic 
CFP expression under the same heat shock treatment (Table 4). This variation is probably due 
to different genomic integration sites and different copy numbers of transgenic cassette in a 
tandem repeat (Thermes et al., 2002). Neither of transgenic integration positions nor copy 
numbers has been determined in this work. Of note, in the alk:HSE:cfp2 line, a proportion of 
F1 and F2 embryos  had very low levels of CFP expression, probably due to a different 
transgene integration site. Those embryos were discarded, considering as neither transgenic 
positive nor transgenic negative sibling both in line maintenance and in the functional studies 




In my heat shock transgenic system, alk is over-and mis-expressed in all cells. In future 
studies, locally restricted alk overexpression should be used to further refine alk function. 
This could be achieved by using a soldering iron or a laser-pointer optical microheater 
(Halloran et al., 2000; Hardy et al., 2007; Placinta et al., 2009) to induce local expression in 
these heat shock lines. However, such regionally restricted heat shock induction has been 
successful only in superficial tissues. Transgenic lines where alk overexpression is driven by 
tissue specific promoters could ideally solve this challenge. To achieve both spatial and 
temporal control of alk overexpression, more complicated and sophisticated transgenic 
systems should be used, such as the Cre/LoxP conditional transgenic system (Seok et al., 
2010; Mosimann et al, 2011), or the Gal4/UAS transactivation system (Scheer and Campos-
Ortega, 1999; Asakawa and Kawakami, 2008; Halpern et al., 2008).  
 
One study using tissue specific overexpression of ALK in transgenic fish was recently 
published by Zhu et al. (2012). In a zebrafish neuroblastoma model, human MYCN and 
ALKF1174L, one of the most frequent mutations in neuroblastoma patients, were overexpressed 
under a dopamine-β-hydroxylase gene (dβh) promoter in the peripheral sympathetic nervous 
system (PSNS). MYCN overexpressed sympathetic ganglia induced neuroblast hyperplasia 
and prevented their differentiation. Overexpressed ALKF1174L in these cells promoted cell 
survival, resulting in continued accumulation of neuroblasts and transformation of 
neuroblastoma. Human ALK was used in this study, which demonstrates that the molecular 
mechanisms underlying ALK-induced neuroblastoma formation might possibly be conserved 
between the fish model and the human situation. Therefore, the heat shock inducible alk 
overexpressing transgenic zebrafish lines established in this thesis could be promising tools 
also for human neuroblastoma research, for example for screening in pharmaceutical drugs. 
 
4.2. Evolution of alk in vertebrates 
Since I found that zebrafish Alk has a strikingly different N-terminus compared to human 
ALK, a more comprehensive sequence alignment and analysis was conducted (Table 5). This 
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included eight mammalian Alks, three bird Alks, six fish Alks and one invertebrate Alk-like 
protein. Their accession numbers in GenBank or Ensembl databases are listed in 2.3.4. 
Medaka fish (Oryzias latipes), another well studied model fish, was not included in this 
analysis. Its annotated “alk” gene (ENSORLT00000019324.1) is more likely to be the 
leukocyte tyrosine kinase (ltk) ortholog, and no other sequence with high sequence similarity 
was found in BLAST using zebrafish alk or human ALK as queries.  
 
All vertebrate Alks show an overall similar hydrophobic arrangement, with some differences 
from fruit fly Alk (Fig. 23). This indicates their common characteristic as transmembrane 
protein. As expected, all mammalian Alks showed higher similarity among each other when 
the complete sequence, or only the tyrosine kinase (TK) domain sequence was used (Table 5, 
alignments not shown). The same clustering was observed for Alk in birds and fish. However, 
the difference among these three groups was dramatically reduced when a TK domain 
alignment was performed (Table 5), suggesting that the variation resides in other parts of the 
protein. Indeed, further analysis among their N-termini showed a clear opposite trend, both 
the length and amino acid identity of its sequence (Table 5). This suggests that the TK domain 
and the N-terminus of Alk possibly experienced different levels of selection pressure during  
 
Fig. 23. Hydrophobic transmembrane structure predictions of Alk proteins in different 
species.  
(A-D) Predictions of transmembrane helices by TransMembrane prediction using Hidden 





Species Category Overall TK N-terminal part 

















mammal 1620 100% 268 100% 1029 100% 
mouse  
(Mus musculus) 
mammal 1621 86.4% 268 98.1% 1033 87.8% 
rat  
(Rattus norvegicus) 
mammal 1617 87.1% 268 98.1% 1033 88.9% 
cattle  
(Bos taurus) 
mammal 1621 88.8% 268 98.5% 1035 89.7% 
horse  
(Equus caballus) 
mammal 1623 92.3% 268 98.9% 1036 91.6% 
dog  
(Canis lupus familiaris) 
mammal 1631 90.6% 268 98.1% 1044 89.5% 
gray short-tailed opossum  
(Monodelphis domestica) 
mammal 1638 76.6% 268 96.3% 1049 71.6% 
dolphin  
(Tursiops truncatus) 





bird 1476 63.8% 268 95.5% 883 60.4% 
turkey  
(Meleagris gallopavo) 
bird 1403 63.2% 268 95.5% 810 58.6% 
zebra finch  
(Taeniopygia guttata) 
bird 1378 59.6% 268 96.3% 786 52.9% 
zebrafish  
(Danio rerio) 































ancient fish 978 
(incomplete) 
36.0% 268 64.9% 346 
(incomplete) 
39.7% 
fruit fly  
(Drosophila melanogaster) 
invertebrate 1701 25.4% 268 58.2% 1105 20.6% 
 
evolution. It is likely that all vertebrate Alks derived from a common ancient ancestor, 
probably an invertebrate Alk/Ltk-like protein similar to the fruit fly Alk. Little variations 
occurred in the intracellular parts possibly due to the critical importance of the tyrosine kinase 
signaling. However, their extracellular parts obviously did not experience such a restriction. 
This opens several possibilities: Given the significant divergence in the extracellular domains 
of various vertebrate Alks, it is possible that different ligands are bound by Alk in the various 
Table 5. Sequence similarities among 17 vertebrate Alks and fruit fly Alk.  
aa 1116-1383 in human ALK was defined as the tyrosine kinase (TK) domain, and aa 1-1029 
as the N-terminus. No N-terminal end and translation start site sequences are available from 
Fugu, tetraodon, stickleback, cod and coelacanth Alk. Dolphin Alk has a short unclear 
sequence in its TK domain. See 2.3.4. for sequence entries used for alignment. * The last 900 
aa in the human ALK N-terminus were used for alignment with bird Alk, and the last 600 aa 
were used for alignment with fish Alk, because the corresponding sequences in these two 
groups are shorter. 
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vertebrate species, with significant functional implications. Alternatively, it is possible that no 
ligand-receptor binding is required for the activation of Alk. The extracellular domain 
therefore lacks important biological function leading to the release from evolutionary 
selection pressure. Not many examples for similar scenarios exist in other transmembrane 
receptors, making Alk a unique example. 
  
In this case, Alk, other than similar RTKs, has no extracellular ligand. It instead might exert 
its biological function by interacting with partners through its transmembrane or intracellular 
parts. The truncated kinase-deficient zebrafish Alk variant used in my study unexpectedly did 
not act as a dominant-negative form, while similar variants of other RTK’s very efficiently 
block endogenous receptors by competing for their respective ligand. My observation that this 
is not the case for the truncated zebrafish Alk version could be interpreted that there is no 
competitive binding to a proposed Alk ligand in zebrafish. In fact, there is no study so far 
showing that similar truncated variants function in any other species by interfering with 
normal Alk function. The only exception is fruit fly Alk, where interestingly an Alk ligand 
(Jeb) has been identified (Lee et al., 2003). Together, these observations open the possibility 
that Alk has no extracellular ligand in vertebrates and that the proposed binding of Midkine to 
Alk, as observed in in vitro binding studies (Stoica et al., 2001 and 2002), requires alternative 
explanations. Interestingly, although Midkine is mostly considered as cell surface growth 
factor, an intracellular function for human Midkine has been reported (Shibata et al., 2002; 
Suzuki et al., 2004).  Human Midkine has been shown to be internalized by endocytosis and 
translocated to the nucleus. This is mediated by low-density lipoprotein receptor-related 
protein (LRP) and Nucleolin (Said et al., 2002; Shibata et al., 2002; Suzuki et al., 2004). This 
intracellular localization opens the theoretical possibility that Midkine interacts with Alk via 
its cytoplasmic domains explaining the reported in vitro binding results. However, this highly 
speculative scenario needs to be tested in future experiments. Alternatively and according to 
the indirect ALK activation model proposed earlier, ALK does not bind an extracellular 
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ligand but is regulated by RPTPz dephosphorylation of its intracellular part (Perez-Pinera et 
al., 2007). According to this model, it is RPTPz and not Alk, which is bound by Midkine. 
 
In another hypothesis, the N-terminus of Alk could bind to a complex involving multiple 
ligands and that extracellular Alk domain and these ligands have undergone co-evolution. 
Thereby, the N-terminus of the receptor accumulated changes faster than its TK domain, and 
eventually diverged in different directions along various branches of vertebrate evolution. As 
a matter of fact, teleost fishes are known to have more divergent genes than mammals, as a 
result of a fish specific whole genome duplication (Meyer and Schartl, 1999; Venkatesh 2003; 
Hoegg et al., 2004; Jaillon et al., 2004; Volff 2005). One example for rapid evolution of 
divergent genes is the Hox gene cluster (Crow et al., 2006). Functional divergence has also 
been described for the two midkine paralogs in zebrafish, mdka and mdkb (Winkler et al., 
2003). One piece of evidence supporting the hypothesis of rapid divergent evolution of 
receptor-ligand interaction is the fruit fly Jeb-Alk model. Jeb so far is the only confirmed 
ligand of Alk in all animals studied by physiological and genetic evidence. Loss-of-function 
mutations of either ligand or receptor phenocopy each other. Fly Alk may represent a far-
related ortholog of vertebrate Alk/Ltk. However, Jeb has no similarity with mammalian Mdk 
or Ptn, and Jeb was demonstrated to be unable to activate mouse Alk (Yang et al., 2007). On 
the other hand, Miple1 and Miple2 are the fly orthologs of Mdk/Ptn. It is unclear yet if 
Miple1/2 interacts with fly Alk (Englund et al., 2006; Toledano-Katchalski et al., 2007). One 
earlier report stated that a “Jeb-like” protein has not been found yet in vertebrates (Palmer et 
al., 2009). In my hypothesis, I propose that Jeb is used in invertebrates as an Alk ligand, while 
Mdk/Ptn is used in mammals, directly or indirectly. Despite different ways of activating Alk 
signaling, the intracellular function of Alk remains similar. Therefore, similar scenarios could 
also happen in birds and fishes, resulting in novel strategies of Alk activation, possibly by 




A third hypothesis about the origin of fish alk is inspired from the study of the zebrafish 
shady mutant, which carries mutations in the gene for leukocyte tyrosine kinase (ltk), the most 
closely related receptor tyrosine kinase gene to alk in vertebrates (Lopes et al., 2008). Also 
zebrafish Ltk is so far considered an orphan receptor. It has a long N-terminus interestingly 
with more features related to mammalian Alk than to mammalian Ltk. Zebrafish Ltk has two 
MAM domains as well as the LDLa motif. In contrast, the zebrafish Alk N-terminus is shorter 
with only one MAM domain. Strikingly, also mammalian Ltk is very short without any of 
these mammalian Alk extracellular domains. This suggests that as decedents from a common 
ancestor, Ltk and Alk evolved their N-termini differently in mammals and in teleosts. As a 
consequence, mammalian Ltk lost some of the fish specific Ltk functions, such as for 
iridophore development (Lopes et al., 2008), a fish-specific pigment cell type. Likewise, 
teleost Alk lost some of the functional features present in mammalian Alk. In human cancers, 
the ALK kinase domain is often found to be fused with other gene products by genetic 
rearrangement. This happens at high frequency and with a variety of fusing partners, 
suggesting a possible rearrangement “hot spot” in the genome regions located between ALK 
extracellular and intracellular parts. Therefore, it is tempting to speculate that after 
duplication of a common Alk/Ltk ancestor some degree of genetic shuffling occurred between 
functional domains of Ltk and Alk, without any significant harmful consequence during 
mammalian and teleost evolution.  
 
Interestingly, a partial alk sequence is available in the Ensembl database for coelacanth 
(Latimeria chalumnae). Coelacanth is a “living fossil” fish thought to be extinct but 
rediscovered recently. This species is extremely interesting as it represents an ancient status 
of the vertebrate genome (Noonan et al., 2004; Smith et al., 2012), for instance when HOX 
genes are analyzed (Amemiya et al., 2010). Based on this partial Alk sequence, which lacks 
the most N-terminal end, the coelacanth Alk TK domain shows a clear difference from all 
other vertebrate sequences, with only 64.9% identity to the human ortholog. In all other 
vertebrates, even in fishes, the TK domain has a minimum of 88.4% identity to human (Table 
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5). In a dramatic contrast, the available 346 aa of the coelacanth Alk N-terminus is more 
similar to mammalian Alk (69.0% aa identity to human) or bird (70.7% to chicken), other 
than to fish Alk (50.0% aa identity to zebrafish). Although this region (mostly the G-rich 
domain close to the transmembrane domain) is not the most divergent part of the Alk N-
terminus (50.1% identity between zebrafish and human), there are several regions in the 
alignment (not shown) that suggest that coelacanth Alk is more closely related to Alk of birds 
and mammals than to Alk of other fishes. Similarly, in the first transmembrane helix region 
(human 1031-1058 aa), the coelacanth Alk sequence is 78.6% identical to human and 82.1% 
to chicken, but only 60.7% to zebrafish. Again, this is a region where mammalian and bird 
Alks are almost identical, but other fishes have their consensus sequence. In summary, the 
available coelacanth N-terminal sequence surprisingly looks more similar to that of birds and 
mammals, and neither appears as a far-related ancestor, in contrast to its TK domain sequence, 
nor being clustered together with other fish sequences. In other words, some parts of 
coelacanth Alk are more like those of mammals and birds than its TK domain. In contrast, 
teleost fish Alks show the opposite trend: the TK domain is more highly conserved with that 
of mammals and birds, while the N-terminus is more divergent. This sharp contrast opens the 
possibility, in line with my third hypothesis, that the intracellular, N-terminal and 
transmembrane sequences of teleost Alk originated from different genetic modules existing in 
the genomes of invertebrates or ancient fish ancestors. I propose that these ‘modules’ have 
been assembled together to result in a teleost-specific Alk found in modern fishes. However, 
this clearly remains highly speculative as this hypothesis is purely based on an incomplete 
coelacanth alk sequence. 
 
In summary, I propose three different hypotheses regarding the evolutionary origin of teleost 
alk and the mechanisms that lead to Alk receptor activation. 1.) The “no ligand” hypothesis: 
According to this model, Alk function is independent from its extracellular part. Alk activity 
is thus regulated by interaction of partners with its intracellular part. 2.) The ligand/receptor 
“co-evolution” hypothesis: The Alk extracellular domain co-evolved with one or multiple 
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ligands in the different branches of vertebrate evolution. This is supported by observations 
with invertebrate Jeb-Alk signaling, together with known scenarios of gene duplication and 
divergence in vertebrates. 3.) The “module swapping” hypothesis: According to this model, 
teleost alk is the product of assembling intracellular and extracellular domains together form 
different ancestral Alk/Ltk modules. Evidence for this comes from the different relationships 
between alk and ltk in fish and mammals, and the observations made in coelacanth alk.  
 
4.3. Conservation of Alk expression in the vertebrate developing nervous system 
In mouse, Alk is prominently expressed in the diencephalon (ventral forebrain), surrounding 
the fourth ventricle neuroepithelium (hindbrain region), the ventricular and subventricular 
zone of the cortex, and the midbrain from day 10.5 to day 16.5 (Vernersson et al., 2006). I 
could show that zebrafish alk is expressed in most of the central nervous system (CNS) 
regions similar to the situation in mouse Alk as described above. However, in mouse and 
chick Alk expression is detected in the spinal cord (Hurley et al., 2006; Vernersson et al., 
2006). In contrast, in my studies, zebrafish alk could not be detected in the spinal cord, 
especially after 24 hpf. This could be due to different detection sensitivities under the 
experimental conditions used. Alternatively, some variation in the expression pattern could 
exist among different vertebrates. 
 
Mouse, rat, and chick Alk are also expressed in peripheral nervous system (PNS) components 
such as the trigeminal ganglia, facial ganglia, vestibulocochlear ganglia, inferior ganglia of 
the vagus nerve, as well as dorsal root ganglia and sympathetic ganglia (Hurley et al., 2006; 
Vernersson et al., 2006; Degoutin et al., 2009). Zebrafish alk expression or function in the 
PNS and other tissues was not analyzed in this study. In other tissues, mouse Alk expression is 
also found in eyes, nasal epithelium, olfactory nerve, tongue, skin, stomach, midgut, as well 
as testis and ovary (Vernersson et al., 2006). This is consistent with my findings in zebrafish, 




The significant sequence divergence in the Alk N-terminus in various vertebrate species 
suggests that different ligands or no ligand at all may be used in Alk activation. On the other 
hand, the spatiotemporal expression pattern of Alk in the CNS during embryonic development 
is highly conserved in mouse (Vernersson et al., 2006), chick (Hurley et al., 2006), and 
zebrafish (this study). This suggests that the activity and function of the highly related Alk 
tyrosine kinase domain is conserved in neurogenesis of various vertebrates. 
 
4.4. Zebrafish alk has multiple functions during embryonic neurogenesis  
4.4.1. alk and cell proliferation in the nervous system 
It is known that receptor protein tyrosine kinases (RTKs) undergo spontaneous dimerization, 
transphosphorylation of monomers, and activation, when its counteracting protein tyrosine 
phosphatase (PTP) is not present. This process is dramatically promoted and stabilized by the 
presence of RTK ligands (reviewed by Weiss and Schlessinger, 1998; Schlessinger, 2000). In 
my heat shock induced alk overexpression experiments, overexpressed Alk proteins may 
increase its monomer concentration on the cell membrane, and drive the equilibrium towards 
spontaneously formed active dimers, resulting in RTK activation. Such autophosphorylation 
of ALK in absence of any ligand was also reported in cell culture (Perez-Pinera et al., 2007). 
The observed ectopic activation of the MAPK signaling pathway further confirmed that the 
overexpressed Alk proteins were functional and activated. Overexpression of alk in these 
transgenic lines resulted in elevated cell proliferation with increased numbers of dividing cells 
in M-phase and up-regulation of ccnd1 expression. Furthermore, I observed the loss of the 
normal neurogenesis pattern with formation of mis-located differentiated neurons. These 
defects appear to be the consequences of ectopic MAPK activation as evident by elevated 
ERK1/2 phosporylation.  
 
Triggering alk overexpression at a late stage lead to similar defects but with less severity. It 
did not affect the entire embryo but rather caused defects in a more locally restricted fashion. 
At least two possibilities could explain this: 1.) Negative regulators of Alk could be present 
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after 24 hpf in zebrafish and could have limited the effects of late expressed alk. Consistent 
with this idea, zebrafish rptpz expression is up-regulated in the CNS after 24 hpf. The 
spontaneous dimerization and transphosphorylation of RTKs is efficiently inhibited by 
dephosphorylation through protein tyrosine phosphatases (PTPs; reviewed by Weiss and 
Schlessinger, 1998). This also applies to ALK by RPTPz as reported (Perez-Pinera et al., 
2007). The constitutive activation of human oncogenic NPM-ALK is believed to occur by the 
NPM part stabilized spontaneous dimerization (reviewed by Chiarle et al., 2008). In my 
overexpression experiments, unlike the mutated NPM-ALK version, overexpressed non-
mutated zebrafish Alk might still be regulated at the protein level. 2.) Alternatively, it is 
possible that alk overexpression is not sufficient to trigger proliferation by itself but requires 
co-factors that are not available at later stages. It could increase the susceptibility for 
proliferation in early embryos when such postulated co-factors are present. More recent 
studies claim that overexpression of mutated ALK work cooperatively with MYCN 
overexpression, another human neuroblastoma related gene, to promote neuroblastoma with 
higher severity (Berry et al., 2012; Zhu et al., 2012). Interestingly, and consistent with this 
second hypothesis, zebrafish nmyc1, the ortholog of human MYCN, is expressed ubiquitously 
at high levels in the CNS before 24 hpf, but becomes restricted thereafter (Loeb-Hennard et 
al., 2005).      
 
Conversely, knock-down of alk by MO injections had no effect on cell proliferation in the 
hindbrain at 24 hpf. Only the hindbrain was quantitatively examined in the present study due 
to its relatively simple organization and the presence of morphological landmarks such as the 
otic vesicles. However, any conclusions regarding proliferation in other regions of the CNS of 
alk morphants and at different developmental stages still need to be confirmed. Interestingly 
and in contrast to the findings described here, decreased cell proliferation has often been 
reported in cancer cell cultures where ALK has been knocked-down by siRNA, as well as in a 
recent report on endogenous chicken Alk (Reiff et al., 2011). This recent report used chicken 
sympathetic neuron cultures derived from sympathetic ganglia (a part of the PNS). 
105 
 
Importantly, unlike in cultured cells, proliferation in the embryo might be regulated in a more 
complicated manner, for example involving its neighboring tissues. Alternatively, functional 
redundancy by other kinases may also explain the unchanged proliferation rates in alk knock-
down embryos. 
 
4.4.2. alk and cell survival in the CNS 
In alk deficient situations, repeated by MO knock-down or a small molecule inhibitor, 
increased apoptosis and reduced proneural gene expression were observed coincidently. Since 
the progenitor marker expression was unchanged and also cell proliferation was not affect in 
hindbrain, this indicates that progenitor cells are not impaired in alk deficiency and that the 
observed increase in apoptosis does not originate from these progenitors. On the other hand, 
reduced proneural gene expression in differentiating neuronal precursors suggests defects in 
differentiation eventually leading to cell death. This could explain the identity of the apoptotic 
cells. 
 
There are several possibilities about how alk deficiency affects cell survival. It remains 
unclear whether 1.) differentiating neural cells die because alk is directly required for their 
survival. Alk could function as a repressor for cell death, and thus reduced proneural gene 
expression could reflect a reduction in differentiating cell numbers; 2.). alk alternatively could 
be required to promote proneural gene expression. Thus, cells that no longer possess 
progenitor identity fail to differentiate and undergo apoptosis; or 3.) a combination of both 
possibilities is true. There are reports showing that proneural genes are also often required for 
cell survival during the process of neuronal differentiation (Tomita et al., 2000; Pogoda et al., 
2006; Yi et al., 2008).  
 
The pathways that mediate Alk downstream intracellular signaling during cell survival in 
zebrafish early neurogenesis might be different from MAPK. MAPK activation, evident as 
ERK1/2 phosporylation, was not detected in WT embryos at 24 hpf in the entire neural tube, 
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but rather in a few cells in the developing brain and laterally localized single cells in the 
spinal cord. Other signaling such as through the PI3K-Akt and STAT3 pathways, which are 
also often altered in ALK-related cancers, were not investigated in this study. These might be 
responsible for Alk-mediated cell survival in the developing CNS. 
 
In both alk ATG-MO and Spl-MO injected groups, the number of differentiated neurons was 
reduced to 54.7% and 50.3% in the hindbrain when compared to WT, respectively. This was 
shown using the pan-neuronal marker HuC/D. In particular neuron types, such as GABAergic 
interneurons in the hindbrain labeled by a GABA antibody, alk ATG-MO and Spl-MO 
injected embryos showed a reduction to 63.4% and 57.0%, respectively. This similar extent of 
reduction suggests that alk deficiency affects overall neuron survival in a more general 
fashion rather than impairing differentiation of a specific neuron type.  
 
I also tried to perform a rescue experiment to recover the compromised proneural gene 
expression in alk morphants by overexpression of alk. Since alk overexpression at early 
developmental stages leads to severe proliferation defects, the following rescue strategy was 
designed: alk Spl-MO was injected into the alk:HSE:cfp line. Overexpression of alk was then 
triggered by heat shock at 22 hpf. Exogenous cDNA derived alk transcripts are not blocked 
by Spl-MO that only target endogenous non-spliced alk pre-mRNA. Embryos were 
investigated at 31 hpf for neurod4 and ascl1b expression, and transgenic positive embryos 
were identified to determine whether reduced proneural gene expression was partially 
restored to WT levels. In the transgenic negative siblings, neurod4 and ascl1b expressions 
were reduced as expected (Fig. 24B,E), when compared to WT embryos (Fig. 24A,D). 
However, in transgenic positive embryos, in which alk was first knocked-down and then 
overexpressed at 22 hpf, expression of neurod4 and ascl1b was reduced even more, in 
contrast to what was expected (Fig. 24C,F). Thus, there was no rescue and instead even more 
severe impairment in proneural gene expression was observed. This unexpected finding can 
be explained as follows: In alk morphants, the number of differentiating neuronal precursors 
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before 22 hpf was reduced as a consequence of alk deficiency. After overexpression of alk at 
22 hpf, the remaining precursors, re-entered the proliferative cell cycle with the consequence 
that no new differentiating precursors were generated. Thus, all cells became progenitor-like 
and continued with proliferation. In contrast, in in alk morphants without overexpression of 
alk, there were always some newly born differentiating precursors that have not re-entered the 
cell cycle and also have not entered apoptosis yet, resulting in the observed proneural gene 
expression. The used heat shock method is suitable for triggering expression of a transgene at 
a particular time point, but it is difficult to adjust its expression level in a specific cell type. 
The further reduced proneural gene expression in alk:HSE:cfp transgenic embryos also 
suggests that the reduced proneural expression observed in alk morphants reflects the 
presence of less numbers of surviving cells, rather than a direct transcriptional regulation of 
proneural genes by alk. This experiment points out dual function of alk in control of cell 
proliferation and cell survival, which are tightly connected. Adequate alk expression levels 
are critical for cell fate decisions, proliferation, differentiation and survival of neurons during 
zebrafish embryogenesis.   
 
 
Fig. 24. Overexpression of alk in the alk:HSE:cfp  line fails to rescue alk deficiency. 
WT embryos (A,D) were not injected with MO. r1-r7, rhomomere 1-7. Embryos from the 
alk:HSE:cfp line (B,C,E,F) were all injected with alk Spl-MO. A heat shock was given at 22 hpf 
to overexpress alk. 31 hpf embryos were investigated by in situ hybridization for neurod4 
expressions in WT (A), in transgenic negative siblings (B) and transgene positive embryos (C), 
and for ascl1b expressions in WT (D), in transgenic negative siblings (E) and transgene 
positive embryos (F). Embryos in all images are shown as dorsal views with anterior to the 




4.5. Possible interactions between Alk, Mdk/Ptn and RPTPz in zebrafish 
This study revealed possible alk functions in the control of cell proliferation and survival in 
zebrafish. When ectopically overexpressed, alk promotes over-proliferation across the entire 
neural tube, and induces pandemic cell death in the brain when knocked-down. In contrast, 
the potential ligands for Alk, encoded by the two midkine paralogs in zebrafish, mdka and 
mdkb, have distinct roles in neural development. Endogenous mdka controls medial floor 
plate formation in the developing spinal cord (Schafer et al., 2005), while mdkb is required for 
the formation of sensory neurons and neural crest cells (Winkler and Moon, 2001; Liedtke 
and Winkler, 2008). Based on this observation, zebrafish mdka/mdkb and alk do not 
necessarily appear as a straightforward ligand-receptor pair, in which one could phenocopy 
the loss-of-function by knocking-down the respective partner, similar to what observed in the 
fruit fly Jeb-Alk mutants (Loren et al., 2003; Englund et al., 2003; Lee et al., 2003). Unlike 
the situation in alk overexpression, when zebrafish Mdka or Mdkb are overexpressed, they 
lead to clearly distinct forebrain patterning defects, cyclopia versus loss of telencephalon with 
eyes, respectively (this study). These Midkine-induced developmental defects affect the 
earliest steps of embryonic patterning during gastrulation and clearly precede neurogenesis. 
Although these patterning defects could be interpreted as locally disturbed cell proliferation 
and survival, it is unlikely that they are mediated through Alk activation. Some local 
interactions between Midkines and Alk in zebrafish development might still exist, but it is 
very likely that zebrafish Midkines use receptors other than Alk.  
 
In fact, the relationship between mammalian Midkine/Pleiotrophin and Alk is also 
questionable. Knock-out mice lacking either Midkine or Pleiotrophin have no obvious early 
neural phenotype (Nakamura et al., 1998; Amet et al., 2001), which could be explained by 
functional redundancy, and double knock-out mice are early embryonic lethal (Muramatsu, 
2002). However, Alk knock-out mice are viable and fertile with normal appearance (Bilsland 
et al., 2008). This suggests that Midkine/Pleiotrophin in mammals have at least some 
functions that do not involve Alk, and vice versa, Alk might have other ligands or interaction 
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partners as well. Alternatively, it is also possible that a related RTK in mice is functionally 
redundant to Alk explaining the absence of a phenotype in the knock-out mice. 
 
Zebrafish alk is broadly expressed in the early developing CNS. In contrast, mdka and mdkb 
have distinct expression patterns. Noteworthy, also rptpz has a dynamic and highly restricted 
pattern. The proposed indirect activation model proposed by studies in human cell culture 
(Fig. 1; Perez-Pinera et al., 2007) involves all three components (Alk, RPTPz, Mdk) and this 
situation might even be more complicated in zebrafish with the presence of duplicated 
paralogs. It is tempting to speculate that such an indirect activation strategy is adopted by a 
fast developing embryo. Here, a central signaling effector (Alk) is pre-deposited in all cells, 
and the activity of a regulator/antagonist (Rptpz) is modulated by ligands (Mdk) when cells 
enter a different status. In such a way, some activities (e.g. cell survival) are maintained in all 
cells, but more specific functions (e.g. proliferation) could be quickly accomplished upon 
activation by growth factors once a cell needs to do so.  
 
In the future, it will be interesting to test the level of Alk phosphorylation in regions where it 
is co-expressed with Rptpz and Mdk, to gain insights about their physiological interactions 
with Alk in development. Several antibodies against human ALK or phospho-ALK were 
tested in this study, but unfortunately did not cross-react with proteins in zebrafish (data not 
shown). Thus, future studies require the generation of zebrafish specific antibodies detecting 
Alk and its interactions partners. It is still unclear whether zebrafish Midkines are indeed 
ligands for Alk, or any unidentified fish specific Alk ligand(s) activates its receptor signaling. 
Biochemistry methods such as pull-down assays would help solving this in the future. 
Another direction worth further investigation is the downstream intracellular substrates upon 
Alk activation. Although my current data suggest that MAPK signaling pathway plays a role 
in Alk promoted cell proliferation, its exact mechanism remains unknown till those Alk 
substrates would be identified. Furthermore, the nature of those protrusions developed on 
embryos has not been clearly defined, when Alk is overexpressed either by mRNA injection 
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or in the heat shock induced transgenic. Tumor markers could be studied, and xenograft 
transplantation could be conducted to test whether those cells could develop into tumors in 
wild type embryos. To further support the role that overexpressed alk plays in elevated 
proliferation and MAPK signaling, small molecule Alk inhibitors could be given in rescue 
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